[
  {
    "title": "Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now",
    "url": "https://www.zacks.com/stock/news/2204570/heres-why-you-should-retain-medtronic-mdt-stock-for-now",
    "time_published": "20240102T171000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995869"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.23334,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.04823",
        "ticker_sentiment_score": "0.097986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.04823",
        "ticker_sentiment_score": "0.097986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.04823",
        "ticker_sentiment_score": "0.097986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.143987",
        "ticker_sentiment_score": "0.055556",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.494156",
        "ticker_sentiment_score": "0.273372",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.237668",
        "ticker_sentiment_score": "0.164475",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.19117",
        "ticker_sentiment_score": "0.106025",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "FluidForm Bio\u2122 Welcomes New Executive Leadership",
    "url": "https://www.prnewswire.com/news-releases/fluidform-bio-welcomes-new-executive-leadership-302025374.html",
    "time_published": "20240103T160700",
    "authors": [
      "FluidForm Bio"
    ],
    "summary": "WALTHAM, Mass., Jan. 3, 2024 /PRNewswire/ -- FluidForm Bio\u2122 announced that it has named Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations.",
    "banner_image": "https://mma.prnewswire.com/media/2296645/FFB_1500x188_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.33605,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.07446",
        "ticker_sentiment_score": "0.06999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.07446",
        "ticker_sentiment_score": "0.06999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RPID",
        "relevance_score": "0.07446",
        "ticker_sentiment_score": "0.06999",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Dr. Stephen Oesterle and Dr. Joshua Makower Join Patient Square Capital as Senior Advisors",
    "url": "https://www.prnewswire.com/news-releases/dr-stephen-oesterle-and-dr-joshua-makower-join-patient-square-capital-as-senior-advisors-302026505.html",
    "time_published": "20240104T162800",
    "authors": [
      "Patient Square Capital"
    ],
    "summary": "MENLO PARK, Calif., Jan. 4, 2024 /PRNewswire/ -- , a leading health care investment firm, today announced that Dr. Joshua Makower and Dr. Stephen Oesterle joined as Senior Advisors to the firm.",
    "banner_image": "https://mma.prnewswire.com/media/1229017/Patient_Square_Capital_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.42824,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "FNA",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.014915",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.014915",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEJMF",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.014915",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.159569",
        "ticker_sentiment_score": "0.065729",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.027855",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Ozempic and other weight-loss drugs' popularity set these stocks up for big gains",
    "url": "https://www.marketwatch.com/story/ozempic-and-other-weight-loss-drugs-popularity-set-these-stocks-up-for-big-gains-fa2a3f33",
    "time_published": "20240104T121000",
    "authors": [
      "Michael Brush"
    ],
    "summary": "Gut-punch to medical technology and processed-food stocks is temporary.",
    "banner_image": "https://images.mktw.net/im-806705/social",
    "source": "MarketWatch",
    "category_within_source": "Top Stories",
    "source_domain": "www.marketwatch.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": -0.053067,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "SMPL",
        "relevance_score": "0.089019",
        "ticker_sentiment_score": "0.03816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDLZ",
        "relevance_score": "0.1185",
        "ticker_sentiment_score": "-0.034339",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.1185",
        "ticker_sentiment_score": "-0.020159",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.089019",
        "ticker_sentiment_score": "0.002098",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.1185",
        "ticker_sentiment_score": "0.085125",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "POST",
        "relevance_score": "0.059415",
        "ticker_sentiment_score": "0.052029",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KLG",
        "relevance_score": "0.059415",
        "ticker_sentiment_score": "0.052029",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.176933",
        "ticker_sentiment_score": "0.02006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UTZ",
        "relevance_score": "0.176933",
        "ticker_sentiment_score": "-0.043394",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "-0.009016",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRBR",
        "relevance_score": "0.059415",
        "ticker_sentiment_score": "0.070995",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSY",
        "relevance_score": "0.059415",
        "ticker_sentiment_score": "-0.201029",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Medtronic and Cardiac Design Labs collaborate to launch heart rhythm monitoring technology in India",
    "url": "https://www.financialexpress.com/healthcare/healthtech/medtronic-and-cardiac-design-labs-collaborate-to-launch-heart-rhythm-monitoring-technology-in-india/3355537/",
    "time_published": "20240104T114421",
    "authors": [
      "Health Desk"
    ],
    "summary": "India Medtronic Private Limited on Thursday announced a strategic collaboration with Cardiac Design Labs ( CDL ) to launch, scale up, and expand access to CDL's novel diagnostic technology, Padma Rhythms, an external loop recorder ( ELR ) patch designed for comprehensive, long-term heart ...",
    "banner_image": "https://www.financialexpress.com/wp-content/uploads/2024/01/Michael-Blackwell-Anand-Madanagopal.jpg",
    "source": "The Financial Express",
    "category_within_source": "n/a",
    "source_domain": "www.financialexpress.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.299398,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.321393",
        "ticker_sentiment_score": "0.302616",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Endoscopy Ultrasound Market to reach USD 1.8 billion and thriving at a CAGR of 5.6% by 2031: TMR Report",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36485832/endoscopy-ultrasound-market-to-reach-usd-1-8-billion-and-thriving-at-a-cagr-of-5-6-by-2031-tmr-rep",
    "time_published": "20240104T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global endoscopy ultrasound market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.386347,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.035714",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HTHIF",
        "relevance_score": "0.035714",
        "ticker_sentiment_score": "0.049299",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.035714",
        "ticker_sentiment_score": "0.371208",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.035714",
        "ticker_sentiment_score": "0.143571",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.071357",
        "ticker_sentiment_score": "0.263165",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.035714",
        "ticker_sentiment_score": "0.143571",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.106857",
        "ticker_sentiment_score": "0.083868",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference",
    "url": "https://www.cnbc.com/2024/01/05/cramers-week-ahead-follow-ceos-at-the-jpmorgan-healthcare-conference.html",
    "time_published": "20240105T234443",
    "authors": [
      "Julie Coleman"
    ],
    "summary": "CNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107113453-NUP_198430_00764r.jpg?v=1693609111&w=1920&h=1080",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.113066,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.032558",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.034838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "-0.092027",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.035171",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.032558",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.032558",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JPM",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.07328",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.034838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.0175",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.034838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.08183",
        "ticker_sentiment_score": "0.032558",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Surpasses Market Returns: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2206588/medtronic-mdt-surpasses-market-returns-some-facts-worth-knowing",
    "time_published": "20240105T225016",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $84.57, signifying a +0.76% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default18.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.218137,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.638317",
        "ticker_sentiment_score": "0.356956",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Advanced Wound Care Market size to grow by USD 4.02 billion from 2022 to 2027, North America to account for 41 ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/advanced-wound-care-market-size-to-grow-by-usd-4-02-billion-from-2022-to-2027--north-america-to-account-for-41-of-market-growth--technavio-302026301.html",
    "time_published": "20240105T190000",
    "authors": [],
    "summary": "Advanced Wound Care Market size to grow by USD 4.02 billion from 2022 to 2027, North America to account for 41 ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.23657,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ETTYF",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.130217",
        "ticker_sentiment_score": "0.051279",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLPBY",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ORGO",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNVVF",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ANIK",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IART",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VCEL",
        "relevance_score": "0.065327",
        "ticker_sentiment_score": "0.068069",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Generative AI Reshapes Healthcare: 3 Stocks in Limelight",
    "url": "https://www.zacks.com/stock/news/2206515/generative-ai-reshapes-healthcare-3-stocks-in-limelight",
    "time_published": "20240105T175300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f0/33677.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.714479"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.437709,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LNVGF",
        "relevance_score": "0.035397",
        "ticker_sentiment_score": "0.160915",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.269228",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.14788",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.140896",
        "ticker_sentiment_score": "0.33108",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.105914",
        "ticker_sentiment_score": "0.234799",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Urinary Catheters Market size to grow by USD 2.44 billion from 2023 to 2028| Growing demand for antimicrobial-coated urinary catheters to drive the market growth - Technavio",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36520388/urinary-catheters-market-size-to-grow-by-usd-2-44-billion-from-2023-to-2028-growing-demand-for-ant",
    "time_published": "20240106T001200",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 05, 2024 ( GLOBE NEWSWIRE ) -- The Urinary Catheters Market size is projected to increase by USD 2.44 billion between 2023 and 2028, and register a CAGR of 7.63%, according to Technavio's latest market research report estimates.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.248523,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BSX",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLPBY",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNVVF",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.093551",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "What's Going On With Medtronic Stock? - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/24/01/36544260/whats-going-on-with-medtronic-stock",
    "time_published": "20240108T205438",
    "authors": [
      "Ryan Gustafson"
    ],
    "summary": "Medtronic plc. MDT shares are trading higher on Monday. The company announced a few new developments amid the stock's continued uptrend. What To Know: Medtronic stock has trended higher since November, a move which was headed by gains following better-than-expected second-quarter results and ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/stethoscope-840125_1280.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.362267,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.880186",
        "ticker_sentiment_score": "0.636351",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "FDA approves Medtronic Percept\u2122 RC neurostimulator with exclusive BrainSense\u2122 technology",
    "url": "https://www.prnewswire.com/news-releases/fda-approves-medtronic-percept-rc-neurostimulator-with-exclusive-brainsense-technology-302028785.html",
    "time_published": "20240108T173800",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Rechargeable neurostimulator joins the Medtronic Percept\u2122 family - the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc ( NYSE:MDT ) , a global leader in healthcare technology, today announced ...",
    "banner_image": "https://mma.prnewswire.com/media/2312298/Medtronic_Percept_RC_Animation.mp4?p=medium",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.164113,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.473427",
        "ticker_sentiment_score": "0.292005",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "-0.038006",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wearable Technology Market Gains Ground, 3 Stocks in Focus",
    "url": "https://www.zacks.com/stock/news/2206848/wearable-technology-market-gains-ground-3-stocks-in-focus",
    "time_published": "20240108T134500",
    "authors": [
      "Moumi Mondal"
    ],
    "summary": "In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/18/20877.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.344721,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GLDAF",
        "relevance_score": "0.043264",
        "ticker_sentiment_score": "0.201312",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.2138",
        "ticker_sentiment_score": "0.303235",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.295867",
        "ticker_sentiment_score": "0.377378",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.374624",
        "ticker_sentiment_score": "0.423993",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Respiratory Devices Market Size to be Worth USD 37.7 billion by 2031, with Notable CAGR of 6.1%| Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36533244/respiratory-devices-market-size-to-be-worth-usd-37-7-billion-by-2031-with-notable-cagr-of-6-1-tran",
    "time_published": "20240108T134448",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global respiratory devices market is estimated to flourish at a CAGR of 6.1% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.43698,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGWPF",
        "relevance_score": "0.097721",
        "ticker_sentiment_score": "0.314085",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.065238",
        "ticker_sentiment_score": "0.216571",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.065238",
        "ticker_sentiment_score": "0.195697",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.16471",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SMGKF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.097721",
        "ticker_sentiment_score": "0.070614",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.097721",
        "ticker_sentiment_score": "0.344995",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Casey's General Stores and Westlake have been highlighted as Zacks Bull and Bear of the Day",
    "url": "https://www.zacks.com/stock/news/2206839/caseys-general-stores-and-westlake-have-been-highlighted-as-zacks-bull-and-bear-of-the-day",
    "time_published": "20240108T133800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Casey's General Stores and Westlake are part of the Zacks Bull and Bear of the Day article.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.313183,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LNVGF",
        "relevance_score": "0.01717",
        "ticker_sentiment_score": "0.147642",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.08569",
        "ticker_sentiment_score": "0.184119",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.0686",
        "ticker_sentiment_score": "0.184868",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WLK",
        "relevance_score": "0.153579",
        "ticker_sentiment_score": "0.05978",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CASY",
        "relevance_score": "0.187133",
        "ticker_sentiment_score": "0.079483",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.08569",
        "ticker_sentiment_score": "0.23531",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.051478",
        "ticker_sentiment_score": "-0.032939",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Telehealth & Telemedicine Market is Expected to Reach $285.7 Billion | MarketsandMarkets.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36530941/telehealth-telemedicine-market-is-expected-to-reach-285-7-billion-marketsandmarkets",
    "time_published": "20240108T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Telehealth & Telemedicine market in terms of revenue was estimated to be worth $120.4 Billion in 2023 and is poised to reach $285.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028 according to a latest report published by ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.252228,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AHKSF",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSCO",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TDOC",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "REZI",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.090989",
        "ticker_sentiment_score": "-0.013566",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ASBRF",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.090989",
        "ticker_sentiment_score": "0.158994",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMWL",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "-0.016622",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Diabetes announces world's first approval for MiniMed 780G System with Simplera Sync disposable, all-in-one sensor",
    "url": "https://investingnews.com/medtronic-diabetes-announces-world-s-first-approval-for-minimed-780g-system-with-simplera-sync-disposable-all-in-one-sensor/",
    "time_published": "20240108T120844",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Medtronic Diabetes announces world's first approval for MiniMed 780G System with Simplera Sync disposable, all-in ... Investing News Network ...",
    "banner_image": "https://investingnews.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTg1ODg1NS9vcmlnaW4ucG5nIiwiZXhwaXJlc19hdCI6MTcwODY4MTIxOX0.Phin9ClvosnPNpkGRdBWHz_VFepTco5fqEYZcXCsZIQ/image.png?width=210",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.189802,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HESG",
        "relevance_score": "0.03631",
        "ticker_sentiment_score": "0.054953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.415128",
        "ticker_sentiment_score": "0.277893",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Diabetes announces world's first approval for MiniMed\u2122 780G System with Simplera Sync\u2122 disposable, all ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/medtronic-diabetes-announces-worlds-first-approval-for-minimed-780g-system-with-simplera-sync-disposable-all-in-one-sensor-302027750.html",
    "time_published": "20240108T114500",
    "authors": [],
    "summary": "Medtronic Diabetes announces world's first approval for MiniMed\u2122 780G System with Simplera Sync\u2122 disposable, all ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.175856,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HESG",
        "relevance_score": "0.034882",
        "ticker_sentiment_score": "0.05474",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.459624",
        "ticker_sentiment_score": "0.268032",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BioPorto implements changes to the Executive Management.",
    "url": "https://www.globenewswire.com/news-release/2024/01/09/2806619/0/en/BioPorto-implements-changes-to-the-Executive-Management.html",
    "time_published": "20240109T184200",
    "authors": [
      "BioPorto A/S"
    ],
    "summary": "January ...",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/b9686d8c-3706-4a6c-b22a-ae722c122c21",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.213086,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.039033",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Dividend Stocks to Double Up On Right Now",
    "url": "https://www.fool.com/investing/2024/01/09/3-dividend-stocks-to-double-up-on-right-now/",
    "time_published": "20240109T104000",
    "authors": [
      "Reuben Gregg Brewer"
    ],
    "summary": "Shares of Medtronic and Texas Instruments are discounted but have long-term appeal. Stanley Black & Decker is a turnaround story.",
    "banner_image": "https://g.foolcdn.com/editorial/images/760578/22_01_26-a-person-looking-at-a-computer-screen-with-a-look-of-unpleasant-surprise-_gettyimages-1216968860.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.019635,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "TXN",
        "relevance_score": "0.328611",
        "ticker_sentiment_score": "-0.024304",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.28387",
        "ticker_sentiment_score": "0.119476",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SWK",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "0.013365",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SWKH",
        "relevance_score": "0.048327",
        "ticker_sentiment_score": "0.155859",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Medtronic Stock Got Off to a Roaring Start This Week",
    "url": "https://www.fool.com/investing/2024/01/08/why-medtronic-stock-got-off-to-a-roaring-start-thi/",
    "time_published": "20240109T010802",
    "authors": [
      "Eric Volkman"
    ],
    "summary": "The company is poised to continue having success with its deep brain stimulation device line.",
    "banner_image": "https://g.foolcdn.com/editorial/images/760616/patient-and-physician-smiling-during-a-visit.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.294429,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.829759",
        "ticker_sentiment_score": "0.479042",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Interbody Fusion Cages Market Size to Exceed USD 2.5 billion by 2031, with a Robust CAGR of 6.3 %| States Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36575720/interbody-fusion-cages-market-size-to-exceed-usd-2-5-billion-by-2031-with-a-robust-cagr-of-6-3-sta",
    "time_published": "20240110T135234",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global interbody fusion cages market is estimated to flourish at a CAGR of 6.3% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.391185,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.033751",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.067441",
        "ticker_sentiment_score": "0.184022",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.033751",
        "ticker_sentiment_score": "0.152697",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.067441",
        "ticker_sentiment_score": "0.238569",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.101012",
        "ticker_sentiment_score": "0.081321",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATEC",
        "relevance_score": "0.067441",
        "ticker_sentiment_score": "0.324769",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Smoke Evacuation System Market Sets Ambitious Course toward a Projected Valuation of US$ 555.6 Million by 2033 | Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36575058/smoke-evacuation-system-market-sets-ambitious-course-toward-a-projected-valuation-of-us-555-6-mill",
    "time_published": "20240110T132000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Smoke Evacuation System Market is a rapidly evolving sector within the healthcare industry, primarily driven by the increasing emphasis on safety and infection control in surgical settings.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.285278,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.047654",
        "ticker_sentiment_score": "0.054733",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.023838",
        "ticker_sentiment_score": "0.28007",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.047654",
        "ticker_sentiment_score": "0.01999",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Top Dividend Stocks to Buy in 2024 and Hold Forever",
    "url": "https://www.fool.com/investing/2024/01/10/2-top-dividend-stocks-to-buy-in-2024-and-hold/",
    "time_published": "20240110T124500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "It's hard to beat these companies' track records.",
    "banner_image": "https://media.ycharts.com/charts/361971a021d466f2989532d51c543986.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.226369,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.055621",
        "ticker_sentiment_score": "-0.019994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MA",
        "relevance_score": "0.055621",
        "ticker_sentiment_score": "0.036001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.469935",
        "ticker_sentiment_score": "0.262389",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.055621",
        "ticker_sentiment_score": "-0.019994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "V",
        "relevance_score": "0.423251",
        "ticker_sentiment_score": "0.177242",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Wins CE Mark for MiniMed 780G With Simplera Sync",
    "url": "https://www.zacks.com/stock/news/2208083/medtronic-mdt-wins-ce-mark-for-minimed-780g-with-simplera-sync",
    "time_published": "20240110T120700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) secures the CE Mark for the MiniMed 780G system with the disposable, all-in-one Simplera Sync CGM.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c3/981.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.216586,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HQY",
        "relevance_score": "0.149038",
        "ticker_sentiment_score": "0.055418",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.38366",
        "ticker_sentiment_score": "0.392814",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.245835",
        "ticker_sentiment_score": "0.09277",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.149038",
        "ticker_sentiment_score": "0.055418",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference - Amgen  ( NASDAQ:AMGN ) , Amazon.com  ( NASDAQ:AMZN ) ",
    "url": "https://www.benzinga.com/news/24/01/36572344/is-ai-more-valuable-in-advertising-than-healthcare-jim-cramer-questions-wall-streets-preference",
    "time_published": "20240110T110256",
    "authors": [
      "Benzinga Neuro"
    ],
    "summary": "In a recent revelation, CNBC's Mad Money host Jim Cramer disclosed that the financial market values artificial intelligence ( AI ) technology more for advertising than for healthcare. What Happened: Cramer shared his insights while attending JPMorgan's healthcare conference, reported CNBC on ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/jim-cramer-shutterstock_1.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.317128,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.175148",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.175148",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.123315",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JPM",
        "relevance_score": "0.107495",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.175148",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Bone Wax Market to Reach USD 107.8 billion by 2031, Rising at a CAGR of 3.3% | Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36571219/bone-wax-market-to-reach-usd-107-8-billion-by-2031-rising-at-a-cagr-of-3-3-transparency-market-res",
    "time_published": "20240110T075618",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global bone wax market is estimated to rise at a CAGR of 3.3% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for bone wax is estimated to reach ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.303616,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAX",
        "relevance_score": "0.096932",
        "ticker_sentiment_score": "0.205777",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.032382",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.096932",
        "ticker_sentiment_score": "0.055751",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.096932",
        "ticker_sentiment_score": "0.056001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.06471",
        "ticker_sentiment_score": "-0.016098",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Biliary Stent Market to Cross USD 666.5 million at a CAGR of 5.2 % by 2031: Transparency Market Research Report",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36571195/biliary-stent-market-to-cross-usd-666-5-million-at-a-cagr-of-5-2-by-2031-transparency-market-resea",
    "time_published": "20240110T074412",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global biliary stent market is estimated to flourish at a CAGR of 5.2% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.335284,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMSI",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.086974",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.179254",
        "ticker_sentiment_score": "0.216235",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.072217",
        "ticker_sentiment_score": "0.148109",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.108141",
        "ticker_sentiment_score": "0.111489",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.108141",
        "ticker_sentiment_score": "0.085311",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Telemedicine Market Growth CAGR 12.7% During 2023-2032 | Xcellent Insights",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36571014/telemedicine-market-growth-cagr-12-7-during-2023-2032-xcellent-insights",
    "time_published": "20240110T070000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Pune, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- The global telemedicine market size was USD 70 billion in 2022 and is expected to register a robust revenue CAGR of 12.7% over the forecast period.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.293824,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CSCO",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.015987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TDOC",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.015987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZM",
        "relevance_score": "0.104911",
        "ticker_sentiment_score": "0.014181",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.015987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.015987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMWL",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.015987",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises As Market Takes a Dip: Key Facts",
    "url": "https://www.zacks.com/stock/news/2209168/medtronic-mdt-rises-as-market-takes-a-dip-key-facts",
    "time_published": "20240111T225020",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $87.09, signifying a +0.01% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default139.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995921"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.183572,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.545136",
        "ticker_sentiment_score": "0.190853",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic's  ( MDT )  Percept RC DBS System Secures FDA Approval",
    "url": "https://www.zacks.com/stock/news/2208690/medtronics-mdt-percept-rc-dbs-system-secures-fda-approval",
    "time_published": "20240111T120600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) latest innovation joins the Percept family, the first and only DBS system with sensing, directionality and advanced programming.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.258254,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HQY",
        "relevance_score": "0.156123",
        "ticker_sentiment_score": "0.057016",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.400531",
        "ticker_sentiment_score": "0.212376",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.25726",
        "ticker_sentiment_score": "0.058486",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.156123",
        "ticker_sentiment_score": "0.057016",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade",
    "url": "https://www.fool.com/investing/2024/01/11/2-ultra-reliable-dividend-stocks-to-buy-in-2024-an/",
    "time_published": "20240111T103900",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "Strong advantages over the competition could allow these businesses to keep raising their dividend payouts for at least another 10 years.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760816%2Fcouple-at-home-with-device-getty.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.205181,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.402941",
        "ticker_sentiment_score": "0.333402",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.308246",
        "ticker_sentiment_score": "0.206293",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.052685",
        "ticker_sentiment_score": "0.124609",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Getting Closer To Key Technical Benchmark",
    "url": "https://www.investors.com/ibd-data-stories/medtronic-getting-closer-to-key-technical-benchmark/",
    "time_published": "20240111T080000",
    "authors": [
      "INVESTOR'S BUSINESS DAILY",
      "Investor's Business Daily"
    ],
    "summary": "The Relative Strength ( RS ) Rating for Medtronic ( MDT ) climbed into a higher percentile Thursday, as it got a lift from 68 to 73. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.354992,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.830573",
        "ticker_sentiment_score": "0.517117",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.353059",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.353059",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Lung Cancer Surgery Market Projected to Reach USD 20.2 billion with Registering at a CAGR of 5.6% by 2031| Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36613349/lung-cancer-surgery-market-projected-to-reach-usd-20-2-billion-with-registering-at-a-cagr-of-5-6-b",
    "time_published": "20240112T161947",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global lung cancer surgery market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.195235,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.034233",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARAY",
        "relevance_score": "0.136306",
        "ticker_sentiment_score": "0.140847",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.034233",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.068404",
        "ticker_sentiment_score": "0.014449",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.068404",
        "ticker_sentiment_score": "0.105458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.233034",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.034233",
        "ticker_sentiment_score": "0.178081",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.023021",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Extracorporeal Membrane Oxygenation Machines Market size to grow by 640.24 million by 2027 with a CAGR of 10.05 ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-machines-market-size-to-grow-by-640-24-million-by-2027-with-a-cagr-of-10-05-between-2022---2027--technavio-302033129.html",
    "time_published": "20240112T031500",
    "authors": [],
    "summary": "Extracorporeal Membrane Oxygenation Machines Market size to grow by 640.24 million by 2027 with a CAGR of 10.05 ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.247318,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CTSO",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LIVN",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNGBY",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FMS",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCRPF",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.128956",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Top Healthcare Stocks to Buy With $100",
    "url": "https://www.fool.com/investing/2024/01/13/the-top-healthcare-stocks-to-buy-with-100/",
    "time_published": "20240113T110500",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These companies are shaping the healthcare of tomorrow.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F760971%2Ftelemedicine_-man-waves-to-doctor.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.997405"
      }
    ],
    "overall_sentiment_score": 0.276305,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.260189",
        "ticker_sentiment_score": "0.285553",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NTLA",
        "relevance_score": "0.131884",
        "ticker_sentiment_score": "0.122701",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TDOC",
        "relevance_score": "0.088147",
        "ticker_sentiment_score": "0.060573",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Two Indian entrepreneurs among Schwab Foundation Social Innovation awardees",
    "url": "https://www.business-standard.com/world-news/two-indian-entrepreneurs-among-schwab-foundation-social-innovation-awardees-124011600934_1.html",
    "time_published": "20240116T173235",
    "authors": [
      "Press Trust of India"
    ],
    "summary": "Two Indians, Ajaita Shah of social commerce platform Frontier Markets and Shuchin Bajaj of hospital chain Ujala Cygnus Hospitals, figured among the recipients of the Schwab Foundation Social Innovation Awards announced here on Tuesday.",
    "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2022-07/08/full/1657220646-3192.jpg?im=FeatureCrop,size=(826,465)",
    "source": "Business Standard",
    "category_within_source": "GoogleRSS",
    "source_domain": "www.business-standard.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.298607,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.104002",
        "ticker_sentiment_score": "0.24217",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ESLOF",
        "relevance_score": "0.052112",
        "ticker_sentiment_score": "0.223659",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Chest Drainage Systems Market Expected to Achieve US$1.5 Billion by 2030, According to Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36645855/chest-drainage-systems-market-expected-to-achieve-us-1-5-billion-by-2030-according-to-persistence-",
    "time_published": "20240116T170000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New york, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Chest drainage systems play a vital role in the medical field, particularly in thoracic surgery and pulmonary medicine. These systems are essential for restoring normal respiratory processes by removing air, blood, or other bodily fluids from the ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.302308,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MMSI",
        "relevance_score": "0.041719",
        "ticker_sentiment_score": "0.02092",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.020866",
        "ticker_sentiment_score": "0.219107",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ICUI",
        "relevance_score": "0.020866",
        "ticker_sentiment_score": "-0.196786",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.020866",
        "ticker_sentiment_score": "0.27422",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.062542",
        "ticker_sentiment_score": "0.224526",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.062542",
        "ticker_sentiment_score": "0.224526",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises But Trails Market: What Investors Should Know",
    "url": "https://www.zacks.com/stock/news/2212457/medtronic-mdt-rises-but-trails-market-what-investors-should-know",
    "time_published": "20240118T225020",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $86.29, signifying a +0.28% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default103.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995921"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.21213,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.600271",
        "ticker_sentiment_score": "0.336344",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Continuous Glucose Monitoring Systems Market to Hit US$20.5 Billion by 2030 | Updated Insights Report by Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36683594/continuous-glucose-monitoring-systems-market-to-hit-us-20-5-billion-by-2030-updated-insights-repor",
    "time_published": "20240118T183000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Continuous glucose monitoring ( CGM ) systems have brought significant advancements to the field of diabetes management by providing real-time data on blood glucose levels.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.388487,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MOOIF",
        "relevance_score": "0.01706",
        "ticker_sentiment_score": "0.199568",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.034112",
        "ticker_sentiment_score": "0.242427",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.034112",
        "ticker_sentiment_score": "0.242427",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.034112",
        "ticker_sentiment_score": "0.198683",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cardiac Sutures Market Estimated to Reach USD 2.3 billion, Advancing at a CAGR of 6.8% by 2031: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36680030/cardiac-sutures-market-estimated-to-reach-usd-2-3-billion-advancing-at-a-cagr-of-6-8-by-2031-trans",
    "time_published": "20240118T153000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cardiac sutures market is estimated to flourish at a CAGR of 6.8% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.419293,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.072987",
        "ticker_sentiment_score": "0.121937",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.109289",
        "ticker_sentiment_score": "0.084521",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.109289",
        "ticker_sentiment_score": "0.118142",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.072987",
        "ticker_sentiment_score": "0.328045",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Anesthesia Machines Market Soars, Forecasting an 8.4% CAGR Surge to Reach US$ 20.5 Billion by 2030 | Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36672808/anesthesia-machines-market-soars-forecasting-an-8-4-cagr-surge-to-reach-us-20-5-billion-by-2030-pe",
    "time_published": "20240118T073000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: Anesthesia machines are sophisticated devices that enable healthcare professionals to precisely deliver and monitor the administration of anesthetic agents, ensuring patients are comfortable and pain-free during surgery or other ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.472937,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.042647",
        "ticker_sentiment_score": "0.210069",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MFCSF",
        "relevance_score": "0.028439",
        "ticker_sentiment_score": "0.132813",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGWPF",
        "relevance_score": "0.028439",
        "ticker_sentiment_score": "0.256962",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 | DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/liquid-biopsy-in-cancer-diagnostics-global-market-is-likely-to-increase-at-a-massive-growth-rate-of-17-by-2028--delveinsight-302039144.html",
    "time_published": "20240119T220100",
    "authors": [
      "LLP",
      "DelveInsight Business Research"
    ],
    "summary": "Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": -0.042033,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.031816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GH",
        "relevance_score": "0.042271",
        "ticker_sentiment_score": "0.018936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.042271",
        "ticker_sentiment_score": "0.018936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EXAS",
        "relevance_score": "0.042271",
        "ticker_sentiment_score": "0.018936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.024956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.031816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SKXJF",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "-0.188371",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "-0.132382",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.024956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSKYF",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "-0.188371",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.024956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "-0.132382",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TECH",
        "relevance_score": "0.042271",
        "ticker_sentiment_score": "0.018936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIOCQ",
        "relevance_score": "0.042271",
        "ticker_sentiment_score": "0.018936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.024956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MYGN",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.031816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.031816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDSX",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "-0.051475",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ADTX",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.031816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEO",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.031816",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.024956",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.042271",
        "ticker_sentiment_score": "0.018936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.021143",
        "ticker_sentiment_score": "0.024956",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Spotlight on Medtronic: Analyzing the Surge in Options Activity - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/options/24/01/36701359/spotlight-on-medtronic-analyzing-the-surge-in-options-activity",
    "time_published": "20240119T203101",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bullish stance on Medtronic MDT. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      }
    ],
    "overall_sentiment_score": 0.181685,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.854393",
        "ticker_sentiment_score": "0.352944",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024",
    "url": "https://www.fool.com/investing/2024/01/21/my-5-top-dividend-stocks-to-buy-in-2024/",
    "time_published": "20240121T111700",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These stocks may help you win in 2024 -- no matter what the market does.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F761894%2Fgettyimages-1172040755.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999365"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.344613,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABBV",
        "relevance_score": "0.231332",
        "ticker_sentiment_score": "0.17327",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.078099",
        "ticker_sentiment_score": "0.311035",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "KO",
        "relevance_score": "0.116914",
        "ticker_sentiment_score": "0.107532",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.155451",
        "ticker_sentiment_score": "0.226339",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.078099",
        "ticker_sentiment_score": "0.188048",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/rehabilitation-equipment-global-market-to-showcase-growth-at-a-cagr-of-5-by-2028-examines-delveinsight-302040512.html",
    "time_published": "20240122T223100",
    "authors": [
      "DelveInsight Business Research",
      "LLP"
    ],
    "summary": "The increasing demand for rehabilitation equipment is driven by several factors, including a growing number of accidents, injuries, and falls.",
    "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.218223,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.089754",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVRO",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.026075",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.079921",
        "ticker_sentiment_score": "-0.002038",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EKSO",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OFIX",
        "relevance_score": "0.05333",
        "ticker_sentiment_score": "0.003986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RWLK",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.05333",
        "ticker_sentiment_score": "0.003986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.05333",
        "ticker_sentiment_score": "0.004985",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.079921",
        "ticker_sentiment_score": "-0.002038",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATEC",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "-0.011827",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SRGAQ",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "-0.011827",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ANIK",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.020645",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.026075",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DNPUF",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSUMF",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.020645",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IART",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "-0.023117",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVCRQ",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DYNT",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MAAL",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.079921",
        "ticker_sentiment_score": "0.011181",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BVS",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.020645",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CMAX",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.098104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.020645",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Brain Implants Market Set for Remarkable Growth: Projected to Reach $8.77 Billion by 2028 As Per The Business Research Company's Brain Implants Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36719319/brain-implants-market-set-for-remarkable-growth-projected-to-reach-8-77-billion-by-2028-as-per-the",
    "time_published": "20240122T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Brain Implants Global Market Report 2024, the global brain implants market has been experiencing rapid growth in recent years and is poised for significant expansion in the coming years.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.28117,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.121772",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.121772",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.121772",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LIVN",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.121772",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tissue Engineering Market is Expected to Reach $8.9 Billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36713761/tissue-engineering-market-is-expected-to-reach-8-9-billion-marketsandmarkets",
    "time_published": "20240122T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Tissue Engineering market in terms of revenue was estimated to be worth $4.4 Billion in 2023 and is poised to reach $8.9 Billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028 according to a latest report published by MarketsandMarkets\u2122.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.22176,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDXG",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TINLF",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DNPUF",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAUHF",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSUMF",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IART",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VCEL",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "-0.040123",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Orthopedic Implants Market Size to Worth USD 61 Million by 2030| According to Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36712657/orthopedic-implants-market-size-to-worth-usd-61-million-by-2030-according-to-persistence-market-re",
    "time_published": "20240122T113000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- The projected rise in the number of patients in need of orthopedic implant surgery is anticipated to propel the global orthopedic implants market in the coming years.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.300831,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TINLF",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.038733",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.040382",
        "ticker_sentiment_score": "0.103875",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.038733",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.038733",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.145597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.038733",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.145597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.038733",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KYOCF",
        "relevance_score": "0.020197",
        "ticker_sentiment_score": "0.038733",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Interventional Pulmonology Market to Reach a Revenue of US$ 1.9 Billion by 2033 End | According to Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36712582/interventional-pulmonology-market-to-reach-a-revenue-of-us-1-9-billion-by-2033-end-according-to-pe",
    "time_published": "20240122T112100",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: In 2022, the interventional pulmonology market generated a global revenue of US$ 1.2 billion, and it is projected to experience a steady growth with a Compound Annual Growth Rate ( CAGR ) of 4.2%.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.180773,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CLAR",
        "relevance_score": "0.019396",
        "ticker_sentiment_score": "0.136492",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.03878",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03878",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.03878",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.019396",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.019396",
        "ticker_sentiment_score": "-0.158109",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "SMGKF",
        "relevance_score": "0.019396",
        "ticker_sentiment_score": "0.039111",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Intravenous Infusion Pump Market to Hit USD 13.2 Billion by 2032, says Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36712525/intravenous-infusion-pump-market-to-hit-usd-13-2-billion-by-2032-says-persistence-market-research",
    "time_published": "20240122T111500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: Newly-released Intravenous Infusion Pumps market analysis report by Persistence Market Research shows that global sales of the Intravenous Infusion Pumps Market in 2021 were held at US$ 5.6 Bn. With a CAGR of 9% during 2022 ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.273467,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAX",
        "relevance_score": "0.042196",
        "ticker_sentiment_score": "-0.024756",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.021106",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.021106",
        "ticker_sentiment_score": "0.111704",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMGKF",
        "relevance_score": "0.021106",
        "ticker_sentiment_score": "0.179682",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.042196",
        "ticker_sentiment_score": "-0.033591",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.021106",
        "ticker_sentiment_score": "0.104288",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wearable Injectors Market Surges Towards US$ 19.4 Billion by 2033 with 10.2% CAGR | Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36711531/wearable-injectors-market-surges-towards-us-19-4-billion-by-2033-with-10-2-cagr-persistence-market",
    "time_published": "20240122T090000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Wearable Injectors Market has witnessed remarkable growth in recent years, driven by a combination of technological advancements and the growing demand for convenient and patient-centric drug delivery solutions.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.421696,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TNDM",
        "relevance_score": "0.029381",
        "ticker_sentiment_score": "0.057117",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.014693",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "YPHDF",
        "relevance_score": "0.014693",
        "ticker_sentiment_score": "0.153666",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WST",
        "relevance_score": "0.014693",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.029381",
        "ticker_sentiment_score": "0.207221",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.029381",
        "ticker_sentiment_score": "0.051516",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.014693",
        "ticker_sentiment_score": "0.047485",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "USD 568.32 million growth expected in Intracranial Pressure Monitoring Devices Market between 2022 and 2027 ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/usd-568-32-million-growth-expected-in-intracranial-pressure-monitoring-devices-market-between-2022-and-2027--analysing-growth-in-invasive-segment-17-000-technavio-research-reports-302039600.html",
    "time_published": "20240122T061500",
    "authors": [],
    "summary": "USD 568.32 million growth expected in Intracranial Pressure Monitoring Devices Market between 2022 and 2027 ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.124351,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "IART",
        "relevance_score": "0.060694",
        "ticker_sentiment_score": "-0.085029",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "III",
        "relevance_score": "0.060694",
        "ticker_sentiment_score": "0.118236",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.060694",
        "ticker_sentiment_score": "-0.085029",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/implantable-drug-delivery-devices-global-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2028-assesses-delveinsight-302041477.html",
    "time_published": "20240123T223100",
    "authors": [
      "DelveInsight Business Research",
      "LLP"
    ],
    "summary": "Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028 ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.262341,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAYZF",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.088505",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.088505",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HTSUF",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.027657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.054175",
        "ticker_sentiment_score": "0.028936",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.054175",
        "ticker_sentiment_score": "0.068904",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARUXF",
        "relevance_score": "0.054175",
        "ticker_sentiment_score": "0.074985",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.054175",
        "ticker_sentiment_score": "0.079826",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENDPQ",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.027657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCRPF",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "-0.01558",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.025235",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.027657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRRMF",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.025235",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.054175",
        "ticker_sentiment_score": "0.068904",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.081184",
        "ticker_sentiment_score": "0.063274",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.025235",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALC",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.088505",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.088505",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LYPHF",
        "relevance_score": "0.054175",
        "ticker_sentiment_score": "0.074985",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WST",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.025235",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "-0.01558",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.081184",
        "ticker_sentiment_score": "0.070488",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UCBJF",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.027657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSOI",
        "relevance_score": "0.027103",
        "ticker_sentiment_score": "0.176605",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst - Inari Medical  ( NASDAQ:NARI ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36745475/arterial-device-focused-inari-medical-likely-acquisition-target-shares-are-attracti",
    "time_published": "20240123T195652",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Needham initiated coverage on Inari Medical Inc NARI, noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient population of 280,000 with pulmonary embolism ( PE ) in the U.S., equating to a total available market ( TAM ) ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/NARI.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Mergers",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.231817,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.213048",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NARI",
        "relevance_score": "0.776097",
        "ticker_sentiment_score": "0.535824",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Is Medtronic Stock a Buy Now?",
    "url": "https://www.fool.com/investing/2024/01/23/is-medtronic-stock-a-buy-now/",
    "time_published": "20240123T164500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "This longtime healthcare leader still has tricks up its sleeve.",
    "banner_image": "https://media.ycharts.com/charts/449df07f857feea40b1d409022b66dee.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.839681"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      }
    ],
    "overall_sentiment_score": 0.305087,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.753867",
        "ticker_sentiment_score": "0.552984",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.173458",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.173458",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Globus Medical  ( GMED )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2214060/heres-why-you-should-retain-globus-medical-gmed-stock-now",
    "time_published": "20240123T134200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors continue to be optimistic about Globus Medical (GMED), backed by the NuVasive merger and its prominence in the musculoskeletal field.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999594"
      }
    ],
    "overall_sentiment_score": 0.361302,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HQY",
        "relevance_score": "0.170275",
        "ticker_sentiment_score": "0.076319",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.042876",
        "ticker_sentiment_score": "0.180632",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.409171",
        "ticker_sentiment_score": "0.491738",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.042876",
        "ticker_sentiment_score": "0.180632",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.170275",
        "ticker_sentiment_score": "0.095983",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.150682",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "5 Magnificent Dividend Growth Stocks to Buy and Hold Forever",
    "url": "https://www.fool.com/investing/2024/01/23/5-magnificent-dividend-growth-stocks-to-buy-and-ho/",
    "time_published": "20240123T114500",
    "authors": [
      "George Budwell"
    ],
    "summary": "These dividend growers ought to shine in 2024 and beyond.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762055%2Fparabola.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.929393"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.839681"
      }
    ],
    "overall_sentiment_score": 0.47811,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MO",
        "relevance_score": "0.282234",
        "ticker_sentiment_score": "0.287294",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PEP",
        "relevance_score": "0.227538",
        "ticker_sentiment_score": "0.386111",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.227538",
        "ticker_sentiment_score": "0.34713",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.171688",
        "ticker_sentiment_score": "0.380978",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.335519",
        "ticker_sentiment_score": "0.37482",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "2 Monster Stocks to Buy Without Any Hesitation",
    "url": "https://www.fool.com/investing/2024/01/23/2-monster-stocks-to-buy-without-any-hesitation/",
    "time_published": "20240123T110000",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These stocks both could deliver great rewards over time.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762141%2Fgettyimages-468679176.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99246"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.321362,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.551295",
        "ticker_sentiment_score": "0.204225",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.065101",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.504646",
        "ticker_sentiment_score": "0.53287",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.120431",
        "ticker_sentiment_score": "0.013032",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Surgical Staplers Market Soars, Forecasting an 4.7% CAGR Surge to Reach US$5.5 Billion by 2030 | Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36732339/surgical-staplers-market-soars-forecasting-an-4-7-cagr-surge-to-reach-us-5-5-billion-by-2030-persi",
    "time_published": "20240123T091500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Surgical Staplers Market is a vital segment within the broader medical device industry, dedicated to simplifying and enhancing surgical procedures.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.375422,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.014506",
        "ticker_sentiment_score": "0.049119",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.029008",
        "ticker_sentiment_score": "-0.04468",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.057977",
        "ticker_sentiment_score": "0.147179",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.043499",
        "ticker_sentiment_score": "0.189608",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Surgical Dressing Market Valuation to Reach US$1.9 Billion by 2030, Driven by 6.1% CAGR | Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36732234/surgical-dressing-market-valuation-to-reach-us-1-9-billion-by-2030-driven-by-6-1-cagr-persistence-",
    "time_published": "20240123T085000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The surgical dressing market plays a vital role in the healthcare industry, providing essential products that aid in the post-operative care of patients and promote wound healing.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.320894,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HLCO",
        "relevance_score": "0.014757",
        "ticker_sentiment_score": "0.040595",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.04425",
        "ticker_sentiment_score": "-0.038999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCK",
        "relevance_score": "0.014757",
        "ticker_sentiment_score": "0.418091",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.04425",
        "ticker_sentiment_score": "-0.038999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.04425",
        "ticker_sentiment_score": "0.014969",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.04425",
        "ticker_sentiment_score": "0.056789",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLPBY",
        "relevance_score": "0.04425",
        "ticker_sentiment_score": "0.125902",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medical Adhesive Tape Market Is Projected to Reach a Value of US$13.1 Billion by The End 2030, According to Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36731378/medical-adhesive-tape-market-is-projected-to-reach-a-value-of-us-13-1-billion-by-the-end-2030-acco",
    "time_published": "20240123T063000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Medical Adhesive Tape Market Booming with Growing Demand and Technological Advancements Medical adhesive tapes are essential in wound care, surgeries, and medical applications.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.381388,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.017795",
        "ticker_sentiment_score": "0.128518",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HLCO",
        "relevance_score": "0.017795",
        "ticker_sentiment_score": "0.197876",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NDEKF",
        "relevance_score": "0.035582",
        "ticker_sentiment_score": "0.155746",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NHBAF",
        "relevance_score": "0.017795",
        "ticker_sentiment_score": "0.149182",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.017795",
        "ticker_sentiment_score": "0.149182",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AVY",
        "relevance_score": "0.035582",
        "ticker_sentiment_score": "0.155746",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.017795",
        "ticker_sentiment_score": "0.149182",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.017795",
        "ticker_sentiment_score": "0.149182",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.035582",
        "ticker_sentiment_score": "0.137674",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Slides as Market Rises: Facts to Know Before You Trade",
    "url": "https://www.zacks.com/stock/news/2215309/medtronic-mdt-stock-slides-as-market-rises-facts-to-know-before-you-trade",
    "time_published": "20240124T225020",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $84.72, signifying a -1.88% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default3.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.188234,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.535653",
        "ticker_sentiment_score": "0.24264",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/drug-eluting-balloons-global-market-is-expected-to-expand-at-a-healthy-growth-rate-of-8-by-2028-predicts-delveinsight-302042856.html",
    "time_published": "20240124T220100",
    "authors": [
      "LLP",
      "DelveInsight Business Research"
    ],
    "summary": "Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.170441,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PGEN",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GBLX",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IONS",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.077292",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MESO",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATHXQ",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SRDX",
        "relevance_score": "0.051943",
        "ticker_sentiment_score": "0.104731",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EWTX",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LSTA",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.032293",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.077292",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCDA",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TNYA",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.051943",
        "ticker_sentiment_score": "0.048943",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SANA",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRDL",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SCPH",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PBIGF",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WINT",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LXRX",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CYTK",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ITCI",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.077292",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSBHF",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "-0.084826",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "REGN",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EVO",
        "relevance_score": "0.025985",
        "ticker_sentiment_score": "0.033663",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Human Insulin Drugs Market In Brazil 2023-2028: Market Analysis, Drivers, Restraints, Opportunities, and Threats ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/human-insulin-drugs-market-in-brazil-2023-2028-market-analysis-drivers-restraints-opportunities-and-threats---17000--technavio-reports-302044119.html",
    "time_published": "20240126T023500",
    "authors": [],
    "summary": "Human Insulin Drugs Market In Brazil 2023-2028: Market Analysis, Drivers, Restraints, Opportunities, and Threats ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.26948,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVS",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.129809",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.129809",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MNKD",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.129809",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.098774",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.129809",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.098774",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024",
    "url": "https://www.fool.com/investing/2024/01/27/my-top-5-ai-growth-stocks-to-buy-for-2024/",
    "time_published": "20240127T100500",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These stocks could deliver top returns now and well into the future.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F762310%2Fartificial-intelligence-ai.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.4114,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.248561",
        "ticker_sentiment_score": "0.306207",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.178989",
        "ticker_sentiment_score": "0.095777",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.213988",
        "ticker_sentiment_score": "0.343755",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.282641",
        "ticker_sentiment_score": "0.368957",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "IBM",
        "relevance_score": "0.107978",
        "ticker_sentiment_score": "0.135107",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.248561",
        "ticker_sentiment_score": "0.370622",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Cartilage Degeneration Market Size Is Expected To Reach A Value Of More Than $15 Billion By 2028 As Per The Business Research Company's Cartilage Degeneration Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36828226/cartilage-degeneration-market-size-is-expected-to-reach-a-value-of-more-than-15-billion-by-2028-as",
    "time_published": "20240129T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Cartilage Degeneration Global Market Report 2024, the global cartilage degeneration market has witnessed a substantial upswing, with the market size surging from $11.88 billion in 2023 to $12.63 billion in 2024, ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.130274,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.053561",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.047017",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.047017",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.047017",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?",
    "url": "https://www.zacks.com/stock/news/2216843/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi",
    "time_published": "20240129T112006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for IHI ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default131.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.219004,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.064973",
        "ticker_sentiment_score": "0.031018",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEM",
        "relevance_score": "0.129516",
        "ticker_sentiment_score": "0.026807",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.129516",
        "ticker_sentiment_score": "0.070142",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.129516",
        "ticker_sentiment_score": "0.070142",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.129516",
        "ticker_sentiment_score": "0.070142",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cardiac Resynchronization Therapy System Market to Witness 4.9% CAGR, Projected to Reach USD 6.9 billion by 2031: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36820877/cardiac-resynchronization-therapy-system-market-to-witness-4-9-cagr-projected-to-reach-usd-6-9-bil",
    "time_published": "20240129T111531",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cardiac resynchronization therapy system market is estimated to sluggishly surge at a CAGR of 4.9% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.426584,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.032602",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AHKSF",
        "relevance_score": "0.032602",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NHNKF",
        "relevance_score": "0.032602",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.129866",
        "ticker_sentiment_score": "0.268491",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.097589",
        "ticker_sentiment_score": "0.233918",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.097589",
        "ticker_sentiment_score": "0.053971",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ASBRF",
        "relevance_score": "0.032602",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "External Ventricular Drain Market to Record a Growth of USD 2.28 billion between 2023 and 2028, North America to ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/external-ventricular-drain-market-to-record-a-growth-of-usd-2-28-billion-between-2023-and-2028--north-america-to-occupy-35-market-share---technavio-302045451.html",
    "time_published": "20240129T092000",
    "authors": [],
    "summary": "External Ventricular Drain Market to Record a Growth of USD 2.28 billion between 2023 and 2028, North America to ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.119424,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "IART",
        "relevance_score": "0.061159",
        "ticker_sentiment_score": "-0.049011",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.061159",
        "ticker_sentiment_score": "-0.049011",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Falls More Steeply Than Broader Market: What Investors Need to Know",
    "url": "https://www.zacks.com/stock/news/2218294/medtronic-mdt-falls-more-steeply-than-broader-market-what-investors-need-to-know",
    "time_published": "20240130T225017",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Medtronic (MDT) settling at $86.97, representing a -0.54% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.185461,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.628699",
        "ticker_sentiment_score": "0.236437",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How Is The Market Feeling About Medtronic? - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/01/36871182/how-is-the-market-feeling-about-medtronic",
    "time_published": "20240131T170015",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has risen 28.36% since its last report. The company recently reported that it has 11.39 million shares sold short, which is 0.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.267375,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.224903",
        "ticker_sentiment_score": "0.158881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer",
    "url": "https://www.globenewswire.com/news-release/2024/01/31/2821051/0/en/CVRx-Announces-Appointment-of-Kevin-Hykes-as-President-and-Chief-Executive-Officer.html",
    "time_published": "20240131T130000",
    "authors": [
      "CVRx",
      "Inc."
    ],
    "summary": "MINNEAPOLIS, Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( \"CVRx\" ) , a commercial-stage medical device company, announced today the appointment of Kevin Hykes as the Company's new President and Chief Executive Officer, effective February 12.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/04c4feba-7841-4ac8-8ca5-6c03be383a0e",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      }
    ],
    "overall_sentiment_score": 0.306399,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.051999",
        "ticker_sentiment_score": "0.043705",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.051999",
        "ticker_sentiment_score": "0.043705",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVRX",
        "relevance_score": "0.351985",
        "ticker_sentiment_score": "0.309205",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer - CVRx  ( NASDAQ:CVRX ) ",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36864586/cvrx-announces-appointment-of-kevin-hykes-as-president-and-chief-executive-officer",
    "time_published": "20240131T130000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Appointment effective February 12 following Nadim Yared's retirement Hykes currently serves as Augmedics' President and CEO, and has served on CVRx's Board of Directors since 2022 MINNEAPOLIS, Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      }
    ],
    "overall_sentiment_score": 0.292879,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.042441",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.042441",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVRX",
        "relevance_score": "0.41608",
        "ticker_sentiment_score": "0.34308",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Insulet  ( PODD )  Gains From Product Innovation, Global Expansion",
    "url": "https://www.zacks.com/stock/news/2219642/insulet-podd-gains-from-product-innovation-global-expansion",
    "time_published": "20240201T152600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      }
    ],
    "overall_sentiment_score": 0.270499,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BRKR",
        "relevance_score": "0.141171",
        "ticker_sentiment_score": "0.054945",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.626173",
        "ticker_sentiment_score": "0.374728",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.047278",
        "ticker_sentiment_score": "0.217648",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.047278",
        "ticker_sentiment_score": "0.217648",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.233108",
        "ticker_sentiment_score": "0.128949",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.141171",
        "ticker_sentiment_score": "0.054945",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "St. Joseph's Children's Hospital First in Tampa Bay to Implant Leadless Pacemaker in Pediatric Heart Patient - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/st-josephs-childrens-hospital-first-in-tampa-bay-to-implant-leadless-pacemaker-in-pediatric-heart-patient-302052436.html",
    "time_published": "20240202T233100",
    "authors": [],
    "summary": "St. Joseph's Children's Hospital First in Tampa Bay to Implant Leadless Pacemaker in Pediatric Heart Patient PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.296185,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.04912",
        "ticker_sentiment_score": "0.179041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Neuromodulation Market Worth $11.0 Billion | MarketsandMarkets\u2122.",
    "url": "https://www.prnewswire.com/news-releases/neuromodulation-market-worth-11-0-billion--marketsandmarkets-302051831.html",
    "time_published": "20240202T153000",
    "authors": [
      "MarketsandMarkets"
    ],
    "summary": "CHICAGO, Feb. 2, 2024 /PRNewswire/ -- Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028 according to a new report by MarketsandMarkets\u2122.",
    "banner_image": "https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.289712,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NPCE",
        "relevance_score": "0.040416",
        "ticker_sentiment_score": "0.097628",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.040416",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.040416",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.093635",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.040416",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Could Medtronic Stock Help You Become a Millionaire?",
    "url": "https://www.fool.com/investing/2024/02/03/could-medtronic-help-you-become-a-millionaire/",
    "time_published": "20240203T150000",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Medtronic has faced some headwinds in recent years, but its future should look brighter.",
    "banner_image": "https://g.foolcdn.com/editorial/images/762952/rich-couple-on-a-boat.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999998"
      }
    ],
    "overall_sentiment_score": 0.268211,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.649187",
        "ticker_sentiment_score": "0.383496",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "The Diversification Conundrum of High Yield Stock Investing",
    "url": "https://www.fool.com/investing/2024/02/03/the-diversification-conundrum-of-high-yield-stock/",
    "time_published": "20240203T122500",
    "authors": [
      "Reuben Gregg Brewer"
    ],
    "summary": "You know not to put all of your investing eggs in one basket, but many dividend investors end up doing just that.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F763184%2F23_04_26-a-pile-of-papers-with-percentages-and-one-on-top-of-the-pile-with-a-question-mark-_mf-dload.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.882182"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.080986,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "CVX",
        "relevance_score": "0.110973",
        "ticker_sentiment_score": "0.078158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.110973",
        "ticker_sentiment_score": "0.078158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TXN",
        "relevance_score": "0.219809",
        "ticker_sentiment_score": "0.006893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.110973",
        "ticker_sentiment_score": "-0.042798",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BKH",
        "relevance_score": "0.110973",
        "ticker_sentiment_score": "0.188525",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FNV",
        "relevance_score": "0.219809",
        "ticker_sentiment_score": "0.02439",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "O",
        "relevance_score": "0.110973",
        "ticker_sentiment_score": "0.0897",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "FDA panel recommends more diversity in pulse oximeter trials",
    "url": "https://www.cnn.com/2024/02/02/health/pulse-oximeters-skin-color-fda/index.html",
    "time_published": "20240203T012400",
    "authors": [
      "Jacqueline Howard"
    ],
    "summary": "The longstanding problem of pulse oximeters providing less-accurate readings for people with dark skin tones got another look Friday from a panel of experts for the US Food and Drug Administration.",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/221206112315-20221206-oximeter-inaccuracy-illustration.jpg?c=16x9&q=h_144,w_256,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "www.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.043069,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.037475",
        "ticker_sentiment_score": "0.036815",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.037475",
        "ticker_sentiment_score": "-0.063587",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.018743",
        "ticker_sentiment_score": "0.042866",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Suffers a Larger Drop Than the General Market: Key Insights",
    "url": "https://www.zacks.com/stock/news/2221357/medtronic-mdt-suffers-a-larger-drop-than-the-general-market-key-insights",
    "time_published": "20240205T225018",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $86.75, signifying a -1% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      }
    ],
    "overall_sentiment_score": 0.133416,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "0.104789",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AWON",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "-0.186537",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "3D Printing Medical Devices Market to grow by USD 3.96 billion from 2022 to 2027, the rising cost efficiency and ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/3d-printing-medical-devices-market-to-grow-by-usd-3-96-billion-from-2022-to-2027--the-rising-cost-efficiency-and-enhanced-productivity-to-drive-growth---technavio-302052807.html",
    "time_published": "20240205T151200",
    "authors": [],
    "summary": "3D Printing Medical Devices Market to grow by USD 3.96 billion from 2022 to 2027, the rising cost efficiency and ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.364782,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ADSK",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DDD",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DM",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MTLS",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.170159",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HESG",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.287254",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GGRGF",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSYS",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ONVO",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RNSHF",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.042999",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Layoffs Mount Amid Eye-Popping Jobs Numbers, Make Meetings More Productive And More",
    "url": "https://www.forbes.com/sites/jenamcgregor/2024/02/05/layoffs-mount-amid-eye-popping-jobs-numbers-make-meetings-more-productive-and-more/",
    "time_published": "20240205T141533",
    "authors": [
      "Jena McGregor"
    ],
    "summary": "This is the published version of Forbes' Future of Work newsletter, which offers the latest news for chief human resources officers and other talent managers on disruptive technologies, managing the workforce and trends in the remote work debate. Click here to get it delivered to your inbox every ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65c0e0b437207e0b89ce50f1/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.094678,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.04451",
        "ticker_sentiment_score": "0.088913",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PYPL",
        "relevance_score": "0.022264",
        "ticker_sentiment_score": "-0.021524",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.022264",
        "ticker_sentiment_score": "0.16376",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "META",
        "relevance_score": "0.022264",
        "ticker_sentiment_score": "0.16376",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NYT",
        "relevance_score": "0.022264",
        "ticker_sentiment_score": "0.190393",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "LRLCF",
        "relevance_score": "0.022264",
        "ticker_sentiment_score": "0.042032",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.022264",
        "ticker_sentiment_score": "0.100397",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Embolization Coil Market to grow by USD 481.9 million from 2022 to 2027, Abbott Laboratories and Achieva Medical ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/embolization-coil-market-to-grow-by-usd-481-9-million-from-2022-to-2027---abbott-laboratories-and-achieva-medical-are-among-the-key-companies--technavio-302053633.html",
    "time_published": "20240206T223600",
    "authors": [],
    "summary": "Embolization Coil Market to grow by USD 481.9 million from 2022 to 2027, Abbott Laboratories and Achieva Medical ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.127694,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MMSI",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.146025",
        "ticker_sentiment_score": "0.04477",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.146025",
        "ticker_sentiment_score": "0.063505",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KANKF",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCRPF",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.04126",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Grounding in Healing To Navigate the DEI Landscape in 2024",
    "url": "https://investingnews.com/grounding-in-healing-to-navigate-the-dei-landscape-in-2024/",
    "time_published": "20240207T184216",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Healing means different things to different people. For me, healing means going from a place of judgment, questioning our self-worth, body-mind dis-ease, and lack of inner vitality, to a place of acceptance, self-worth, mind-body wellbeing, and the reignition of that internal life spark - the ...",
    "banner_image": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy81MTI3NDYwMC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcxNzQ1OTMwNn0.kjLEuLnBAc8utn4dfQyabjMGtO9KVSvQh1965g2yHPE/img.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.434684,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.183546",
        "ticker_sentiment_score": "0.297094",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VTLE",
        "relevance_score": "0.046273",
        "ticker_sentiment_score": "0.180848",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medical Electronics Market to Reach $23.0 Billion, Globally, by 2032 at 6.73% CAGR: Allied Market Research",
    "url": "https://www.prnewswire.com/news-releases/medical-electronics-market-to-reach-23-0-billion-globally-by-2032-at-6-73-cagr-allied-market-research-302055874.html",
    "time_published": "20240207T103900",
    "authors": [
      "Allied Market Research"
    ],
    "summary": "The medical electronics market is driven by factors such as rise in demand for efficient healthcare solutions globally coupled with technological advancements and increase in healthcare demands.",
    "banner_image": "https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.310385,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.133104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.034185",
        "ticker_sentiment_score": "0.164184",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Declines While Market Improves: Some Information for Investors",
    "url": "https://www.zacks.com/stock/news/2223695/medtronic-mdt-stock-declines-while-market-improves-some-information-for-investors",
    "time_published": "20240208T224519",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $86.18, denoting a -1.12% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default250.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.214353,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "0.331058",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Wearable Medical Devices Market to grow by USD 15.54 billion from 2022 to 2027; Market is fragmented due to the ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/wearable-medical-devices-market-to-grow-by-usd-15-54-billion-from-2022-to-2027-market-is-fragmented-due-to-the-presence-of-prominent-companies-like-abbott-laboratories-alphabet-inc-apple-inc-and-many-more---technavio-302057089.html",
    "time_published": "20240208T223600",
    "authors": [],
    "summary": "Wearable Medical Devices Market to grow by USD 15.54 billion from 2022 to 2027. Market is fragmented due to the ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.220358,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DFKCY",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRMN",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSNLF",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OMRNF",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BTCY",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.009265",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ECG Cables and Lead Wires Market is Projected to Attain a Value of USD 4.0 billion by 2031, Exhibiting a CAGR of 6.70%: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37013175/ecg-cables-and-lead-wires-market-is-projected-to-attain-a-value-of-usd-4-0-billion-by-2031-exhibit",
    "time_published": "20240208T170000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 08, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global ECG cables and lead wires market is estimated to flourish at a CAGR of 6.70% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.425165,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NHNKF",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "0.109589",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "-0.131001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.068797",
        "ticker_sentiment_score": "0.204571",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "-0.131001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "0.286597",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "0.211633",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.103035",
        "ticker_sentiment_score": "0.105594",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.03443",
        "ticker_sentiment_score": "0.270198",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Invest in Boston Scientific  ( BSX )  Now",
    "url": "https://www.zacks.com/stock/news/2223513/heres-why-you-should-invest-in-boston-scientific-bsx-now",
    "time_published": "20240208T153400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999476"
      }
    ],
    "overall_sentiment_score": 0.275819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "UHS",
        "relevance_score": "0.20279",
        "ticker_sentiment_score": "0.149944",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.051221",
        "ticker_sentiment_score": "0.090462",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.051221",
        "ticker_sentiment_score": "0.090462",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ITGR",
        "relevance_score": "0.20279",
        "ticker_sentiment_score": "0.073558",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.051221",
        "ticker_sentiment_score": "0.090462",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.251941",
        "ticker_sentiment_score": "0.246126",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.051221",
        "ticker_sentiment_score": "0.090462",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.051221",
        "ticker_sentiment_score": "0.090462",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.102231",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PXXXF",
        "relevance_score": "0.102231",
        "ticker_sentiment_score": "0.119803",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medical Device Technologies Market is Anticipated to Reach USD 662.7 billion by 2028: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37004095/medical-device-technologies-market-is-anticipated-to-reach-usd-662-7-billion-by-2028-transparency-",
    "time_published": "20240208T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 08, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global medical device technologies market is estimated to flourish at a CAGR of 4.3% from 2021 to 2028.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.423859,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.063174",
        "ticker_sentiment_score": "0.107762",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.12322",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.063174",
        "ticker_sentiment_score": "0.317822",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.148981",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.145032",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.094638",
        "ticker_sentiment_score": "0.1079",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.221755",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.333601",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.063174",
        "ticker_sentiment_score": "0.193004",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.333601",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.148981",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.031612",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.063174",
        "ticker_sentiment_score": "0.193004",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SEALSQ Broadens Market Reach and Semiconductor Innovation in the United States",
    "url": "https://www.globenewswire.com/news-release/2024/02/09/2826842/0/en/SEALSQ-Broadens-Market-Reach-and-Semiconductor-Innovation-in-the-United-States.html",
    "time_published": "20240209T140600",
    "authors": [
      "SEAL Semiconductors"
    ],
    "summary": "Tortola, British Virgin Islands , Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- SEALSQ Corp ( \"SEALSQ\" or \"Company\" ) ( NASDAQ: LAES ) , a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced a significant leap ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/4071513d-3f7c-4a38-a055-8da38cfb60df",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.251389,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LAES",
        "relevance_score": "0.492118",
        "ticker_sentiment_score": "0.287075",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.040622",
        "ticker_sentiment_score": "-0.00886",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:ECC",
        "relevance_score": "0.040622",
        "ticker_sentiment_score": "0.058794",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Pain Management Devices Market Projected to Attain a Valuation of USD 7.1 billion by 2028, Exhibiting a CAGR of 6.4%: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37032016/pain-management-devices-market-projected-to-attain-a-valuation-of-usd-7-1-billion-by-2028-exhibiti",
    "time_published": "20240209T124500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global pain management devices market is estimated to flourish at a CAGR of 6.4% from 2021 to 2028.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.180755,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.032513",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVRO",
        "relevance_score": "0.032513",
        "ticker_sentiment_score": "0.217442",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.064973",
        "ticker_sentiment_score": "0.077484",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.064973",
        "ticker_sentiment_score": "-0.009135",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.032513",
        "ticker_sentiment_score": "-0.190734",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.129516",
        "ticker_sentiment_score": "0.122344",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.032513",
        "ticker_sentiment_score": "0.202453",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.097325",
        "ticker_sentiment_score": "0.036503",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.032513",
        "ticker_sentiment_score": "-0.008874",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "What's in the Cards for Medtronic  ( MDT )  in Q3 Earnings?",
    "url": "https://www.zacks.com/stock/news/2224881/whats-in-the-cards-for-medtronic-mdt-in-q3-earnings",
    "time_published": "20240212T162400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal third-quarter performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.330028,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GDRX",
        "relevance_score": "0.114318",
        "ticker_sentiment_score": "0.037593",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMSI",
        "relevance_score": "0.114318",
        "ticker_sentiment_score": "0.048685",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.466718",
        "ticker_sentiment_score": "0.508339",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SRPT",
        "relevance_score": "0.114318",
        "ticker_sentiment_score": "0.088738",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Intrathecal Pumps Market Anticipated to Touch USD 405.6 million, Projected a CAGR of 4.5% by 2031: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37070871/intrathecal-pumps-market-anticipated-to-touch-usd-405-6-million-projected-a-cagr-of-4-5-by-2031-tr",
    "time_published": "20240212T152500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 12, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global intrathecal pumps market is estimated to flourish at a CAGR of 4.5% from 2022 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.380917,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.05005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.080115",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GAHC",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.127966",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.22692",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.211061",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.138464",
        "ticker_sentiment_score": "0.266909",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.104078",
        "ticker_sentiment_score": "0.079878",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.17536",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Accelus Strengthens Leadership with New Board Appointments",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37067241/accelus-strengthens-leadership-with-new-board-appointments",
    "time_published": "20240212T134500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "PALM BEACH GARDENS, Fla., Feb. 12, 2024 ( GLOBE NEWSWIRE ) -- Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, has announced the appointment of two new members to its Board of Directors: Kevin McGann ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.37024,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ALC",
        "relevance_score": "0.052918",
        "ticker_sentiment_score": "0.111829",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.052918",
        "ticker_sentiment_score": "0.097973",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCUL",
        "relevance_score": "0.052918",
        "ticker_sentiment_score": "0.111829",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "QuidelOrtho  ( QDEL )  Misses Q4 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2225799/quidelortho-qdel-misses-q4-earnings-and-revenue-estimates",
    "time_published": "20240213T223005",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "QuidelOrtho (QDEL) delivered earnings and revenue surprises of -42.08% and 6.97%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default92.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.148296,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.140485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QDEL",
        "relevance_score": "0.404563",
        "ticker_sentiment_score": "0.13094",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV\u00c9 TO CHAIR OF THE BOARD OF DIRECTORS",
    "url": "https://www.globenewswire.com/news-release/2024/02/13/2828367/0/en/GLUCOTRACK-ANNOUNCES-THE-APPOINTMENT-OF-LUIS-MALAV%C3%89-TO-CHAIR-OF-THE-BOARD-OF-DIRECTORS.html",
    "time_published": "20240213T143000",
    "authors": [
      "Inc.",
      "GlucoTrack"
    ],
    "summary": "Rutherford, NJ, Feb. 13, 2024 ( GLOBE NEWSWIRE ) -- Glucotrack, Inc. ( Nasdaq: GCTK ) ( \"Glucotrack\" or the \"Company\" ) , a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes announced today that Luis Malav\u00e9 has been ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/b8950d4f-96bd-4c9a-936d-f586de9157da",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.321871,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GCTK",
        "relevance_score": "0.614697",
        "ticker_sentiment_score": "0.635948",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.152983",
        "ticker_sentiment_score": "0.051994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.076847",
        "ticker_sentiment_score": "0.040603",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.076847",
        "ticker_sentiment_score": "0.040603",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Advances But Underperforms Market: Key Facts",
    "url": "https://www.zacks.com/stock/news/2226424/medtronic-mdt-advances-but-underperforms-market-key-facts",
    "time_published": "20240214T224518",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the latest trading session, Medtronic (MDT) closed at $83.68, marking a +0.11% move from the previous day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default68.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.166131,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.520477",
        "ticker_sentiment_score": "0.226579",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "What Analyst Projections for Key Metrics Reveal About Medtronic  ( MDT )  Q3 Earnings",
    "url": "https://www.zacks.com/stock/news/2226081/what-analyst-projections-for-key-metrics-reveal-about-medtronic-mdt-q3-earnings",
    "time_published": "20240214T141524",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Medtronic (MDT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default98.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999986"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.12264,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.329992",
        "ticker_sentiment_score": "0.098183",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "DaVita  ( DVA )  Q4 2023 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/02/13/davita-dva-q4-2023-earnings-call-transcript/",
    "time_published": "20240214T010021",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "DVA earnings call for the period ending December 31, 2023.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.274859,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAC",
        "relevance_score": "0.006043",
        "ticker_sentiment_score": "0.140939",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.006043",
        "ticker_sentiment_score": "0.126057",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.018128",
        "ticker_sentiment_score": "0.254355",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications",
    "url": "https://www.prnewswire.com/news-releases/global-advanced-drug-delivery-systems-market-report-2024-review-of-patents-and-patent-applications-filed-on-drug-delivery-release-mechanisms-and-novel-applications-302063265.html",
    "time_published": "20240215T224500",
    "authors": [
      "Research and Markets"
    ],
    "summary": "Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.163653,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVS",
        "relevance_score": "0.042876",
        "ticker_sentiment_score": "0.09682",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.042876",
        "ticker_sentiment_score": "0.09682",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.042876",
        "ticker_sentiment_score": "0.09682",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.042876",
        "ticker_sentiment_score": "0.09682",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Agios Pharmaceuticals  ( AGIO )  Reports Q4 Loss, Misses Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2226669/agios-pharmaceuticals-agio-reports-q4-loss-misses-revenue-estimates",
    "time_published": "20240215T132505",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of -4.88% and 9.84%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999953"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.130444,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.139265",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AGIO",
        "relevance_score": "0.401331",
        "ticker_sentiment_score": "0.138281",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Global Neonatal Intensive Care Analysis Report 2024: Market to Reach $5.23 Billion by 2030 - Enhanced NICU Access and Quality Driven by Global Recognition of Neonatal Care Importance",
    "url": "https://www.prnewswire.com/news-releases/global-neonatal-intensive-care-analysis-report-2024-market-to-reach-5-23-billion-by-2030---enhanced-nicu-access-and-quality-driven-by-global-recognition-of-neonatal-care-importance-302064071.html",
    "time_published": "20240216T193000",
    "authors": [
      "Research and Markets"
    ],
    "summary": "Global Neonatal Intensive Care Analysis Report 2024: Market to Reach $5.23 Billion by 2030 - Enhanced NICU Access ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.410047,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MASI",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.227041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.227041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.227041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DGWPF",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.227041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.227041",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "2 Healthcare Stocks You Can Buy and Hold for the Next Decade",
    "url": "https://www.fool.com/investing/2024/02/16/2-healthcare-stocks-you-can-buy-and-hold-for-the/",
    "time_published": "20240216T121500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "Don't count these companies out too soon.",
    "banner_image": "https://g.foolcdn.com/editorial/images/764648/physician-shaking-patients-hand.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.996718"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      }
    ],
    "overall_sentiment_score": 0.3577,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.353418",
        "ticker_sentiment_score": "0.372289",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.353418",
        "ticker_sentiment_score": "0.395476",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Skin Excision Market to Reach $59.14 Billion by 2031 Owing to Increasing Prevalence of Skin Cancers and Advanced Healthcare Infrastructure | Says Coherent Market Insights",
    "url": "https://www.prnewswire.com/news-releases/skin-excision-market-to-reach-59-14-billion-by-2031-owing-to-increasing-prevalence-of-skin-cancers-and-advanced-healthcare-infrastructure--says-coherent-market-insights-302064945.html",
    "time_published": "20240219T112500",
    "authors": [
      "Coherent Market Insights"
    ],
    "summary": "Skin Excision Market to Reach $59.14 Billion by 2031 Owing to Increasing Prevalence of Skin Cancers and Advanced ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.166227,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.133339",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.133339",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNVVF",
        "relevance_score": "0.02668",
        "ticker_sentiment_score": "0.095391",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q3 Earnings Beat Estimates, 2024 View Up",
    "url": "https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up",
    "time_published": "20240220T191900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/95/59803.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.199491,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CURN",
        "relevance_score": "0.042496",
        "ticker_sentiment_score": "0.190028",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.168785",
        "ticker_sentiment_score": "0.12995",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.250816",
        "ticker_sentiment_score": "0.149666",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.168785",
        "ticker_sentiment_score": "0.030474",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.168785",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q3 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/02/20/medtronic-mdt-q3-2024-earnings-call-transcript/",
    "time_published": "20240220T173016",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "MDT earnings call for the period ending December 31, 2023.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.343521,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.12014",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.12014",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.129688",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.129688",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.080432",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.12014",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.009201",
        "ticker_sentiment_score": "0.165276",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.064337",
        "ticker_sentiment_score": "0.17868",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:UYU",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.073346",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:ARS",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.073346",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.004601",
        "ticker_sentiment_score": "0.232843",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Biotech Crashes 64% After Unexpected Liver Failure Sidelines Two Tests",
    "url": "https://www.investors.com/news/technology/biotech-stock-rapt-crashes-to-record-low-after-side-effect-sidelines-two-clinical-studies/",
    "time_published": "20240220T171400",
    "authors": [
      "ALLISON GATLIN",
      "Investor's Business Daily"
    ],
    "summary": "Biotech Stock Rapt Crashes 65% To Record Low After Side Effect Sidelines Two Clinical Studies Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2024/02/Stock-Raptfda-shutt.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.986714"
      }
    ],
    "overall_sentiment_score": 0.185839,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.120431",
        "ticker_sentiment_score": "0.68065",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "REGN",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "-0.06969",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RAPT",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "-0.154152",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "-0.06969",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Anoscope Market Size Is Expected To Grow At A Rate Of More Than 6% Through 2024-2028 As Per The Business Research Company's Anoscope Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37216847/anoscope-market-size-is-expected-to-grow-at-a-rate-of-more-than-6-through-2024-2028-as-per-the-bus",
    "time_published": "20240220T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 20, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Anoscope Global Market Report 2024, the anoscope market has witnessed robust growth in recent years, fueled by factors such as the prevalence of anorectal disorders, an aging population, and the increasing ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.387933,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.063933",
        "ticker_sentiment_score": "0.272686",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.063933",
        "ticker_sentiment_score": "0.272686",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.063933",
        "ticker_sentiment_score": "0.272686",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Unexpected Setback That Sent This Biotech Tumbling",
    "url": "https://www.investors.com/news/technology/axsm-stock-tumbles-on-an-unexpected-setback-for-axsome-alzheimers-drug/",
    "time_published": "20240220T160800",
    "authors": [
      "Investor's Business Daily",
      "ALLISON GATLIN"
    ],
    "summary": "AXSM Stock Tumbles On An Unexpected Setback For Axsome's Alzheimer's Drug Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2024/02/Stock-AxsomeTherapeutics-02-adobe.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      }
    ],
    "overall_sentiment_score": 0.036713,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.64381",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "AXSM",
        "relevance_score": "0.591634",
        "ticker_sentiment_score": "-0.092693",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "4 Ultra-Safe Passive Income Vehicles to Buy and Hold Forever",
    "url": "https://www.fool.com/investing/2024/02/20/4-ultra-safe-passive-income-vehicles-to-buy-and-ho/",
    "time_published": "20240220T154500",
    "authors": [
      "George Budwell"
    ],
    "summary": "These four dividend stocks won't keep you awake at night.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F765949%2Fpassive-income-2.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999897"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.419094,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.267413",
        "ticker_sentiment_score": "0.442816",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "LMT",
        "relevance_score": "0.162437",
        "ticker_sentiment_score": "0.095751",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.162437",
        "ticker_sentiment_score": "0.141674",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.162437",
        "ticker_sentiment_score": "0.058813",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Is Medtronic Stock Trading Higher Today? - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/02/37213380/medtronic-to-exit-unprofitable-ventilator-product-line-boosts-annual-guidance-on-strong-demand",
    "time_published": "20240220T142456",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Tuesday, Medtronic Plc MDT reported third-quarter 2024 sales of $8.1 billion, up 4.7% year-on-year ( Y/Y ) as reported and 4.6% organic, slightly beating the consensus of $7.95 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Medtronic-PulseSelect-PFA-System.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.388336,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.664235",
        "ticker_sentiment_score": "0.518009",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Surges On Strong Beat, Outlook Boost",
    "url": "https://www.investors.com/news/technology/medtronic-stock-surges-after-easily-beating-quarterly-views-raises-full-year-outlook/",
    "time_published": "20240220T135900",
    "authors": [
      "Investor's Business Daily",
      "ALLISON GATLIN"
    ],
    "summary": "Medtronic Stock Surges After Easily Beating Quarterly Views. Raises Full-Year Outlook Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2019/08/stock-Medtronic-03-shutter.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.918141"
      }
    ],
    "overall_sentiment_score": 0.251597,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.76676",
        "ticker_sentiment_score": "0.309303",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INMD",
        "relevance_score": "0.157483",
        "ticker_sentiment_score": "0.279893",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q3 Earnings and Revenues Beat Estimates",
    "url": "https://www.zacks.com/stock/news/2228310/medtronic-mdt-q3-earnings-and-revenues-beat-estimates",
    "time_published": "20240220T125502",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) delivered earnings and revenue surprises of 3.17% and 1.73%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default251.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.150401,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.402403",
        "ticker_sentiment_score": "0.174592",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Penumbra  ( PEN )  Stock for Now",
    "url": "https://www.zacks.com/stock/news/2228289/heres-why-you-should-retain-penumbra-pen-stock-for-now",
    "time_published": "20240220T121200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors remain optimistic for Penumbra (PEN), backed by the strength of its portfolio.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.995869"
      }
    ],
    "overall_sentiment_score": 0.238738,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.198221",
        "ticker_sentiment_score": "0.098287",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.050044",
        "ticker_sentiment_score": "0.061911",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.050044",
        "ticker_sentiment_score": "0.061911",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.427827",
        "ticker_sentiment_score": "0.332313",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.198221",
        "ticker_sentiment_score": "0.168849",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.050044",
        "ticker_sentiment_score": "0.061911",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.198221",
        "ticker_sentiment_score": "0.105878",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic reports third quarter fiscal 2024 financial results",
    "url": "https://www.prnewswire.com/news-releases/medtronic-reports-third-quarter-fiscal-2024-financial-results-302065574.html",
    "time_published": "20240220T114500",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance",
    "banner_image": "https://mma.prnewswire.com/media/2343029/Medtronic_plc_FY24_Q3_Earnings_Social_Video.mp4?p=medium",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.275771,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.29099",
        "ticker_sentiment_score": "0.227777",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.016541",
        "ticker_sentiment_score": "0.153592",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 American Century Mutual Funds for Excellent Returns",
    "url": "https://www.zacks.com/stock/news/2228248/3-american-century-mutual-funds-for-excellent-returns",
    "time_published": "20240220T110300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Consider investing in American Century mutual funds like AFYDX, AGYWX and ALVDX for consistent performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a8/346.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.270926,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.132004",
        "ticker_sentiment_score": "0.058955",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.132004",
        "ticker_sentiment_score": "0.058955",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.132004",
        "ticker_sentiment_score": "0.058955",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.051063",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRK-A",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.051063",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.051063",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "S&P 500 futures lower as Nvidia dips ahead of earnings midweek",
    "url": "https://www.marketwatch.com/story/s-p-500-futures-lower-as-nvidia-dips-ahead-of-earnings-midweek-2c8696b8",
    "time_published": "20240220T095900",
    "authors": [
      "Jamie Chisholm"
    ],
    "summary": "U.S. stock-index futures moved lower as investors returned from the holiday weekend in cautious mood ahead of earnings reports that will shed light on the health of the consumer and crucial results from AI-darling Nvidia.",
    "banner_image": "https://images.mktw.net/im-05929300/social",
    "source": "MarketWatch",
    "category_within_source": "Top Stories",
    "source_domain": "www.marketwatch.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.905476"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.083744,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "TOL",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MTTR",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.44622",
        "ticker_sentiment_score": "0.026963",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.078611",
        "ticker_sentiment_score": "0.067937",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TDOC",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LGIH",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HD",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.038712",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.156461",
        "ticker_sentiment_score": "0.038712",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Making Earlier Detection of Ovarian Cancer a Reality",
    "url": "https://investingnews.com/making-earlier-detection-of-ovarian-cancer-a-reality/",
    "time_published": "20240220T095615",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance",
    "banner_image": "https://investingnews.com/media-library/cleo-diagnostics.png?id=47662596&width=1200&height=600&coordinates=0%2C75%2C0%2C75",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.491972,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.514619",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/02/37205663/medtronic-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurat",
    "time_published": "20240220T072305",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Medtronic plc MDT is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 20, 2024. Analysts expect the Dublin, Ireland-based company to report quarterly earnings at $1.26 per share, down from year-ago earnings of $1.3 per share.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/20/medtronic_-_logo.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.141614,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.560594",
        "ticker_sentiment_score": "0.286646",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.122894",
        "ticker_sentiment_score": "-0.093712",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts",
    "url": "https://markets.businessinsider.com/news/stocks/medtronic-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-street-s-most-accurate-analysts-1033081780",
    "time_published": "20240220T072305",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Medtronic Gears Up For Q3 Print. Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ...",
    "banner_image": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/02/20/medtronic_-_logo.jpg",
    "source": "Business Insider",
    "category_within_source": "RSS",
    "source_domain": "markets.businessinsider.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.133091,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.465901",
        "ticker_sentiment_score": "0.266353",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.123526",
        "ticker_sentiment_score": "0.063382",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment",
    "url": "https://www.prnewswire.com/apac/news-releases/medithinq-marks-milestone-as-first-asian-startup-to-globally-launch-xr-surgical-displays-securing-key-partnerships-and-multimillion-dollar-investment-302061410.html",
    "time_published": "20240220T060000",
    "authors": [
      "VentureBlick"
    ],
    "summary": "MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/2339447/photo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.37463,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.176287",
        "ticker_sentiment_score": "0.268746",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "MDT vs. LMAT: Which Stock Should Value Investors Buy Now?",
    "url": "https://www.zacks.com/stock/news/2229499/mdt-vs-lmat-which-stock-should-value-investors-buy-now",
    "time_published": "20240221T164013",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "MDT vs. LMAT: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default213.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.714479"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.496392,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.737428",
        "ticker_sentiment_score": "0.633954",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "LMAT",
        "relevance_score": "0.616447",
        "ticker_sentiment_score": "0.596398",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Flexible Endoscopes Market Is Expected To Reach A Value Of $12.9 Billion By 2028 At A CAGR Of More Than 7% As Per The Business Research Company's Flexible Endoscopes Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37240174/flexible-endoscopes-market-is-expected-to-reach-a-value-of-12-9-billion-by-2028-at-a-cagr-of-more-",
    "time_published": "20240221T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Flexible Endoscopes Global Market Report 2024, the flexible endoscopes market has experienced robust growth in recent years, fueled by advancements in medical technology and a rising prevalence of gastrointestinal ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.427554,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.242348",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.242348",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.242348",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Esophageal Catheters Market Set for Strong Growth: Market Size To Reach $3.3 Billion By 2028 As Per The Business Research Company's Esophageal Catheters Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37240178/esophageal-catheters-market-set-for-strong-growth-market-size-to-reach-3-3-billion-by-2028-as-per-",
    "time_published": "20240221T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Esophageal Catheters Global Market Report 2024, the esophageal catheters market has demonstrated robust growth in recent years, driven by critical care advancements, increasing prevalence of cardiac and ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.279153,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.05749",
        "ticker_sentiment_score": "0.09796",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.05749",
        "ticker_sentiment_score": "0.09796",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Disposable Endoscopes Market Overview 2024-2028: Projected Market Size, Major Drivers And Leading Regions As Per The Business Research Company's Disposable Endoscopes Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37240179/disposable-endoscopes-market-overview-2024-2028-projected-market-size-major-drivers-and-leading-re",
    "time_published": "20240221T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the disposable endoscopes market, the disposable endoscopes industry has witnessed remarkable growth in recent years, driven by factors such as infection control, regulatory approvals, cost-efficiency, and ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.370653,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AMBBY",
        "relevance_score": "0.110209",
        "ticker_sentiment_score": "0.233178",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "0.209015",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "0.209015",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.055236",
        "ticker_sentiment_score": "0.209015",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Esophagoscopes And Gastroscopes Market Is Set For Significant Growth At A Rate Of More Than 6% As Per The Business Research Company's Esophagoscopes And Gastroscopes Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37240175/esophagoscopes-and-gastroscopes-market-is-set-for-significant-growth-at-a-rate-of-more-than-6-as-p",
    "time_published": "20240221T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's research on the esophagoscopes and gastroscopes market, the esophagoscopes and gastroscopes market has witnessed robust growth in recent years, driven by the prevalence of gastrointestinal disorders, an aging ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.215123,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.054732",
        "ticker_sentiment_score": "0.119994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.054732",
        "ticker_sentiment_score": "0.119994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.109206",
        "ticker_sentiment_score": "0.133074",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Medtronic Stock a Buy Now?",
    "url": "https://www.fool.com/investing/2024/02/21/is-medtronic-stock-a-buy-now/",
    "time_published": "20240221T145300",
    "authors": [
      "Justin Pope"
    ],
    "summary": "A dividend legend is navigating some bumpy waters right now.",
    "banner_image": "https://media.ycharts.com/charts/fa5190668a291d946798c9d57ed659a2.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.995921"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.10725,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.685178",
        "ticker_sentiment_score": "0.233478",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.046379",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Company News for Feb 21, 2024",
    "url": "https://www.zacks.com/stock/news/2229229/company-news-for-feb-21-2024",
    "time_published": "20240221T142300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Companies in The News Are: ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2c/122.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": -0.022186,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NFLX",
        "relevance_score": "0.674691",
        "ticker_sentiment_score": "-0.060631",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MPC",
        "relevance_score": "0.674691",
        "ticker_sentiment_score": "-0.221813",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.674691",
        "ticker_sentiment_score": "-0.094089",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.674691",
        "ticker_sentiment_score": "0.162458",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Buy Zimmer Biomet  ( ZBH )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2229035/heres-why-you-should-buy-zimmer-biomet-zbh-stock-now",
    "time_published": "20240221T121700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Strategic plans to drive the Knee business bode well for Zimmer Biomet (ZBH).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/1871.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999594"
      }
    ],
    "overall_sentiment_score": 0.323804,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.432291",
        "ticker_sentiment_score": "0.426072",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.180798",
        "ticker_sentiment_score": "0.160744",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.146257",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.180798",
        "ticker_sentiment_score": "0.1496",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.180798",
        "ticker_sentiment_score": "0.09747",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Medtronic Stock Jumped Today",
    "url": "https://www.fool.com/investing/2024/02/20/why-medtronic-stock-jumped-today/",
    "time_published": "20240221T022230",
    "authors": [
      "Steve Symington"
    ],
    "summary": "The medical device leader announced strong quarterly results and raised its full-year outlook.",
    "banner_image": "https://g.foolcdn.com/editorial/images/766103/doctors-reviewing-information-on-tablet-computer.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.998947"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.323477,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.693563",
        "ticker_sentiment_score": "0.679916",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.135347",
        "ticker_sentiment_score": "-0.025988",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Executive is convicted of insider trading related to medical device firm acquisition",
    "url": "https://apnews.com/article/minnesota-insider-trading-mazor-medtronic-7cc47535a6ced90d80931046797ac945",
    "time_published": "20240221T005712",
    "authors": [],
    "summary": "ST. PAUL, Minn. ( AP ) - An executive at a medical device company has been convicted in Minnesota of insider trading for a scheme involving negotiations for the acquisition of the firm that was valued at $1.6 billion, federal prosecutors said Tuesday.",
    "banner_image": "https://dims.apnews.com/dims4/default/d0f4fd4/2147483647/strip/true/crop/3600x2398+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F5d%2F34%2F7bd607b5111b4265988a9a5c0c8d%2F4377e37ed8da48bcb4a1dbab5267a187",
    "source": "Associated Press",
    "category_within_source": "Markets",
    "source_domain": "apnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.04428,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.154455",
        "ticker_sentiment_score": "-0.091571",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Surgical Staplers Market Revenue to Reach USD 8.5 billion by 2031 | Says Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37262345/surgical-staplers-market-revenue-to-reach-usd-8-5-billion-by-2031-says-transparency-market-researc",
    "time_published": "20240222T144000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global surgical staplers market is estimated to flourish at a CAGR of 6.9% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.363138,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LEIC",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.148844",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "-0.211925",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.099202",
        "ticker_sentiment_score": "0.044504",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.099432",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.099202",
        "ticker_sentiment_score": "0.223381",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.099202",
        "ticker_sentiment_score": "0.1188",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Where Will Medtronic Stock Be in 3 Years?",
    "url": "https://www.fool.com/investing/2024/02/22/where-will-medtronic-stock-be-in-3-years/",
    "time_published": "20240222T141500",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Can this struggling medical device maker turn things around?",
    "banner_image": "https://g.foolcdn.com/editorial/images/765981/medical-professional-smiling.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.993856"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.321476,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.811513",
        "ticker_sentiment_score": "0.487958",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "5 Top No-Load Mutual Funds to Enhance Your Returns",
    "url": "https://www.zacks.com/stock/news/2229869/5-top-no-load-mutual-funds-to-enhance-your-returns",
    "time_published": "20240222T122100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in no-load mutual funds like FIKAX, FSPCX, VSMIX, STSEX and BMIIX to ensure high returns.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/55/20158.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.9545"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.13505,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.065061",
        "ticker_sentiment_score": "0.165313",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.047642",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRHI",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.046698",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVE",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.046698",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRK-A",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.047642",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.046698",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRV",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.041985",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.044812",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.081851",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.044812",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GD",
        "relevance_score": "0.032558",
        "ticker_sentiment_score": "0.047642",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Monster Stocks to Buy Without Any Hesitation",
    "url": "https://www.fool.com/investing/2024/02/22/2-monster-stocks-to-buy-without-any-hesitation/",
    "time_published": "20240222T114500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "Investors can sleep easy at night with these stocks in their portfolios.",
    "banner_image": "https://g.foolcdn.com/editorial/images/765695/physician-giving-a-high-five-to-a-young-patient.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      }
    ],
    "overall_sentiment_score": 0.270386,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.23156",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.3007",
        "ticker_sentiment_score": "0.301339",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Ingestible Sensors Market Size to be Worth USD 1.5 billion by 2031, Growing 13.0% CAGR: Insights from Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37256273/ingestible-sensors-market-size-to-be-worth-usd-1-5-billion-by-2031-growing-13-0-cagr-insights-from",
    "time_published": "20240222T112500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global ingestible sensors market was projected to attain US$ 516.7 million in 2022. It is anticipated to garner a 13% CAGR from 2023 to 2031 and by 2031, the market is likely to attain ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.336836,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MOOIF",
        "relevance_score": "0.037213",
        "ticker_sentiment_score": "0.322707",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.037213",
        "ticker_sentiment_score": "0.050573",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.111315",
        "ticker_sentiment_score": "0.302191",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.111315",
        "ticker_sentiment_score": "0.048507",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "If You Invested $10,000 in Medtronic in 2019, This Is How Much You Would Have Today",
    "url": "https://www.fool.com/investing/2024/02/25/if-you-invested-10000-in-medtronic-in-2019-this-is/",
    "time_published": "20240225T193700",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "Medtronic is an excellent dividend-paying company.",
    "banner_image": "https://media.ycharts.com/charts/aabfec2f2cb44be506e57949cad73c70.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.98396"
      }
    ],
    "overall_sentiment_score": 0.19928,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.641196",
        "ticker_sentiment_score": "0.290247",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Buy Edward Lifesciences  ( EW )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2231893/heres-why-you-should-buy-edward-lifesciences-ew-stock-now",
    "time_published": "20240226T165400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999336"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.271747,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EW",
        "relevance_score": "0.249361",
        "ticker_sentiment_score": "0.27727",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.050679",
        "ticker_sentiment_score": "0.146323",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.200688",
        "ticker_sentiment_score": "0.036188",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.050679",
        "ticker_sentiment_score": "0.146323",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.200688",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.200688",
        "ticker_sentiment_score": "0.147212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.050679",
        "ticker_sentiment_score": "0.146323",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Pediatric Medical Devices Market Set to Hit USD 47.4 billion by 2031, with 6.3% CAGR: Analysis by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37313934/pediatric-medical-devices-market-set-to-hit-usd-47-4-billion-by-2031-with-6-3-cagr-analysis-by-tra",
    "time_published": "20240226T153300",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global pediatric medical devices market was projected to attain US$ 27.6 billion in 2022. It is anticipated to garner a 6.3% CAGR from 2023 to 2031 and by 2031, the market is likely to ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.185444,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAX",
        "relevance_score": "0.042346",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.042346",
        "ticker_sentiment_score": "0.051514",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.042346",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.042346",
        "ticker_sentiment_score": "0.074192",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.126561",
        "ticker_sentiment_score": "0.05234",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.042346",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Bridge Builder Mutual Funds for Great Returns",
    "url": "https://www.zacks.com/stock/news/2231388/3-bridge-builder-mutual-funds-for-great-returns",
    "time_published": "20240226T120100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Consider investing in Bridge Builder mutual funds like BBVLX, BBVSX and BBGLX for impressive returns.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6a/353.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.264178,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.077094",
        "ticker_sentiment_score": "0.050549",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AME",
        "relevance_score": "0.077094",
        "ticker_sentiment_score": "0.049537",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.077094",
        "ticker_sentiment_score": "0.047512",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PM",
        "relevance_score": "0.077094",
        "ticker_sentiment_score": "0.047512",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZO",
        "relevance_score": "0.077094",
        "ticker_sentiment_score": "0.049537",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "V",
        "relevance_score": "0.077094",
        "ticker_sentiment_score": "0.050549",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Implantable Loop Recorders Market Revenue to Reach USD 3.1 billion by 2031| Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37306715/implantable-loop-recorders-market-revenue-to-reach-usd-3-1-billion-by-2031-transparency-market-res",
    "time_published": "20240226T095800",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global implantable loop recorders market was projected to attain US$ 1.3 billion in 2022. It is anticipated to garner a 10.2% CAGR from 2023 to 2031 and by 2031, the market is likely ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.236265,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.039353",
        "ticker_sentiment_score": "0.050992",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.039353",
        "ticker_sentiment_score": "-0.016674",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.117678",
        "ticker_sentiment_score": "0.049566",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.078611",
        "ticker_sentiment_score": "0.04761",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Mark Cuban's Surprising Advice: Should Entrepreneurs Heed It?",
    "url": "https://www.forbes.com/sites/dileeprao/2024/02/27/mark-cubans-surprising-advice-should-entrepreneurs-heed-it/",
    "time_published": "20240227T224014",
    "authors": [
      "Dileep Rao"
    ],
    "summary": "Mark Cuban started his first venture at the age of 12 to sell garbage bags. He started his second venture, MicroSolutions after he graduated from college, and then sold it to H&R Block for $6 million in 1990. He then joined his third venture, Broadcast.com, with Chris Jaeb and Todd Wagner in ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65de62e2080274d4e4b44475/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.221176,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNEJF",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "-0.048265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BBY",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "-0.048265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HRB",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UBER",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Norfolk Southern proxy fight draws heavyweight politicians and regulatory scrutiny a year after derailment",
    "url": "https://www.cnbc.com/2024/02/27/norfolk-southern-activists-seek-to-oust-ceo-alan-shaw-replace-board.html",
    "time_published": "20240227T183001",
    "authors": [
      "Rohan Goswami"
    ],
    "summary": "Ancora is seeking to oust Norfolk Southern CEO Alan Shaw in a proxy fight, and bigwig politicians are lining up on either side of the battle.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107376954-17086209031708620901-33438181046-1080pnbcnews.jpg?v=1708620903&w=750&h=422&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.098176,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "HD",
        "relevance_score": "0.023441",
        "ticker_sentiment_score": "0.164462",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.023441",
        "ticker_sentiment_score": "0.081649",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NSC",
        "relevance_score": "0.340602",
        "ticker_sentiment_score": "0.049145",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic",
    "url": "https://www.zacks.com/stock/news/2233110/the-zacks-analyst-blog-highlights-eli-lilly-the-procter-gamble-morgan-stanley-att-and-medtronic",
    "time_published": "20240228T141200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3d/451.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.215939,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.384102",
        "ticker_sentiment_score": "0.13888",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSBHF",
        "relevance_score": "0.079921",
        "ticker_sentiment_score": "0.287274",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.159043",
        "ticker_sentiment_score": "0.039287",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.079921",
        "ticker_sentiment_score": "0.030431",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.052852",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PG",
        "relevance_score": "0.45283",
        "ticker_sentiment_score": "0.361651",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Intracranial Stents Market Projected to Achieve USD 3.4 billion by 2031, with a 5.2% CAGR Growth: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37357287/intracranial-stents-market-projected-to-achieve-usd-3-4-billion-by-2031-with-a-5-2-cagr-growth-tra",
    "time_published": "20240228T100234",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 28, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global intracranial stents market is projected to grow at a CAGR of 5.2% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 3.4 billion is anticipated for the ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.2082,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PEN",
        "relevance_score": "0.040078",
        "ticker_sentiment_score": "0.160178",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.040078",
        "ticker_sentiment_score": "0.051125",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.040078",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.11983",
        "ticker_sentiment_score": "0.036437",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.040078",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.040078",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Endoscopic Camera Market Size Is Expected To Grow At A Rate Of More Than 9% Through 2024-2028 As Per The Business Research Company's Endoscopic Camera Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37398975/endoscopic-camera-market-size-is-expected-to-grow-at-a-rate-of-more-than-9-through-2024-2028-as-pe",
    "time_published": "20240229T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Endoscopic Camera Global Market Report 2024, the endoscopic camera market has witnessed robust growth in recent years, with significant advancements in minimally invasive surgery, medical training, and patient ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.276314,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.155008",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.155008",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.155008",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Urinary Incontinence Treatment Devices Market Size is Estimated to Reach USD 6.02 billion by 2030, Growing at a CAGR of 6.58%: Straits Research",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37453577/global-urinary-incontinence-treatment-devices-market-size-is-estimated-to-reach-usd-6-02-billion-b",
    "time_published": "20240304T130500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- A medical disease called urinary incontinence causes uncontrollable urine loss. Medical devices are used to treat chronic urine incontinence and to grow and strengthen the pelvic floor muscles.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.144111,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "META",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.105774",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade",
    "url": "https://www.fool.com/investing/2024/03/05/3-high-yield-sp-500-dividend-stocks-down-more-than/",
    "time_published": "20240305T113700",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "Each of these companies has decades-long consecutive annual dividend-raising streaks.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F767798%2Finvestment-presentation-getty.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.986714"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.330708,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MCO",
        "relevance_score": "0.061003",
        "ticker_sentiment_score": "0.320427",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MO",
        "relevance_score": "0.298023",
        "ticker_sentiment_score": "0.165019",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DG",
        "relevance_score": "0.061003",
        "ticker_sentiment_score": "0.227151",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FDX",
        "relevance_score": "0.061003",
        "ticker_sentiment_score": "0.227151",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.298023",
        "ticker_sentiment_score": "0.352803",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "O",
        "relevance_score": "0.298023",
        "ticker_sentiment_score": "0.38726",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "InnovationRx: Biopharma VCs Placed Fewer But Surer Bets In 2023",
    "url": "https://www.forbes.com/sites/alexknapp/2024/03/06/innovationrx-biopharma-vcs-placed-fewer-but-surer-bets-in-2023/",
    "time_published": "20240306T224839",
    "authors": [
      "Katie Jennings"
    ],
    "summary": "Biopharma venture capitalists placed fewer bets in 2023, per PitchBook Forbes ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65e4f1630e643d81ee8fec49/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.007238,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.093289",
        "ticker_sentiment_score": "-0.058102",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "-0.320867",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "WBA",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "0.003996",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients",
    "url": "https://www.globenewswire.com/news-release/2024/03/06/2841438/0/en/Orchestra-BioMed-Announces-Presentation-of-Results-from-Clinical-Study-Demonstrating-Favorable-Hemodynamic-Effects-of-AVIM-Therapy-In-Hypertensive-Pacemaker-Patients.html",
    "time_published": "20240306T133700",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., March 06, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the presentation of new ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.121876,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.017638",
        "ticker_sentiment_score": "0.069578",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.140382",
        "ticker_sentiment_score": "0.103987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.226193",
        "ticker_sentiment_score": "0.141842",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.017638",
        "ticker_sentiment_score": "0.083067",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Recalls Neurosurgery Catheter Tubing, FDA Identifies As Serious Recall - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/03/37544478/medtronic-recalls-neurosurgery-catheter-tubing-fda-identifies-as-serious-recall",
    "time_published": "20240307T195702",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Medtronic Plc's MDT Neurosurgery unit on Thursday said it is recalling the Duet External Drainage and Monitoring System ( EDMS ) catheter tubing due to a potential for the catheter disconnection from the patient line stopcock connectors.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/MDT.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.215593,
    "overall_sentiment_label": "Somewhat-Bearish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.416844",
        "ticker_sentiment_score": "0.259915",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed to Participate in Upcoming Investor Conferences",
    "url": "https://www.globenewswire.com/news-release/2024/03/07/2842179/0/en/Orchestra-BioMed-to-Participate-in-Upcoming-Investor-Conferences.html",
    "time_published": "20240307T130000",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., March 07, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.11866,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.102172",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.092812",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.423054",
        "ticker_sentiment_score": "0.264237",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.092812",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Medical Device Stocks to Buy Hand Over Fist in March",
    "url": "https://www.fool.com/investing/2024/03/08/2-medical-device-stocks-to-buy-hand-over-fist/",
    "time_published": "20240308T141500",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Don't let their modest gains over the past year mislead you. these stocks can make for great long-term investments.",
    "banner_image": "https://g.foolcdn.com/editorial/images/768037/medical-professional-smiling.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.917436"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99793"
      }
    ],
    "overall_sentiment_score": 0.394669,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.374714",
        "ticker_sentiment_score": "0.468722",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.374714",
        "ticker_sentiment_score": "0.386946",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets for diabetes management",
    "url": "https://investingnews.com/new-real-world-data-shows-minimed-780g-system-sustains-strong-global-performance-exceeding-international-targets-for-diabetes-management/",
    "time_published": "20240309T113515",
    "authors": [
      "Investing News Network"
    ],
    "summary": "New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets ... Investing News Network ...",
    "banner_image": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy81MTI3NDYwMC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcxNzQ1OTMwNn0.kjLEuLnBAc8utn4dfQyabjMGtO9KVSvQh1965g2yHPE/img.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.310957,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.343279",
        "ticker_sentiment_score": "0.298504",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "THCH",
        "relevance_score": "0.03545",
        "ticker_sentiment_score": "0.139324",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "New real-world data shows MiniMed\u2122 780G system sustains strong global performance, exceeding international ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/new-real-world-data-shows-minimed-780g-system-sustains-strong-global-performance-exceeding-international-targets-for-diabetes-management-302084607.html",
    "time_published": "20240309T104000",
    "authors": [],
    "summary": "New real-world data shows MiniMed\u2122 780G system sustains strong global performance, exceeding international ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.29556,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.387875",
        "ticker_sentiment_score": "0.299624",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.033703",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic's  ( MDT )  MiniMed 780G System Study Data Favorable",
    "url": "https://www.zacks.com/stock/news/2238698/medtronics-mdt-minimed-780g-system-study-data-favorable",
    "time_published": "20240311T131700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.988787"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.262765,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CAH",
        "relevance_score": "0.199447",
        "ticker_sentiment_score": "0.134178",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.341587",
        "ticker_sentiment_score": "0.343822",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.199447",
        "ticker_sentiment_score": "0.034428",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.199447",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Surgical Sutures Market size is set to grow by USD 1102.57 mn from 2023-2027. Increase in volume of surgeries boost ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/surgical-sutures-market-size-is-set-to-grow-by-usd-1102-57-mn-from-2023-2027--increase-in-volume-of-surgeries-boost-the-market--technavio-302084033.html",
    "time_published": "20240311T081600",
    "authors": [],
    "summary": "Surgical Sutures Market size is set to grow by USD 1102.57 mn from 2023-2027. Increase in volume of surgeries boost ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.5"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.076667,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.044141",
        "ticker_sentiment_score": "-0.044637",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "E",
        "relevance_score": "0.044141",
        "ticker_sentiment_score": "0.161694",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.044141",
        "ticker_sentiment_score": "0.012994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.088147",
        "ticker_sentiment_score": "-0.047171",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now",
    "url": "https://www.zacks.com/stock/news/2239072/heres-why-you-should-retain-medtronic-mdt-stock-for-now",
    "time_published": "20240312T120300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.997845"
      }
    ],
    "overall_sentiment_score": 0.319885,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CAH",
        "relevance_score": "0.158781",
        "ticker_sentiment_score": "0.148603",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.2741",
        "ticker_sentiment_score": "0.335866",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.158781",
        "ticker_sentiment_score": "0.103728",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.039944",
        "ticker_sentiment_score": "0.095015",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.158781",
        "ticker_sentiment_score": "0.090542",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.039944",
        "ticker_sentiment_score": "0.095015",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "IBD Stock Of The Day Lingers In Buy Zone As Diabetes Play Eyes Obesity",
    "url": "https://www.investors.com/research/ibd-stock-of-the-day/dexcom-stock-buy-zone-diabetes-obesity-continuous-glucose-monitors/",
    "time_published": "20240313T160442",
    "authors": [
      "ALLISON GATLIN",
      "Investor's Business Daily"
    ],
    "summary": "Dexcom ( DXCM ) is Wednesday's IBD Stock Of The Day. Dexcom stock is lingering in a buy zone, bolstered by U.S. clearance of a new body-worn glucose monitor. The company developed Stelo, its newest continuous glucose monitor, for the roughly 25 million people in the U.S. with type 2 diabetes ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2024/03/SOTD-3-13-24DXCM.png",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.996023"
      }
    ],
    "overall_sentiment_score": 0.138038,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.053149",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.10132",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.10132",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.057767",
        "ticker_sentiment_score": "-0.23901",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.531326",
        "ticker_sentiment_score": "0.152339",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.053149",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Globus Medical  ( GMED )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2240217/heres-why-you-should-retain-globus-medical-gmed-stock-now",
    "time_published": "20240313T160100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.228581,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.181748",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.181748",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.289462",
        "ticker_sentiment_score": "0.273524",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.24289",
        "ticker_sentiment_score": "0.152285",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.181748",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.195419",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.195419",
        "ticker_sentiment_score": "0.132129",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.181748",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Funding Commitment Agreement Update",
    "url": "https://investingnews.com/funding-commitment-agreement-update/",
    "time_published": "20240314T054947",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced two oral presentations were given at the Cardiovascular Research Technologies ( ...",
    "banner_image": "https://investingnews.com/media-library/cardiex-limited.png?id=51731485&width=1200&height=600&coordinates=0%2C75%2C0%2C75",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.0165,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.209365",
        "ticker_sentiment_score": "0.011475",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.574235",
        "ticker_sentiment_score": "0.024003",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Think Stock Prices Are Too High? 5 Ways to Prepare for a Drop.",
    "url": "https://www.barrons.com/amp/articles/stock-market-defensive-plays-97e5c1c5",
    "time_published": "20240315T171700",
    "authors": [
      "Teresa Rivas"
    ],
    "summary": "Think the Market Is Too Hot? 5 Ways to Get Defensive Now. ...",
    "banner_image": "https://images.barrons.com/im-35403619/social",
    "source": "Barrons",
    "category_within_source": "n/a",
    "source_domain": "www.barrons.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.174517,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CELH",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.108004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.144574",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MO",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "-0.170977",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "KHC",
        "relevance_score": "0.149656",
        "ticker_sentiment_score": "-0.203166",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "CL",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.16537",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CBOE",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.16537",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AGR",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.108004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.160818",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.160818",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MA",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.160818",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "KDP",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.108004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CME",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "0.16537",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.075161",
        "ticker_sentiment_score": "-0.170977",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Fortune Launches First Innovation Forum in Hong Kong March 27- 28",
    "url": "https://www.prnewswire.com/news-releases/fortune-launches-first-innovation-forum-in-hong-kong-march-27--28-302090419.html",
    "time_published": "20240315T133200",
    "authors": [
      "Fortune Media (USA) Corporation"
    ],
    "summary": "All new annual conference on critical issues in tech, finance, talent and energy, with a spotlight on Asia and convening industry leaders and investors from some of the world's most dynamic companies Over 60 speakers, including top executives from Google, Amazon, Intel, Nike, Rakuten, Walmart, ...",
    "banner_image": "https://mma.prnewswire.com/media/2167808/Fortune_Media_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.530977,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.170598",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HKXCF",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.173925",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RKUNF",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.170598",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NKE",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.170598",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ACN",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.263773",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.170598",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.05234",
        "ticker_sentiment_score": "0.170598",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 Companies With Strong Irish Operations",
    "url": "https://www.fool.com/investing/2024/03/17/3-companies-with-strong-irish-operations/",
    "time_published": "20240317T084500",
    "authors": [
      "Chuck Saletta",
      "and Jason Hall",
      "Eric Volkman"
    ],
    "summary": "St. Patrick's Day provides the perfect opportunity to raise a toast to some of the great companies that operate from the Emerald Isle.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F769419%2Fimg_7612.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.260338,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ACN",
        "relevance_score": "0.276313",
        "ticker_sentiment_score": "0.236465",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.313817",
        "ticker_sentiment_score": "0.30267",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DEO",
        "relevance_score": "0.199365",
        "ticker_sentiment_score": "0.154086",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Buy Insulet  ( PODD )  Stock Right Now",
    "url": "https://www.zacks.com/stock/news/2241929/heres-why-you-should-buy-insulet-podd-stock-right-now",
    "time_published": "20240318T122300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors remain confident in the Insulet (PODD) stock due to the huge success of Omnipod 5.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.998917"
      }
    ],
    "overall_sentiment_score": 0.239111,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PODD",
        "relevance_score": "0.358798",
        "ticker_sentiment_score": "0.280503",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.184246",
        "ticker_sentiment_score": "0.162927",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.046452",
        "ticker_sentiment_score": "0.150407",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.13873",
        "ticker_sentiment_score": "0.076301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.184246",
        "ticker_sentiment_score": "0.098811",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here Are My Top Artificial Intelligence  ( AI )  Stocks to Buy in March",
    "url": "https://www.fool.com/investing/2024/03/18/here-are-my-top-artificial-intelligence-ai-stocks/",
    "time_published": "20240318T073000",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "AI already is boosting revenue at these companies...",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F769439%2Fgettyimages-1320686310.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.875462"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.336203,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.156024",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.274628",
        "ticker_sentiment_score": "0.309211",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SMCI",
        "relevance_score": "0.111747",
        "ticker_sentiment_score": "0.102373",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLTR",
        "relevance_score": "0.111747",
        "ticker_sentiment_score": "0.200134",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cartilage Repair Market Anticipates Rapid Growth, Projected To Reach $2.3 Billion In 2028 As Per The Business Research Company's Cartilage Repair Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37826138/cartilage-repair-market-anticipates-rapid-growth-projected-to-reach-2-3-billion-in-2028-as-per-the",
    "time_published": "20240319T154000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The Business Research Company's Cartilage Repair Market Global Report 2024 forecasts significant growth, with the cartilage repair market size expected to rise from $1.24 billion in 2023 to $1.42 billion in 2024, demonstrating a compound annual growth ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.289805,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.056407",
        "ticker_sentiment_score": "0.10634",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.056407",
        "ticker_sentiment_score": "0.10634",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BVS",
        "relevance_score": "0.112532",
        "ticker_sentiment_score": "0.235268",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.056407",
        "ticker_sentiment_score": "0.10634",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cardiovascular Implants Market Poised For Strong Growth, Reaching $34.5 Billion In 2028: Latest Report Unveils Insights As Per The Business Research Company's Cardiovascular Implants Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37826136/cardiovascular-implants-market-poised-for-strong-growth-reaching-34-5-billion-in-2028-latest-repor",
    "time_published": "20240319T154000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The global cardiovascular implants market is experiencing robust growth, as highlighted in the newest report \"Cardiovascular Implants Market Global Report 2024\", by The Business Research Company.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.353544,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.348987",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.348987",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.106778",
        "ticker_sentiment_score": "0.321013",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "People with darker skin are 32% more likely to have pulse oximeter readings overestimate oxygen levels, report says",
    "url": "https://www.cnn.com/2024/03/20/health/pulse-oximeter-skin-tone/index.html",
    "time_published": "20240320T214500",
    "authors": [
      "Jacqueline Howard"
    ],
    "summary": "Scientists have long known that pulse oximeters are less accurate when used for people with dark skin tones - and now, a new report offers some insight into just how much more inaccurate these fingertip clamps can be.",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/221206112315-20221206-oximeter-inaccuracy-illustration.jpg?c=16x9&q=h_144,w_256,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "www.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.019209,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.05986",
        "ticker_sentiment_score": "0.038019",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.029951",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities' - Getty Images Holdings  ( NYSE:GETY ) , GE HealthCare Techs  ( NASDAQ:GEHC ) ",
    "url": "https://www.benzinga.com/markets/equities/24/03/37838206/jim-cramer-reveals-nvidias-non-tech-partners-that-can-be-potential-market-winner-best-opportunit",
    "time_published": "20240320T030350",
    "authors": [
      "Benzinga Neuro"
    ],
    "summary": "CNBC host Jim Cramer has spotlighted several lesser-known partners of NVIDIA Corp NVDA that could potentially benefit from the company's advanced artificial intelligence ( AI ) technology.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/jim-cramer-nvidia-shutter_6.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.274768,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.181137",
        "ticker_sentiment_score": "0.218314",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.507932",
        "ticker_sentiment_score": "0.261207",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SSTK",
        "relevance_score": "0.181137",
        "ticker_sentiment_score": "0.145654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GETY",
        "relevance_score": "0.181137",
        "ticker_sentiment_score": "0.145654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.091162",
        "ticker_sentiment_score": "0.158334",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.181137",
        "ticker_sentiment_score": "0.218314",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents",
    "url": "https://www.newswire.ca/news-releases/u-s-patent-office-rejects-axonics-latest-challenge-to-medtronic-patents-810336965.html",
    "time_published": "20240321T185100",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "DUBLIN, March 21, 2024 /CNW/ -- Medtronic ( NYSE:MDT ) , the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board ( PTAB ) of the U.S.",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.116829,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.819822",
        "ticker_sentiment_score": "0.223634",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.319933",
        "ticker_sentiment_score": "0.028799",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/03/37876726/looking-into-medtronics-recent-short-interest",
    "time_published": "20240321T171522",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has fallen 9.76% since its last report. The company recently reported that it has 9.81 million shares sold short, which is 0.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.77 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Down 2.2% Since Last Earnings Report: Can It Rebound?",
    "url": "https://www.zacks.com/stock/news/2244247/medtronic-mdt-down-22-since-last-earnings-report-can-it-rebound",
    "time_published": "20240321T153029",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default38.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      }
    ],
    "overall_sentiment_score": 0.212509,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.277958",
        "ticker_sentiment_score": "0.112169",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.047278",
        "ticker_sentiment_score": "0.197614",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PBH",
        "relevance_score": "0.047278",
        "ticker_sentiment_score": "0.061108",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Bull Market and Beyond: 2 Stocks to Buy and Hold Forever",
    "url": "https://www.fool.com/investing/2024/03/21/bull-market-and-beyond-2-stocks-to-buy-and-hold/",
    "time_published": "20240321T134500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "These stocks have been providing excellent returns for a long time.",
    "banner_image": "https://g.foolcdn.com/editorial/images/769484/doctor-smiling-and-holding-patients-hand.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.354035,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.382193",
        "ticker_sentiment_score": "0.502221",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "1 Magnificent Growth Stock to Buy and Hold",
    "url": "https://www.fool.com/investing/2024/03/21/1-magnificent-growth-stock-to-buy-and-hold/",
    "time_published": "20240321T124500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "Investing in this company 10 years ago would have produced excellent returns, but it's not too late -- far from it.",
    "banner_image": "https://media.ycharts.com/charts/c61dc5c86256b5d93b6ae8dff7ca618f.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.171972,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.062597",
        "ticker_sentiment_score": "0.036019",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.567746",
        "ticker_sentiment_score": "0.216088",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.124809",
        "ticker_sentiment_score": "0.041961",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tandem Diabetes  ( TNDM )  Gains From Innovation Amid Competition",
    "url": "https://www.zacks.com/stock/news/2245088/tandem-diabetes-tndm-gains-from-innovation-amid-competition",
    "time_published": "20240322T162400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Tandem Diabetes (TNDM), in 2024, intends to advance its AID algorithm and expand its indications to include people living with Type 2 diabetes.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      }
    ],
    "overall_sentiment_score": 0.242862,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.052674",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.196847",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.106083",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.180798",
        "ticker_sentiment_score": "0.041454",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.106083",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.052674",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.090989",
        "ticker_sentiment_score": "0.130005",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Artificial Intelligence  ( AI )  in Healthcare: 2 Top Stock Picks",
    "url": "https://www.fool.com/investing/2024/03/23/artificial-intelligence-in-healthcare-2-top-buys/",
    "time_published": "20240323T074600",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These particular healthcare stocks are dirt cheap now considering their AI potential.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770101%2Fgettyimages-872676342-1200x800-5b2df79.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.417081,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.104449",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.43768",
        "ticker_sentiment_score": "0.60294",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.43768",
        "ticker_sentiment_score": "0.397308",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "IBM",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.208558",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Peer-Review Further Supports CLEO's Ovarian Cancer Detection Technology",
    "url": "https://investingnews.com/peer-review-further-supports-cleos-ovarian-cancer-detection-technology/",
    "time_published": "20240324T234717",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Medtronic moves for patent infringement litigation to resume Medtronic ( NYSE:MDT ) , the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board ( PTAB ) of the U.S.",
    "banner_image": "https://investingnews.com/media-library/cleo-diagnostics.png?id=47662596&width=1200&height=600&coordinates=0%2C75%2C0%2C75",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.243064,
    "overall_sentiment_label": "Somewhat-Bearish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.981374",
        "ticker_sentiment_score": "-0.421144",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.443626",
        "ticker_sentiment_score": "-0.169593",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Abbott  ( ABT )  Expands in Canada With First Eterna SCS Use",
    "url": "https://www.zacks.com/stock/news/2245409/abbott-abt-expands-in-canada-with-first-eterna-scs-use",
    "time_published": "20240325T131500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.166758,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.104002",
        "ticker_sentiment_score": "0.078013",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVRO",
        "relevance_score": "0.206245",
        "ticker_sentiment_score": "0.046751",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer",
    "url": "https://markets.businessinsider.com/news/stocks/tricares-announces-the-appointment-of-ahmed-elmouelhi-as-president-chief-executive-officer-1033191681",
    "time_published": "20240325T060000",
    "authors": [
      "markets.businessinsider.com"
    ],
    "summary": "Paris, France and Munich, Germany, March 25, 2024 - TRiCares SAS ( \"TRiCares\" ) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer ( CEO ) .",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/b7926093-fc48-4e23-bec8-3dc7cbed4110/image2.jpeg",
    "source": "Business Insider",
    "category_within_source": "RSS",
    "source_domain": "markets.businessinsider.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.325206,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.053992",
        "ticker_sentiment_score": "0.127",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATRC",
        "relevance_score": "0.053992",
        "ticker_sentiment_score": "0.127",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.053992",
        "ticker_sentiment_score": "0.127",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Prediction: Healthcare Stocks Could Become the Biggest Winners of the Artificial Intelligence  ( AI )  Boom and Here's Why.",
    "url": "https://www.fool.com/investing/2024/03/26/prediction-healthcare-stocks-may-be-big-ai-winners/",
    "time_published": "20240326T140000",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "A key player in AI is very optimistic about the technology's potential in healthcare.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770377%2Fgettyimages-1253877215.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.419737,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.215894",
        "ticker_sentiment_score": "0.058595",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.41627",
        "ticker_sentiment_score": "0.360928",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors",
    "url": "https://www.globenewswire.com/news-release/2024/03/26/2852278/0/en/Orchestra-BioMed-Announces-Appointment-of-Medical-Device-Industry-Expert-David-Pacitti-to-Board-of-Directors.html",
    "time_published": "20240326T120000",
    "authors": [
      "Inc.",
      "Orchestra BioMed Holdings"
    ],
    "summary": "NEW HOPE, Pa., March 26, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the appointment of David ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.185658,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.032121",
        "ticker_sentiment_score": "0.089376",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.06419",
        "ticker_sentiment_score": "0.12045",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.427081",
        "ticker_sentiment_score": "0.330286",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.06419",
        "ticker_sentiment_score": "0.12045",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst - Boston Scientific  ( NYSE:BSX ) , Johnson & Johnson  ( NYSE:JNJ ) , Medtronic  ( NYSE:MDT ) , Shockwave Medical  ( NASDAQ:SWAV ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37970454/johnson-johnson-strong-strategic-fit-for-shockwave-medical-but-medtronic-boston-sci",
    "time_published": "20240327T202327",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Tuesday, Shockwave Medical Inc SWAV shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson JNJ is reportedly in talks to acquire the company. Shockwave Medical is a cardiovascular medical device.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Johnson-and-Johnson_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.311393,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.331765",
        "ticker_sentiment_score": "0.448714",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.331765",
        "ticker_sentiment_score": "0.448714",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SWAV",
        "relevance_score": "0.883917",
        "ticker_sentiment_score": "0.4855",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.608634",
        "ticker_sentiment_score": "0.494139",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update",
    "url": "https://www.globenewswire.com/news-release/2024/03/27/2853625/0/en/Orchestra-BioMed-Reports-Full-Year-2023-Financial-Results-and-Provides-Fourth-Quarter-Business-Update.html",
    "time_published": "20240327T201700",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., March 27, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.259681,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.020404",
        "ticker_sentiment_score": "0.058491",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.081483",
        "ticker_sentiment_score": "0.148825",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.260474",
        "ticker_sentiment_score": "0.274985",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.20186",
        "ticker_sentiment_score": "0.210205",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why Is Medtronic Stock Trading Higher On Wednesday? - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/03/37967261/medtronics-latest-generation-of-transcatheter-aortic-valve-replacement-implant-passes-fdas-muster-",
    "time_published": "20240327T181401",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Wednesday, the FDA approved Medtronic plc's MDT Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.245174,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.381463",
        "ticker_sentiment_score": "0.275997",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Buy Zimmer Biomet  ( ZBH )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2246920/heres-why-you-should-buy-zimmer-biomet-zbh-stock-now",
    "time_published": "20240327T162300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Zimmer Biomet (ZBH), led by expansion in the knee business and recovery across the business.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999336"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.261595,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.318897",
        "ticker_sentiment_score": "0.27015",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.161485",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.230892",
        "ticker_sentiment_score": "0.105112",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.161485",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.185662",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.185662",
        "ticker_sentiment_score": "0.137475",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.161485",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:CHF",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.038894",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:JPY",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.038894",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.038894",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis",
    "url": "https://investingnews.com/medtronic-announces-fda-approval-of-newest-generation-evolut-tavr-system-for-treatment-of-symptomatic-severe-aortic-stenosis/",
    "time_published": "20240327T124523",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... Investing News Network ...",
    "banner_image": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy81MTI3NDYwMC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcxNzQ1OTMwNn0.kjLEuLnBAc8utn4dfQyabjMGtO9KVSvQh1965g2yHPE/img.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.210215,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.503559",
        "ticker_sentiment_score": "0.410573",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... - Canada NewsWire",
    "url": "https://www.newswire.ca/news-releases/medtronic-announces-fda-approval-of-newest-generation-evolut-tavr-system-for-treatment-of-symptomatic-severe-aortic-stenosis-865092119.html",
    "time_published": "20240327T120000",
    "authors": [],
    "summary": "Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... Canada ...",
    "banner_image": null,
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.191669,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.410697",
        "ticker_sentiment_score": "0.352677",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000",
    "url": "https://www.fool.com/investing/2024/03/27/3-no-brainer-healthcare-stocks-to-buy-right-now/",
    "time_published": "20240327T085000",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "Each of these three companies are entering a new era of growth.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770674%2Finvestors-look-at-tablet-outside.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999346"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.330564,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.305058",
        "ticker_sentiment_score": "0.485723",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "VRTX",
        "relevance_score": "0.052112",
        "ticker_sentiment_score": "0.049686",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.206245",
        "ticker_sentiment_score": "0.11208",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "National Vision  ( EYE )  Down 4.1% Since Last Earnings Report: Can It Rebound?",
    "url": "https://www.zacks.com/stock/news/2247526/national-vision-eye-down-41-since-last-earnings-report-can-it-rebound",
    "time_published": "20240328T153041",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default109.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.998645"
      }
    ],
    "overall_sentiment_score": 0.08546,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "EYE",
        "relevance_score": "0.499789",
        "ticker_sentiment_score": "0.129629",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.21258",
        "ticker_sentiment_score": "0.058225",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.107255",
        "ticker_sentiment_score": "0.106385",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Shockwave Medical  ( SWAV )  Up on Potential Acquisition Rumors",
    "url": "https://www.zacks.com/stock/news/2247467/shockwave-medical-swav-up-on-potential-acquisition-rumors",
    "time_published": "20240328T140200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Shockwave Medical's (SWAV) shares gain as rumors about its potential acquisition by an industry giant get media attention.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      }
    ],
    "overall_sentiment_score": 0.273013,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CAH",
        "relevance_score": "0.215574",
        "ticker_sentiment_score": "0.058873",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.072655",
        "ticker_sentiment_score": "0.187663",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.144708",
        "ticker_sentiment_score": "0.079357",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.072655",
        "ticker_sentiment_score": "0.187663",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SWAV",
        "relevance_score": "0.684158",
        "ticker_sentiment_score": "0.438425",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.284696",
        "ticker_sentiment_score": "0.228902",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Ben & Jerry's Long, Strange Trip to a Multibillion-Dollar Valuation",
    "url": "https://www.barrons.com/amp/articles/ben-jerrys-unilever-multibillion-dollar-valuation-48f01dc6",
    "time_published": "20240328T053000",
    "authors": [
      "Andy Serwer"
    ],
    "summary": "In a game of word association, \"ice cream\" and \"complexity\" might not leap to mind, but these days they should. You probably saw last week that global goliath Unilever said it was looking to jettison its ice cream business, which includes America's grooviest company, Ben & Jerry's.",
    "banner_image": "https://images.barrons.com/im-01366946/social",
    "source": "Barrons",
    "category_within_source": "n/a",
    "source_domain": "www.barrons.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      }
    ],
    "overall_sentiment_score": 0.054733,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BCS",
        "relevance_score": "0.02665",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.02665",
        "ticker_sentiment_score": "-0.026876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NSRGF",
        "relevance_score": "0.02665",
        "ticker_sentiment_score": "0.003655",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRK-A",
        "relevance_score": "0.02665",
        "ticker_sentiment_score": "-0.036155",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UL",
        "relevance_score": "0.261678",
        "ticker_sentiment_score": "-0.013946",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Titan Medical Reports Fiscal Year 2023 Results",
    "url": "https://www.globenewswire.com/news-release/2024/03/29/2854853/0/en/Titan-Medical-Reports-Fiscal-Year-2023-Results.html",
    "time_published": "20240329T214100",
    "authors": [
      "Titan Medical Inc."
    ],
    "summary": "TORONTO, Ontario, March 29, 2024 ( GLOBE NEWSWIRE ) -- Titan Medical Inc. ( \"Titan\" or the \"Company\" ) ( TSX: TMD. OTC: TMDIF ) , today reported financial results for the fiscal year ended December 31, 2023.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/e9df9371-cb74-4840-8337-d9d5faea1dce",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.271129,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.107016",
        "ticker_sentiment_score": "0.2279",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.035768",
        "ticker_sentiment_score": "0.157169",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMDIF",
        "relevance_score": "0.142355",
        "ticker_sentiment_score": "0.211099",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade",
    "url": "https://www.fool.com/investing/2024/03/30/3-reliable-dividend-growth-stocks-with-yields-abov/",
    "time_published": "20240330T091900",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "These advantaged businesses have what it takes to keep raising their payouts.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F770568%2Fgroup-of-investors-looking-at-charts.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.967321"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      }
    ],
    "overall_sentiment_score": 0.238472,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABBV",
        "relevance_score": "0.146916",
        "ticker_sentiment_score": "-0.045412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.049221",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.098255",
        "ticker_sentiment_score": "0.049573",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SWAV",
        "relevance_score": "0.049221",
        "ticker_sentiment_score": "0.133067",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.098255",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance",
    "url": "https://www.fool.com/investing/2024/03/31/better-dividend-stock-medtronic-vs-walgreens-boots/",
    "time_published": "20240331T181700",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "Which dividend-paying healthcare stock is better positioned to produce a rapidly growing payout?",
    "banner_image": "https://media.ycharts.com/charts/3a94aeb185f7486db5df46d000e6ef23.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.149059,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.31482",
        "ticker_sentiment_score": "0.229714",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WBA",
        "relevance_score": "0.192183",
        "ticker_sentiment_score": "-0.065914",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Healthcare Artificial Intelligence  ( AI )  Stocks That Could Be Smart Investment Bets",
    "url": "https://www.fool.com/investing/2024/03/31/2-healthcare-artificial-intelligence-stocks-that/",
    "time_published": "20240331T114500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "There are many ways to cash in on the rise of AI.",
    "banner_image": "https://media.ycharts.com/charts/53b4c3303e0bc94c8815885f91f799c8.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.333497,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.576851",
        "ticker_sentiment_score": "0.529084",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.439786",
        "ticker_sentiment_score": "0.337208",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Smartest Dividend Stocks to Buy With $400 Right Now",
    "url": "https://www.fool.com/investing/2024/03/31/the-smartest-dividend-stocks-to-buy-with-400-now/",
    "time_published": "20240331T102000",
    "authors": [
      "Selena Maranjian"
    ],
    "summary": "Dividend-payers aren't just for your grandparents -- they actually outperform non-payers, according to one study.",
    "banner_image": "https://g.foolcdn.com/editorial/images/770240/getty-peace-of-mind-sleep-at-night-financial-security.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.918141"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99737"
      }
    ],
    "overall_sentiment_score": 0.30627,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.16849",
        "ticker_sentiment_score": "0.179126",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SBUX",
        "relevance_score": "0.380426",
        "ticker_sentiment_score": "0.297707",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PEP",
        "relevance_score": "0.112797",
        "ticker_sentiment_score": "0.069453",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results - Acutus Medical  ( NASDAQ:AFIB ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38032455/acutus-medical-reports-fourth-quarter-and-full-year-2023-financial-results",
    "time_published": "20240401T200500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "CARLSBAD, Calif., April 01, 2024 ( GLOBE NEWSWIRE ) -- Acutus Medical, Inc. ( \"Acutus\" or the \"Company\" ) AFIB today reported results for the fourth quarter and full year ended December 31,2023.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999894"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.201029,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AFIB",
        "relevance_score": "0.090134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.222838",
        "ticker_sentiment_score": "0.259996",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Tandem Diabetes  ( TNDM )  Gains From Innovation Amid Macro Issues",
    "url": "https://www.zacks.com/stock/news/2248459/tandem-diabetes-tndm-gains-from-innovation-amid-macro-issues",
    "time_published": "20240401T144100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Tandem Diabetes (TNDM) seeks to grow its business through the acquisition of products or technologies and investments in businesses.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/15/2078.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      }
    ],
    "overall_sentiment_score": 0.211286,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.136888",
        "ticker_sentiment_score": "0.052832",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.136888",
        "ticker_sentiment_score": "0.197444",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.119368",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.181819",
        "ticker_sentiment_score": "0.041623",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.119368",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.136888",
        "ticker_sentiment_score": "0.052832",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.136888",
        "ticker_sentiment_score": "0.097528",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic's  ( MDT )  Newest Evolut TAVR System Gets FDA Approval",
    "url": "https://www.zacks.com/stock/news/2248171/medtronics-mdt-newest-evolut-tavr-system-gets-fda-approval",
    "time_published": "20240401T121500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) announces the FDA approval of the newest-generation Evolut TAVR system for the treatment of symptomatic severe aortic stenosis.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      }
    ],
    "overall_sentiment_score": 0.226527,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CAH",
        "relevance_score": "0.195419",
        "ticker_sentiment_score": "0.043915",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.289462",
        "ticker_sentiment_score": "0.302414",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.147216",
        "ticker_sentiment_score": "0.053762",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.147216",
        "ticker_sentiment_score": "0.053762",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38045112/electroceuticalsbioelectric-medicine-market-is-expected-to-reach-33-6-billion-marketsandmarkets",
    "time_published": "20240402T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, April 02, 2024 ( GLOBE NEWSWIRE ) -- Electroceuticals/Bioelectric Medicine market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a latest report published by ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.221399,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NPCE",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ECOR",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVRO",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STIM",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CHEOF",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LIVN",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCRPF",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "BioPorto appoints Peter M\u00f8rch Eriksen as permanent Group Chief Executive Officer",
    "url": "https://www.globenewswire.com/news-release/2024/04/02/2855633/0/en/BioPorto-appoints-Peter-M%C3%B8rch-Eriksen-as-permanent-Group-Chief-Executive-Officer.html",
    "time_published": "20240402T055400",
    "authors": [
      "BioPorto A/S"
    ],
    "summary": "April 2, 2024Announcement no. ...",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/b9686d8c-3706-4a6c-b22a-ae722c122c21",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.158523,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.046184",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Transformative Growth Expected In The Global Medical Equipment Market: Market Size To Reach $1,077 Billion By 2028 As Per The Business Research Company's Medical Equipment Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38072444/transformative-growth-expected-in-the-global-medical-equipment-market-market-size-to-reach-1-077-b",
    "time_published": "20240403T153000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, April 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Medical Equipment Global Market Report 2024, the medical equipment market has witnessed robust growth in recent years, with the market size expected to reach $775.42 billion in 2024, reflecting a compound annual ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.338179,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.299729",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.126428",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.126428",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.126428",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?",
    "url": "https://www.zacks.com/stock/news/2249507/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi",
    "time_published": "20240403T102006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for IHI ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default211.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.216422,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.064449",
        "ticker_sentiment_score": "0.031013",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEM",
        "relevance_score": "0.128478",
        "ticker_sentiment_score": "0.026704",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.128478",
        "ticker_sentiment_score": "0.069872",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.128478",
        "ticker_sentiment_score": "0.069872",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.128478",
        "ticker_sentiment_score": "0.069872",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Registers a Bigger Fall Than the Market: Important Facts to Note",
    "url": "https://www.zacks.com/stock/news/2250777/medtronic-mdt-registers-a-bigger-fall-than-the-market-important-facts-to-note",
    "time_published": "20240404T215017",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default129.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.094287,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.593715",
        "ticker_sentiment_score": "0.111461",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Globus Medical  ( GMED )  Gains From New Launches Amid Macro Issues - DaVita  ( NYSE:DVA ) , Cardinal Health  ( NYSE:CAH ) ",
    "url": "https://www.benzinga.com/news/24/04/38092269/globus-medical-gmed-gains-from-new-launches-amid-macro-issues",
    "time_published": "20240404T172954",
    "authors": [
      "Zacks"
    ],
    "summary": "Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding in the overseas markets through the expansion of direct and distributor sales force.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/04/piron-guillaume-u4fycp3-kzy-unsplash.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.980509"
      }
    ],
    "overall_sentiment_score": 0.338979,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.043979",
        "ticker_sentiment_score": "0.159813",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.043979",
        "ticker_sentiment_score": "0.159813",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.455895",
        "ticker_sentiment_score": "0.436703",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.180333",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.043979",
        "ticker_sentiment_score": "0.159813",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.131403",
        "ticker_sentiment_score": "0.083659",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.043979",
        "ticker_sentiment_score": "0.159813",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.130187",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Globus Medical  ( GMED )  Gains From New Launches Amid Macro Issues",
    "url": "https://www.zacks.com/stock/news/2250489/globus-medical-gmed-gains-from-new-launches-amid-macro-issues",
    "time_published": "20240404T124100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b3/30471.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.980509"
      }
    ],
    "overall_sentiment_score": 0.321439,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.159925",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.159925",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.460377",
        "ticker_sentiment_score": "0.436508",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.176502",
        "ticker_sentiment_score": "0.14695",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.159925",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.132855",
        "ticker_sentiment_score": "0.052023",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.159925",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.176502",
        "ticker_sentiment_score": "0.098644",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SMART trial one-year data demonstrates Medtronic Evolut\u2122 TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women",
    "url": "https://www.prnewswire.com/news-releases/smart-trial-one-year-data-demonstrates-medtronic-evolut-tavr-platform-as-optimal-treatment-for-severe-aortic-stenosis-in-patients-with-small-annulus-which-is-primarily-women-302109869.html",
    "time_published": "20240407T134500",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "SMART trial one-year data demonstrates Medtronic Evolut\u2122 TAVR platform as optimal treatment for severe aortic ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.252947,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.376667",
        "ticker_sentiment_score": "0.385639",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "SMART trial one-year data demonstrates Medtronic Evolut\u2122 TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women",
    "url": "https://www.newswire.ca/news-releases/smart-trial-one-year-data-demonstrates-medtronic-evolut-tm-tavr-platform-as-optimal-treatment-for-severe-aortic-stenosis-in-patients-with-small-annulus-which-is-primarily-women-864122676.html",
    "time_published": "20240407T134500",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "SMART trial one-year data demonstrates Medtronic Evolut\u2122 TAVR platform as optimal treatment for severe aortic ... Canada ...",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.252947,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.376667",
        "ticker_sentiment_score": "0.385639",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "New survey uncovers lack of awareness around heart valve disease and risk factors among women",
    "url": "https://www.prnewswire.com/news-releases/new-survey-uncovers-lack-of-awareness-around-heart-valve-disease-and-risk-factors-among-women-302109798.html",
    "time_published": "20240407T120000",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.257272,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.267478",
        "ticker_sentiment_score": "0.320648",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "New survey uncovers lack of awareness around heart valve disease and risk factors among women",
    "url": "https://www.newswire.ca/news-releases/new-survey-uncovers-lack-of-awareness-around-heart-valve-disease-and-risk-factors-among-women-826708284.html",
    "time_published": "20240407T120000",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.257272,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.267478",
        "ticker_sentiment_score": "0.320648",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "mHealth Market size worth $ 122.50 Billion, Globally, by 2031 at 10.54% CAGR - Report By Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38143169/mhealth-market-size-worth-122-50-billion-globally-by-2031-at-10-54-cagr-report-by-verified-market-",
    "time_published": "20240408T140000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Jersey City, New Jersey, April 08, 2024 ( GLOBE NEWSWIRE ) -- The Global mHealth Solutions Market is projected to grow at a CAGR of 10.54% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.407825,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AAPL",
        "relevance_score": "0.03068",
        "ticker_sentiment_score": "0.183589",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZTCOF",
        "relevance_score": "0.03068",
        "ticker_sentiment_score": "0.183589",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03068",
        "ticker_sentiment_score": "0.183589",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.03068",
        "ticker_sentiment_score": "0.199326",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.03068",
        "ticker_sentiment_score": "0.082435",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.03068",
        "ticker_sentiment_score": "0.169824",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation",
    "url": "https://investingnews.com/the-medtronic-sphere-360-pulse-field-ablation-catheter-a-new-paradigm-in-single-shot-ablation-demonstrates-impressive-results-in-treating-paroxysmal-atrial-fibrillation/",
    "time_published": "20240408T124048",
    "authors": [
      "Investing News Network"
    ],
    "summary": "The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates ... Investing News Network ...",
    "banner_image": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy81MTI3NDYwMC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcxNzQ1OTMwNn0.kjLEuLnBAc8utn4dfQyabjMGtO9KVSvQh1965g2yHPE/img.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.32683,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.369076",
        "ticker_sentiment_score": "0.40727",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "The Medtronic Sphere-360\u2122 Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation ... - Canada NewsWire",
    "url": "https://www.newswire.ca/news-releases/the-medtronic-sphere-360-tm-pulse-field-ablation-pfa-catheter-a-new-paradigm-in-single-shot-ablation-demonstrates-impressive-results-in-treating-paroxysmal-atrial-fibrillation-815326749.html",
    "time_published": "20240408T120000",
    "authors": [],
    "summary": "The Medtronic Sphere-360\u2122 Pulse Field Ablation ( PFA ) catheter, a new paradigm in single-shot ablation ... Canada ...",
    "banner_image": null,
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.318238,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.29485",
        "ticker_sentiment_score": "0.329149",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "ThoughtSpot Named Google Cloud Technology Partner of the Year for Data - Business Intelligence",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38153239/thoughtspot-named-google-cloud-technology-partner-of-the-year-for-data-business-intelligence",
    "time_published": "20240409T001500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MOUNTAIN VIEW, Calif., April 08, 2024 ( GLOBE NEWSWIRE ) -- ThoughtSpot, the AI-Powered Analytics company, today announced it has been named the 2024 Google Cloud Technology Partner of the Year Award for Data - Business Intelligence.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.286411,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CVS",
        "relevance_score": "0.048621",
        "ticker_sentiment_score": "0.147581",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.639616",
        "ticker_sentiment_score": "0.36629",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.024322",
        "ticker_sentiment_score": "0.151779",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RBCPF",
        "relevance_score": "0.024322",
        "ticker_sentiment_score": "0.151779",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.024322",
        "ticker_sentiment_score": "0.151779",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.024322",
        "ticker_sentiment_score": "0.108765",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials",
    "url": "https://investingnews.com/cleo-appoints-cro-to-manage-us-ovarian-cancer-clinical-trials/",
    "time_published": "20240410T234014",
    "authors": [
      "Investing News Network"
    ],
    "summary": "AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.723918,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.817578",
        "ticker_sentiment_score": "0.874931",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Falls More Steeply Than Broader Market: What Investors Need to Know",
    "url": "https://www.zacks.com/stock/news/2253672/medtronic-mdt-falls-more-steeply-than-broader-market-what-investors-need-to-know",
    "time_published": "20240410T215019",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default71.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.120946,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.648164",
        "ticker_sentiment_score": "0.224143",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20",
    "url": "https://markets.businessinsider.com/news/stocks/jim-cramer-says-wesco-international-is-a-buy-recommends-buying-this-stock-under-20-1033237299",
    "time_published": "20240410T133934",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer recommended buying Medtronic ( NYSE:MDT ) . \"I like what they're doing in AI. You've got a good one with a good yield,\" he noted. On March 27, the FDA approved Medtronic's Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for ...",
    "banner_image": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/04/10/jim_cramer_copy.jpg",
    "source": "Business Insider",
    "category_within_source": "GoogleRSS",
    "source_domain": "markets.businessinsider.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.255713,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CLF",
        "relevance_score": "0.454174",
        "ticker_sentiment_score": "0.32804",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.31282",
        "ticker_sentiment_score": "0.335872",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WCC",
        "relevance_score": "0.454174",
        "ticker_sentiment_score": "0.343197",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Boston Scientific  ( BSX )  Faces Rising Costs, Competition",
    "url": "https://www.zacks.com/stock/news/2253274/boston-scientific-bsx-faces-rising-costs-competition",
    "time_published": "20240410T133000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0e/879.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.993781"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.076668,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "EW",
        "relevance_score": "0.055881",
        "ticker_sentiment_score": "0.061889",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.055881",
        "ticker_sentiment_score": "0.061889",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.274012",
        "ticker_sentiment_score": "0.068335",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.055881",
        "ticker_sentiment_score": "0.061889",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.42503",
        "ticker_sentiment_score": "0.172827",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.220809",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.055881",
        "ticker_sentiment_score": "0.061889",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.220809",
        "ticker_sentiment_score": "0.158494",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.055881",
        "ticker_sentiment_score": "0.061889",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.055881",
        "ticker_sentiment_score": "0.112092",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20 - Cleveland-Cliffs  ( NYSE:CLF ) , Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/04/38176505/jim-cramer-says-wesco-international-is-a-buy-recommends-buying-this-stock-under-20",
    "time_published": "20240410T131807",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer recommended buying Medtronic MDT. \"I like what they're doing in AI. You've got a good one with a good yield,\" he noted. On March 27, the FDA approved Medtronic's Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for symptomatic ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/10/jim_cramer_copy.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.270832,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CLF",
        "relevance_score": "0.512093",
        "ticker_sentiment_score": "-0.061305",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.397098",
        "ticker_sentiment_score": "0.558962",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WCC",
        "relevance_score": "0.614086",
        "ticker_sentiment_score": "0.461498",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic's  ( MDT )  Sphere-360 PFA Study Outcome Favorable",
    "url": "https://www.zacks.com/stock/news/2253903/medtronics-mdt-sphere-360-pfa-study-outcome-favorable",
    "time_published": "20240411T133100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.231256,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.102013",
        "ticker_sentiment_score": "0.127329",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.102013",
        "ticker_sentiment_score": "0.127329",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.152499",
        "ticker_sentiment_score": "0.198608",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.152499",
        "ticker_sentiment_score": "0.039459",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Boston Scientific  ( BSX )  Faces Rising Costs, Competition - Boston Scientific  ( NYSE:BSX ) , Cardinal Health  ( NYSE:CAH ) ",
    "url": "https://www.benzinga.com/news/24/04/38185400/boston-scientific-bsx-faces-rising-costs-competition",
    "time_published": "20240411T104536",
    "authors": [
      "Zacks"
    ],
    "summary": "Boston Scientific Corporation BSX has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in the large medical device market also pose a tough challenge for Boston Scientific. The stock carries a Zacks Rank #4 ( Sell ) currently.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/10/hush-naidoo-jade-photography-yo01z-9hqaw-unsplash.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.993781"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.091136,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "EW",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "0.061864",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "0.061864",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.271576",
        "ticker_sentiment_score": "0.041982",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "0.061864",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.421485",
        "ticker_sentiment_score": "0.177616",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "0.061864",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.178814",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "0.061864",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "0.112071",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Got $200? 2 Healthcare Stocks to Buy and Hold Forever.",
    "url": "https://www.fool.com/investing/2024/04/11/got-200-2-healthcare-stocks-to-buy-and-hold/",
    "time_published": "20240411T101500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "These companies provide stability, reliability, and passive income.",
    "banner_image": "https://media.ycharts.com/charts/82310276ba6dc41056260e1c00a407ca.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.327868,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.410697",
        "ticker_sentiment_score": "0.393096",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.30021",
        "ticker_sentiment_score": "0.179566",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here Are My Top Artificial Intelligence  ( AI )  Stocks to Buy Now",
    "url": "https://www.fool.com/investing/2024/04/11/here-are-my-top-artificial-intelligence-ai-stocks/",
    "time_published": "20240411T100500",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These three players offer you a great entry point right now.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F772345%2Fan-ai-powered-robotic-finger-and-a-human-finger-touch.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.369171,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.095517",
        "ticker_sentiment_score": "0.10302",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.047844",
        "ticker_sentiment_score": "0.129792",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.142847",
        "ticker_sentiment_score": "0.321237",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.281153",
        "ticker_sentiment_score": "0.257726",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.281153",
        "ticker_sentiment_score": "0.213394",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic PLC  ( MDT )  is Attracting Investor Attention: Here is What You Should Know",
    "url": "https://www.zacks.com/stock/news/2254350/medtronic-plc-mdt-is-attracting-investor-attention-here-is-what-you-should-know",
    "time_published": "20240412T130011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default95.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.623304"
      }
    ],
    "overall_sentiment_score": 0.226598,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.482982",
        "ticker_sentiment_score": "0.110051",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Third Point, Saddle Point win board seats at Advance Auto Parts. A plan to improve margins may unfold",
    "url": "https://www.cnbc.com/2024/04/13/how-third-point-and-saddle-point-may-help-boost-margins-at-advance-auto-parts.html",
    "time_published": "20240413T112448",
    "authors": [
      "Kenneth Squire"
    ],
    "summary": "The two activists recently picked up three board seats at the auto parts retailer.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107215480-1679919932371-gettyimages-1249566879-PWeaver-SunburyPlaza-14.jpeg?v=1712955703&w=1920&h=1080",
    "source": "CNBC",
    "category_within_source": "Investing",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99999"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.13247,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "AAP",
        "relevance_score": "0.323549",
        "ticker_sentiment_score": "0.166718",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "UNIEF",
        "relevance_score": "0.073886",
        "ticker_sentiment_score": "0.101844",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.110632",
        "ticker_sentiment_score": "0.110832",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ORLY",
        "relevance_score": "0.073886",
        "ticker_sentiment_score": "0.101844",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZO",
        "relevance_score": "0.036983",
        "ticker_sentiment_score": "0.040236",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.073886",
        "ticker_sentiment_score": "0.101844",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PSHZF",
        "relevance_score": "0.036983",
        "ticker_sentiment_score": "0.052448",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.073886",
        "ticker_sentiment_score": "0.101844",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA Why Is Medical Device Manufacture Integer Stock Gaining Today? - Integer Holdings  ( NYSE:ITGR ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38256857/medical-device-manufacture-integer-to-gain-from-expanding-pulsed-field-ablation-mar",
    "time_published": "20240415T184259",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "BofA Securities upgraded Integer Holdings Corporation ITGR, citing the anticipated growth in pulsed field ablation ( PFA ) for treating atrial fibrillation. Integer is one of the largest medical device outsourcing manufacturers, serving the cardiac rhythm management, neuromodulation, ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/15/Medical-Examination-And-Healthcare-Busin.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.286622,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITGR",
        "relevance_score": "0.82927",
        "ticker_sentiment_score": "0.458772",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.215894",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.215894",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.215894",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wearable Injectors Market size worth $ 21.48 Billion, Globally, by 2031 at 15.30% CAGR - Report By Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38249532/wearable-injectors-market-size-worth-21-48-billion-globally-by-2031-at-15-30-cagr-report-by-verifi",
    "time_published": "20240415T141500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Jersey City, New Jersey, April 15, 2024 ( GLOBE NEWSWIRE ) -- The Global Wearable Injectors Market is projected to grow at a CAGR of 15.30% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.297805,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PODD",
        "relevance_score": "0.035189",
        "ticker_sentiment_score": "0.153917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.035189",
        "ticker_sentiment_score": "0.153917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.035189",
        "ticker_sentiment_score": "0.153917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.035189",
        "ticker_sentiment_score": "0.153917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.035189",
        "ticker_sentiment_score": "0.17207",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Sinks As Market Gains: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2256410/medtronic-mdt-stock-sinks-as-market-gains-what-you-should-know",
    "time_published": "20240416T215017",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $79.35, signifying a -1.1% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default214.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.110874,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.610329",
        "ticker_sentiment_score": "0.263315",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/ascential-medical--life-sciences-appoints-anupam-girdhar-as-divisional-ceo-302117492.html",
    "time_published": "20240416T130000",
    "authors": [],
    "summary": "Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.184108,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.061949",
        "ticker_sentiment_score": "0.033299",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.061949",
        "ticker_sentiment_score": "0.033299",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.184363",
        "ticker_sentiment_score": "0.050694",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Artificial Intelligence  ( AI )  in Healthcare Stocks to Buy and Hold for Great Long-Term Potential",
    "url": "https://www.fool.com/investing/2024/04/16/2-ai-in-healthcare-stocks-to-buy/",
    "time_published": "20240416T085500",
    "authors": [
      "Adria Cimino"
    ],
    "summary": "These companies have gotten in on AI early and could emerge as winners.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F772819%2Fgettyimages-872676342-1200x800-5b2df79-1.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.891286"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.365812,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.282886",
        "ticker_sentiment_score": "0.393004",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.33628",
        "ticker_sentiment_score": "0.266365",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IBM",
        "relevance_score": "0.057767",
        "ticker_sentiment_score": "0.152992",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "These 4 NYSE Stocks Just Broke Below Previous Price Support",
    "url": "https://www.forbes.com/sites/johnnavin/2024/04/15/these-4-nyse-stocks-just-broke-below-previous-price-support/",
    "time_published": "20240416T003444",
    "authors": [
      "John Navin"
    ],
    "summary": "When buyers fail to show up at the price where they previously paid, it's a sign of weakness for a stock. You don't need a thorough understanding of technical analysis to appreciate this. It's not that much different than a goods store marking down merchandise since it's not being purchased at ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/5e6850d67d6f2600068f2e28/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.055334,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.151064",
        "ticker_sentiment_score": "0.121349",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GME",
        "relevance_score": "0.075874",
        "ticker_sentiment_score": "0.012318",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR - Report By Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38294071/blood-collection-market-size-worth-14-76-billion-globally-by-2031-at-5-10-cagr-report-by-verified-",
    "time_published": "20240417T143000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Jersey City, New Jersey, April 17, 2024 ( GLOBE NEWSWIRE ) -- The Global Blood Collection Market is projected to grow at a CAGR of 5.10% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.284943,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.171113",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic",
    "url": "https://www.zacks.com/stock/news/2256500/the-zacks-analyst-blog-highlights-mastercard-netflix-coca-cola-berkshire-hathaway-and-medtronic",
    "time_published": "20240417T100000",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/45/414.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.818451"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.340547,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NFLX",
        "relevance_score": "0.28387",
        "ticker_sentiment_score": "0.215589",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "KO",
        "relevance_score": "0.414559",
        "ticker_sentiment_score": "0.193511",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MA",
        "relevance_score": "0.28387",
        "ticker_sentiment_score": "0.261162",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.144275",
        "ticker_sentiment_score": "0.037031",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRK-A",
        "relevance_score": "0.072435",
        "ticker_sentiment_score": "0.030157",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/04/38320376/looking-into-medtronics-recent-short-interest",
    "time_published": "20240418T170030",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has risen 8.05% since its last report. The company recently reported that it has 12.43 million shares sold short, which is 0.94% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.18 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now",
    "url": "https://www.zacks.com/stock/news/2257854/heres-why-you-should-retain-medtronic-mdt-stock-for-now",
    "time_published": "20240418T150900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      }
    ],
    "overall_sentiment_score": 0.299826,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.038906",
        "ticker_sentiment_score": "0.047187",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.038906",
        "ticker_sentiment_score": "0.047187",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.038906",
        "ticker_sentiment_score": "0.047187",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LMAT",
        "relevance_score": "0.116348",
        "ticker_sentiment_score": "0.080369",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.154703",
        "ticker_sentiment_score": "0.08129",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.339356",
        "ticker_sentiment_score": "0.367527",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.116348",
        "ticker_sentiment_score": "0.103952",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Stock: Buy, Sell, or Hold?",
    "url": "https://www.fool.com/investing/2024/04/18/medtronic-stock-buy-sell-or-hold/",
    "time_published": "20240418T130500",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Can this struggling healthcare specialist turn things around?",
    "banner_image": "https://media.ycharts.com/charts/8365c2bd4c5938b5444498df0eb05708.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.818451"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      }
    ],
    "overall_sentiment_score": 0.359993,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.47672",
        "ticker_sentiment_score": "0.55026",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/endoscopy-devices-market-size-is-set-to-grow-by-usd-14-24-billion-from-2024-2028--advances-in-endoscopy-technologies-boost-the-market--technavio-302120829.html",
    "time_published": "20240419T221200",
    "authors": [],
    "summary": "Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.206034,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLAR",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.033656",
        "ticker_sentiment_score": "0.036539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.067252",
        "ticker_sentiment_score": "0.074881",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity",
    "url": "https://investingnews.com/medtronic-americans-favor-quality-over-quantity-in-pursuit-of-longevity/",
    "time_published": "20240419T164453",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Americans overwhelmingly say that when they think about longevity, it's more than just living longer - it's about living their healthiest, best lives. While most want to live to 90-well past the average U.S. life expectancy of 77.5 years-nearly two-thirds ( 66% ) would choose a shorter, healthier ...",
    "banner_image": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy81MTI3NDYwMC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcxNzQ1OTMwNn0.kjLEuLnBAc8utn4dfQyabjMGtO9KVSvQh1965g2yHPE/img.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.251064,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.533481",
        "ticker_sentiment_score": "0.40708",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Cardiex: Biomarker Technologies, Digital Solutions to Address the World's Largest Health Disorders",
    "url": "https://investingnews.com/cardiex-biomarker-technologies-digital-solutions-to-address-the-worlds-largest-health-disorders/",
    "time_published": "20240419T132434",
    "authors": [
      "Investing News Network"
    ],
    "summary": "According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues Americans overwhelmingly say that when they think about longevity, it's more than just living longer-it's about living ...",
    "banner_image": null,
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.192395,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.524949",
        "ticker_sentiment_score": "0.262402",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Laps the Stock Market: Here's Why",
    "url": "https://www.zacks.com/stock/news/2259647/medtronic-mdt-laps-the-stock-market-heres-why",
    "time_published": "20240422T215016",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default219.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.107856,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.596978",
        "ticker_sentiment_score": "0.236578",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "March Quarterly Appendix 4C",
    "url": "https://investingnews.com/cardiex-march-2024-quarterly-appendix-4c/",
    "time_published": "20240423T231314",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Americans overwhelmingly say that when they think about longevity, it's more than just living longer - it's about living their healthiest, best lives. While most want to live to 90-well past the average U.S. life expectancy of 77.5 years-nearly two-thirds ( 66% ) would choose a shorter, healthier ...",
    "banner_image": "https://www.accesswire.com/imagelibrary/4aec960e-3718-4227-b981-d3aeb99d4d1e/854945/f75528e9-c33e-435d-bd28-5f6458ee2609.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.281979,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.366061",
        "ticker_sentiment_score": "0.30399",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa Flicek as Chief Information Officer",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38385689/blue-cross-and-blue-shield-of-minnesota-announces-chris-boles-as-vice-president-of-medicare-meliss",
    "time_published": "20240423T170000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "EAGAN, Minn., April 23, 2024 ( GLOBE NEWSWIRE ) -- Blue Cross and Blue Shield of Minnesota ( Blue Cross ) today announced the addition of two executive hires within its government markets and operations divisions.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.238908,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.057907",
        "ticker_sentiment_score": "0.056964",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.057907",
        "ticker_sentiment_score": "-0.214003",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "ELV",
        "relevance_score": "0.057907",
        "ticker_sentiment_score": "0.01006",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Less burnout for doctors, better clinical trials, among the benefits of AI in health care",
    "url": "https://www.cnbc.com/2024/04/23/less-burnout-for-doctors-among-the-benefits-of-ai-in-healthcare.html",
    "time_published": "20240423T133636",
    "authors": [
      "Rachel Curry"
    ],
    "summary": "Artificial intelligence has traditionally been used to make healthcare safer and better. Now generative AI is making efficency a priority.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107371853-1707515973931-gettyimages-1515913422-reeerr.jpeg?v=1710862397&w=600&h=300&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.149578,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.146692",
        "ticker_sentiment_score": "0.130847",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ACN",
        "relevance_score": "0.036869",
        "ticker_sentiment_score": "-0.042365",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.036869",
        "ticker_sentiment_score": "0.138028",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.036869",
        "ticker_sentiment_score": "0.138028",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Investing in Cardiovascular MedTech Companies",
    "url": "https://investingnews.com/investing-in-cardiovascular-medtech-companies/",
    "time_published": "20240424T224704",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Efforts to address the core risk factors associated with cardiovascular diseases are coinciding with recent innovations in medical technology, which have been critical in not only preventing and managing them but also increasing the survival rate.",
    "banner_image": "https://investingnews.com/media-library/illustration-of-heart-attack.png?id=52093924&width=1200&height=800&quality=85&coordinates=0%2C0%2C0%2C0",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.426531,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CDEXF",
        "relevance_score": "0.101725",
        "ticker_sentiment_score": "0.094903",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.101725",
        "ticker_sentiment_score": "0.089634",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.205849",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.101725",
        "ticker_sentiment_score": "0.089634",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.084292",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Electrotherapy System Market size worth $ 1587.04 Billion, Globally, by 2031 at 4.39% CAGR - Report By Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38405941/electrotherapy-system-market-size-worth-1587-04-billion-globally-by-2031-at-4-39-cagr-report-by-ve",
    "time_published": "20240424T141500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Jersey City, New Jersey, April 24, 2024 ( GLOBE NEWSWIRE ) -- The Global Electrotherapy System Market is projected to grow at a CAGR of 4.39% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.248539,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NURO",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.108375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVRO",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.108375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.108375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.169329",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZYXI",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.108375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.108375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.449046",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "CRYPTO:NANO",
        "relevance_score": "0.059562",
        "ticker_sentiment_score": "-0.115",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic PLC  ( MDT )  Is a Trending Stock: Facts to Know Before Betting on It",
    "url": "https://www.zacks.com/stock/news/2260949/medtronic-plc-mdt-is-a-trending-stock-facts-to-know-before-betting-on-it",
    "time_published": "20240424T130011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default42.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      }
    ],
    "overall_sentiment_score": 0.213139,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.483888",
        "ticker_sentiment_score": "0.086015",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO",
    "url": "https://www.prnewswire.com/news-releases/valcare-medical-inc-announces-corporate-restructuring-and-appointment-of-new-ceo-302125431.html",
    "time_published": "20240424T120000",
    "authors": [
      "Valcare Medical"
    ],
    "summary": "TAMPA, Fla., April 24, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure aimed at accelerating the company's plans to initiate the AMEND clinical studies following the recent company ...",
    "banner_image": "https://mma.prnewswire.com/media/2395528/Valcare_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.365571,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.130571",
        "ticker_sentiment_score": "0.241027",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EBRCZ",
        "relevance_score": "0.065506",
        "ticker_sentiment_score": "0.203189",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VMTHF",
        "relevance_score": "0.065506",
        "ticker_sentiment_score": "0.07709",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Council Post: Challenges For Underrepresented Groups In Tech  ( And How To Solve Them ) ",
    "url": "https://www.forbes.com/sites/forbestechcouncil/2024/04/26/challenges-for-underrepresented-groups-in-tech-and-how-to-solve-them/",
    "time_published": "20240426T171506",
    "authors": [
      "Expert Panel\u00ae"
    ],
    "summary": "Challenges For Underrepresented Groups In Tech ( And How To Solve Them ) Forbes ...",
    "banner_image": "https://blogs-images.forbes.com/assets/images/avatars/blog-3949_400_6d18078e84d93600baaf18165a1394f8.jpg",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.156903,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.026299",
        "ticker_sentiment_score": "0.079066",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FJTSF",
        "relevance_score": "0.026299",
        "ticker_sentiment_score": "0.164014",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic receives FDA approval for Inceptiv\u2122 closed-loop spinal cord stimulator",
    "url": "https://www.newswire.ca/news-releases/medtronic-receives-fda-approval-for-inceptiv-tm-closed-loop-spinal-cord-stimulator-816987802.html",
    "time_published": "20240426T115600",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "DUBLIN, April 26, 2024 /CNW/ -- Medtronic plc ( NYSE:MDT ) , a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration ( FDA ) has approved the Inceptiv\u2122 closed-loop rechargeable spinal cord stimulator ( SCS ) for the treatment of chronic pain.",
    "banner_image": "https://mma.prnewswire.com/media/2372644/Medtronic_Inceptiv_B_Roll.mp4?p=medium",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.122601,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.436759",
        "ticker_sentiment_score": "0.228758",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises Higher Than Market: Key Facts",
    "url": "https://www.zacks.com/stock/news/2264520/medtronic-mdt-rises-higher-than-market-key-facts",
    "time_published": "20240429T215015",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default334.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      }
    ],
    "overall_sentiment_score": 0.146996,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.5341",
        "ticker_sentiment_score": "0.241177",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits Research",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38491562/global-drug-infusion-system-market-size-grows-steadily-at-a-cagr-of-6-9-straits-research",
    "time_published": "20240429T140500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, April 29, 2024 ( GLOBE NEWSWIRE ) -- A drug infusion system is a medical device that allows fluids, medicines, and therapeutic substances to be administered directly into a patient's bloodstream in a controlled and regulated manner.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.967645"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.237591,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.033421",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.033421",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.033421",
        "ticker_sentiment_score": "0.1422",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Decoding Medtronic's Options Activity: What's the Big Picture? - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38533887/decoding-medtronics-options-activity-whats-the-big-picture",
    "time_published": "20240430T201625",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Deep-pocketed investors have adopted a bullish approach towards Medtronic MDT, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.278276,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.610572",
        "ticker_sentiment_score": "0.415247",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents - Orchestra BioMed Hldgs  ( NASDAQ:OBIO ) ",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38518027/orchestra-biomed-announces-avim-therapy-global-intellectual-property-estate-reaches-110-issued-pat",
    "time_published": "20240430T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Patent estate covering atrioventricular interval modulation ( \"AVIM\" ) therapy includes 37 issued U.S. patents and 73 patents outside the U.S. that collectively comprise over 1,800 claims related to the treatment of hypertension",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.1403,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.025379",
        "ticker_sentiment_score": "0.065928",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.10126",
        "ticker_sentiment_score": "0.152152",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.34396",
        "ticker_sentiment_score": "0.293026",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.025379",
        "ticker_sentiment_score": "0.082828",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Masimo's billionaire CEO put shares on margin to get cash while keeping ownership ahead of proxy fight",
    "url": "https://www.cnbc.com/2024/05/01/masimo-ceo-joe-kiani-pledged-400-million-in-masimo-stock-for-loans.html",
    "time_published": "20240501T200521",
    "authors": [
      "Rohan Goswami"
    ],
    "summary": "Masimo has allowed founder Joe Kiani to pledge more than half his $660 million stake in the company as collateral for personal loans.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107392476-17113980811711398078-33862467404-1080pnbcnews.jpg?v=1711398080&w=750&h=422&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.692272"
      }
    ],
    "overall_sentiment_score": 0.095777,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.08391",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.652441",
        "ticker_sentiment_score": "0.22536",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Council Post: 16 Surprising Ways AI Enhances Healthcare Diagnostics And Delivery",
    "url": "https://www.forbes.com/sites/forbestechcouncil/2024/05/01/16-surprising-ways-ai-enhances-healthcare-diagnostics-and-delivery/",
    "time_published": "20240501T171524",
    "authors": [
      "Expert Panel\u00ae"
    ],
    "summary": "16 Surprising Ways AI Enhances Healthcare Diagnostics And Delivery Forbes ...",
    "banner_image": "https://blogs-images.forbes.com/assets/images/avatars/blog-3949_400_6d18078e84d93600baaf18165a1394f8.jpg",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.377122,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.030998",
        "ticker_sentiment_score": "0.359909",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.030998",
        "ticker_sentiment_score": "0.359909",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Haemonetics  ( HAE )  Banks on Plasma Arm Growth Amid Rising Costs",
    "url": "https://www.zacks.com/stock/news/2266232/haemonetics-hae-banks-on-plasma-arm-growth-amid-rising-costs",
    "time_published": "20240501T155100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.302043,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "FSNUF",
        "relevance_score": "0.053035",
        "ticker_sentiment_score": "0.095658",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.053035",
        "ticker_sentiment_score": "0.095658",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.450607",
        "ticker_sentiment_score": "0.327129",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.209819",
        "ticker_sentiment_score": "0.220811",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.053035",
        "ticker_sentiment_score": "0.095658",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCA",
        "relevance_score": "0.158173",
        "ticker_sentiment_score": "0.173258",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/global-angioplasty-balloons-and-stents-market-to-exhibit-substantial-growth-at-a-cagr-of-4-by-2030--delveinsight-302134067.html",
    "time_published": "20240502T213100",
    "authors": [
      "DelveInsight Business Research",
      "LLP"
    ],
    "summary": "The surge in demand for angioplasty balloons and stents is mainly driven by the increasing prevalence of cardiovascular diseases ( CVDs ) , the growing preference for minimally invasive procedures, and advancements in drug-coated/drug-eluting balloon technologies, among other factors.",
    "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.152657,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSBHF",
        "relevance_score": "0.024826",
        "ticker_sentiment_score": "-0.084334",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.024826",
        "ticker_sentiment_score": "0.024841",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.049629",
        "ticker_sentiment_score": "-0.000999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCRPF",
        "relevance_score": "0.024826",
        "ticker_sentiment_score": "0.024841",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.024826",
        "ticker_sentiment_score": "0.024841",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LSTA",
        "relevance_score": "0.024826",
        "ticker_sentiment_score": "-0.003625",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Robotic Surgeon Will See You Now",
    "url": "https://www.investors.com/news/technology/intuitive-surgical-stock-isrg-robotic-surgery-medtronic-jnj/",
    "time_published": "20240503T123000",
    "authors": [
      "ALLISON GATLIN",
      "Investor's Business Daily"
    ],
    "summary": "Intuitive Surgical Stock Builds On Its Robotic Surgery Prowess, But Challengers Loom Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2024/05/wRobSurgGrth-050624-300x239.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999897"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.818451"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.167233,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAC",
        "relevance_score": "0.013561",
        "ticker_sentiment_score": "0.124188",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PRCT",
        "relevance_score": "0.027118",
        "ticker_sentiment_score": "0.026302",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.08123",
        "ticker_sentiment_score": "-0.005169",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLVT",
        "relevance_score": "0.027118",
        "ticker_sentiment_score": "-0.027055",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLDAF",
        "relevance_score": "0.027118",
        "ticker_sentiment_score": "0.133624",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.094709",
        "ticker_sentiment_score": "0.061916",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.329112",
        "ticker_sentiment_score": "0.049837",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why You Shouldn't Get Upset When Your Reliable Dividend Stocks Stumble",
    "url": "https://www.fool.com/investing/2024/05/05/why-you-shouldnt-get-upset-when-your-reliable-divi/",
    "time_published": "20240505T114500",
    "authors": [
      "Reuben Gregg Brewer"
    ],
    "summary": "If you buy a dividend stock and its price falls, don't get upset -- think about the extra shares you can buy.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F775091%2F22_03_07-a-person-putting-a-100-dollar-bill-into-a-piggy-bank-_gettyimages-1203959263.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.158339,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MO",
        "relevance_score": "0.047749",
        "ticker_sentiment_score": "-0.024771",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TXN",
        "relevance_score": "0.047749",
        "ticker_sentiment_score": "0.174564",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.047749",
        "ticker_sentiment_score": "0.174564",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IBM",
        "relevance_score": "0.280615",
        "ticker_sentiment_score": "0.18184",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NUE",
        "relevance_score": "0.095327",
        "ticker_sentiment_score": "0.128333",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PG",
        "relevance_score": "0.047749",
        "ticker_sentiment_score": "0.082924",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2269130/medtronic-mdt-rises-yet-lags-behind-market-some-facts-worth-knowing",
    "time_published": "20240506T215006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Medtronic (MDT) settling at $81.76, representing a +0.09% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default55.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.839681"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.080339,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.620664",
        "ticker_sentiment_score": "0.187165",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic PLC  ( MDT )  is Attracting Investor Attention: Here is What You Should Know",
    "url": "https://www.zacks.com/stock/news/2268521/medtronic-plc-mdt-is-attracting-investor-attention-here-is-what-you-should-know",
    "time_published": "20240506T130009",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default148.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      }
    ],
    "overall_sentiment_score": 0.219748,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.493128",
        "ticker_sentiment_score": "0.10837",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Patient Monitoring Devices Market is Expected to Reach $71.1 billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38640933/patient-monitoring-devices-market-is-expected-to-reach-71-1-billion-marketsandmarkets",
    "time_published": "20240506T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, May 06, 2024 ( GLOBE NEWSWIRE ) -- Patient Monitoring Devices market in terms of revenue was estimated to be worth $48.5 billion in 2024 and is poised to reach $71.1 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029 according to a latest report published by MarketsandMarkets\u2122.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.387942,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "OMRNF",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NHNKF",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGWPF",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNGBY",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.034381",
        "ticker_sentiment_score": "-0.027212",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Bio-Rad Laboratories  ( BIO )  Q1 Earnings Surpass Estimates",
    "url": "https://www.zacks.com/stock/news/2269989/bio-rad-laboratories-bio-q1-earnings-surpass-estimates",
    "time_published": "20240507T213009",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Bio-Rad (BIO) delivered earnings and revenue surprises of 12.25% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default67.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.123602,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.095919",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "National Vision  ( EYE )  Q1 Earnings Top Estimates",
    "url": "https://www.zacks.com/stock/news/2270239/national-vision-eye-q1-earnings-top-estimates",
    "time_published": "20240508T111507",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "National Vision (EYE) delivered earnings and revenue surprises of 7.14% and 2.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default348.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999981"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.133074,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "EYE",
        "relevance_score": "0.393977",
        "ticker_sentiment_score": "0.120735",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.136499",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Apyx Medical Reports Q1 Loss, Tops Revenue Estimates - Apyx Medical  ( NASDAQ:APYX ) , Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/earnings-misses/24/05/38732801/apyx-medical-reports-q1-loss-tops-revenue-estimates",
    "time_published": "20240509T181146",
    "authors": [
      "Zacks"
    ],
    "summary": "Apyx Medical APYX came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -22.22%.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/09/drew-hays-tgyrlchfobe-unsplash.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.112806,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "APYX",
        "relevance_score": "0.137278",
        "ticker_sentiment_score": "-0.069027",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.137278",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Apyx Medical  ( APYX )  Reports Q1 Loss, Tops Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2271205/apyx-medical-apyx-reports-q1-loss-tops-revenue-estimates",
    "time_published": "20240509T122007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default129.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.098602,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "APYX",
        "relevance_score": "0.140485",
        "ticker_sentiment_score": "-0.064431",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.140485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cronos Group Reports 2024 First Quarter Results",
    "url": "https://www.globenewswire.com/news-release/2024/05/09/2878647/0/en/Cronos-Group-Reports-2024-First-Quarter-Results.html",
    "time_published": "20240509T113000",
    "authors": [
      "Cronos Group Inc."
    ],
    "summary": "Industry-leading balance sheet with $855 million in cash and cash equivalents ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/68e2d88b-b8e0-404a-995d-415a33773982",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.200014,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CRON",
        "relevance_score": "0.273212",
        "ticker_sentiment_score": "0.174501",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MO",
        "relevance_score": "0.007744",
        "ticker_sentiment_score": "-0.014352",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.007744",
        "ticker_sentiment_score": "-0.021133",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CBHC",
        "relevance_score": "0.007744",
        "ticker_sentiment_score": "0.187498",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MOTS",
        "relevance_score": "0.015487",
        "ticker_sentiment_score": "-0.022636",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery",
    "url": "https://www.globenewswire.com/news-release/2024/05/09/2878574/0/en/Arecor-and-Medtronic-Diabetes-establish-collaboration-to-develop-a-novel-thermostable-insulin-for-implantable-pump-delivery.html",
    "time_published": "20240509T110000",
    "authors": [
      "Arecor Therapeutics plc"
    ],
    "summary": "Arecor Therapeutics plc ( \"Arecor\" or the \"Company\" ...",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/90dff5e5-3d86-4f0e-bff2-b8114123328c",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.211528,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.342487",
        "ticker_sentiment_score": "0.108272",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch - Bayer  ( OTC:BAYRY ) , GE Aero  ( NYSE:GE ) ",
    "url": "https://www.benzinga.com/general/biotech/24/05/38768537/from-hype-to-reality-ai-reshapes-pharmaceutical-industry-across-drug-discovery-to-marketing-stock",
    "time_published": "20240510T184935",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Pharmaceutical companies have been at the forefront of artificial intelligence for quite some time. Researchers have been using advanced AI models to understand disease mechanisms even before the recent surge in interest.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/10/Businessman-On-Blurred-Background-Using-.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.316912,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.285526",
        "ticker_sentiment_score": "0.201815",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IBM",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.072876",
        "ticker_sentiment_score": "0.121453",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MU",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.145145",
        "ticker_sentiment_score": "0.067022",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Medtronic  ( MDT )  Is Placed Ahead of Q4 Earnings",
    "url": "https://www.zacks.com/stock/news/2272057/heres-how-medtronic-mdt-is-placed-ahead-of-q4-earnings",
    "time_published": "20240510T131000",
    "authors": [
      "Moumi Mondal"
    ],
    "summary": "Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/06/667.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.266589,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.305268",
        "ticker_sentiment_score": "0.339448",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.104078",
        "ticker_sentiment_score": "0.079454",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRBR",
        "relevance_score": "0.104078",
        "ticker_sentiment_score": "0.074063",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "James Brodie of Johnson & Johnson MedTech Appointed Chair of the Medtech Canada Board of Directors - Canada NewsWire",
    "url": "https://www.newswire.ca/news-releases/james-brodie-of-johnson-amp-johnson-medtech-appointed-chair-of-the-medtech-canada-board-of-directors-866765198.html",
    "time_published": "20240510T130000",
    "authors": [],
    "summary": "James Brodie of Johnson & Johnson MedTech Appointed Chair of the Medtech Canada Board of Directors Canada ...",
    "banner_image": null,
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.416029,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SOLV",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.031972",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.07497",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.031972",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.07497",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.172919",
        "ticker_sentiment_score": "0.111187",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.031972",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.031972",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLPBY",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.07497",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNVVF",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.183",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Advances While Market Declines: Some Information for Investors",
    "url": "https://www.zacks.com/stock/news/2273162/medtronic-mdt-advances-while-market-declines-some-information-for-investors",
    "time_published": "20240513T215006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $83.52, denoting a +0.82% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default249.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.947132"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.170598,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.675573",
        "ticker_sentiment_score": "0.227701",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update",
    "url": "https://www.globenewswire.com/news-release/2024/05/13/2880923/0/en/Orchestra-BioMed-Reports-First-Quarter-2024-Financial-Results-and-Provides-a-Business-Update.html",
    "time_published": "20240513T205800",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., May 13, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.194715,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.019995",
        "ticker_sentiment_score": "0.061",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.079855",
        "ticker_sentiment_score": "0.123084",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.217213",
        "ticker_sentiment_score": "0.216115",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.158911",
        "ticker_sentiment_score": "0.135767",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Dr. Kelly Wei Joins NVE Corporation's Board of Directors",
    "url": "https://www.globenewswire.com/news-release/2024/05/13/2880858/7753/en/Dr-Kelly-Wei-Joins-NVE-Corporation-s-Board-of-Directors.html",
    "time_published": "20240513T200500",
    "authors": [
      "NVE Corporation"
    ],
    "summary": "EDEN PRAIRIE, Minn., May 13, 2024 ( GLOBE NEWSWIRE ) -- NVE Corporation ( Nasdaq: NVEC ) announced today that its Board of Directors elected Kelly Wei, Ph.D. to join the Board, effective today, filling the unexpired term of Richard W. Kramp, who passed away recently.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/4c377969-61ef-4d97-8fd4-8a38e69bbecc",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.051592,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.200688",
        "ticker_sentiment_score": "-0.040429",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.101154",
        "ticker_sentiment_score": "-0.027704",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVEC",
        "relevance_score": "0.388879",
        "ticker_sentiment_score": "0.275125",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Exagen Inc.  ( XGN )  Reports Q1 Loss, Tops Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2272711/exagen-inc-xgn-reports-q1-loss-tops-revenue-estimates",
    "time_published": "20240513T131002",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Exagen (XGN) delivered earnings and revenue surprises of 52.50% and 9.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default77.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.110001,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.140485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XGN",
        "relevance_score": "0.404563",
        "ticker_sentiment_score": "0.071478",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Urology Devices Market size is set to grow by USD 14103.27 million from 2023-2027, increasing prevalence of ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/urology-devices-market-size-is-set-to-grow-by-usd-14103-27-million-from-2023-2027--increasing-prevalence-of-urological-diseases-to-boost-the-market-growth-technavio-302142342.html",
    "time_published": "20240513T065600",
    "authors": [],
    "summary": "Urology Devices Market size is set to grow by USD 14103.27 million from 2023-2027, increasing prevalence of ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.191192,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SMAWF",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.101725",
        "ticker_sentiment_score": "0.087157",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.087538",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLPBY",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FMS",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.126887",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.135347",
        "ticker_sentiment_score": "0.099055",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.03399",
        "ticker_sentiment_score": "0.087538",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market What's Going On With Insulet Corp Stock On Tuesday? - Insulet  ( NASDAQ:PODD ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/05/38826162/will-insulets-monopoly-crumble-appellate-court-ruling-signals-shift-in-automated-insulin-delivery-",
    "time_published": "20240514T184439",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Tuesday, Blue Orca Capital released a report on Insulet Corporation PODD, saying it is short on the insulin delivery patch pump manufacturer.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/14/Insulet-insulin-omnipod.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.11357,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.322023",
        "ticker_sentiment_score": "0.114582",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.593715",
        "ticker_sentiment_score": "0.050279",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Hershey Company Ranks No.1 on Fair360's 2024 Top 50 Companies List - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/the-hershey-company-ranks-no1-on-fair360s-2024-top-50-companies-list-302144978.html",
    "time_published": "20240514T133800",
    "authors": [],
    "summary": "The Hershey Company Ranks No.1 on Fair360's 2024 Top 50 Companies List PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.381846,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HUM",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.092944",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.173121",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WH",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.091931",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.091931",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CI",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.092944",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCO",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.092944",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.150592",
        "ticker_sentiment_score": "0.116985",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.092944",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSY",
        "relevance_score": "0.657566",
        "ticker_sentiment_score": "0.511845",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain",
    "url": "https://www.prnewswire.com/news-releases/brixton-biosciences-announces-33m-in-series-b-funding-to-advance-novel-technology-for-the-treatment-of-pain-302143985.html",
    "time_published": "20240514T130000",
    "authors": [
      "Brixton Biosciences"
    ],
    "summary": "After promising results from first-in-man studies with its novel Neural Ice\u2122 technology, the Massachusetts-based company will use the capital to initiate pivotal clinical studies in both chronic and acute pain indications",
    "banner_image": "https://mma.prnewswire.com/media/2275114/Brixton_Biosciences_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.214626,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.098054",
        "ticker_sentiment_score": "0.046929",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATRC",
        "relevance_score": "0.04912",
        "ticker_sentiment_score": "0.062901",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FLGT",
        "relevance_score": "0.098054",
        "ticker_sentiment_score": "0.067977",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Hershey Company Ranks No.1 on Fair360's 2024 Top 50 Companies List - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/the-hershey-company-ranks-no1-on-fair360s-2024-top-50-companies-list-302144184.html",
    "time_published": "20240514T110000",
    "authors": [],
    "summary": "The Hershey Company Ranks No.1 on Fair360's 2024 Top 50 Companies List PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.409176,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HUM",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.094654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.174495",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WH",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.092612",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.092612",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CI",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.094654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCO",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.094654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "0.121783",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.094654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSY",
        "relevance_score": "0.31482",
        "ticker_sentiment_score": "0.374822",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "LogicSource Expands Healthcare Leadership Team with 30-Year Industry Veteran, Matthew Gattuso - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/logicsource-expands-healthcare-leadership-team-with-30-year-industry-veteran-matthew-gattuso-302144189.html",
    "time_published": "20240514T100000",
    "authors": [],
    "summary": "LogicSource Expands Healthcare Leadership Team with 30-Year Industry Veteran, Matthew Gattuso PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.393447,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BEAT",
        "relevance_score": "0.054114",
        "ticker_sentiment_score": "0.083764",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OMI",
        "relevance_score": "0.054114",
        "ticker_sentiment_score": "0.166002",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.054114",
        "ticker_sentiment_score": "0.166002",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.054114",
        "ticker_sentiment_score": "0.165798",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "ThoughtSpot Appoints James Smith as VP of EMEA as Worldwide Adoption of AI-Powered Analytics Accelerates",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38808148/thoughtspot-appoints-james-smith-as-vp-of-emea-as-worldwide-adoption-of-ai-powered-analytics-accel",
    "time_published": "20240514T080000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MOUNTAIN VIEW, Calif., May 14, 2024 ( GLOBE NEWSWIRE ) -- ThoughtSpot, the AI-Powered Analytics company, today announced the appointment of James Smith as its Vice President of EMEA. In his role, Smith will be responsible for managing ThoughtSpot's operations across Europe, the Middle East, and ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.397612,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CVS",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.163917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.163917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RBCPF",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.163917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.054236",
        "ticker_sentiment_score": "0.163917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.366061",
        "ticker_sentiment_score": "0.482257",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "1 No-Brainer Growth Stock to Buy and Hold for 10 Years",
    "url": "https://www.fool.com/investing/2024/05/15/1-no-brainer-growth-stock-to-buy-and-hold-for-10/",
    "time_published": "20240515T141500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "This company's potential far outweighs its risks.",
    "banner_image": "https://media.ycharts.com/charts/22f04dff8470cf02bd8b3f976eadcfe1.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.174683,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.058615",
        "ticker_sentiment_score": "-0.095012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.443626",
        "ticker_sentiment_score": "0.214206",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.058615",
        "ticker_sentiment_score": "-0.095012",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "These Dividend Stocks Are an Investor's Best Friend",
    "url": "https://www.fool.com/investing/2024/05/16/these-dividend-stocks-are-an-investors-best-friend/",
    "time_published": "20240516T120000",
    "authors": [
      "George Budwell"
    ],
    "summary": "These two healthcare stocks are well-known for their top-tier dividend programs.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F777461%2Fdividends.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      }
    ],
    "overall_sentiment_score": 0.427908,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.310843",
        "ticker_sentiment_score": "0.411438",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.18967",
        "ticker_sentiment_score": "0.209958",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "CVRx Announces Key Senior Leadership Team Hires",
    "url": "https://www.globenewswire.com/news-release/2024/05/16/2883291/0/en/CVRx-Announces-Key-Senior-Leadership-Team-Hires.html",
    "time_published": "20240516T113000",
    "authors": [
      "CVRx",
      "Inc."
    ],
    "summary": "MINNEAPOLIS, May 16, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( \"CVRx\" ) , a commercial-stage medical device company, today announced three additions to its senior leadership team. Philip B. Adamson, MD, MSc, FACC, FESC, FRCP ( Ed ) has been appointed as Chief Medical Officer, ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/04c4feba-7841-4ac8-8ca5-6c03be383a0e",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.241974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.051003",
        "ticker_sentiment_score": "0.055976",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVRX",
        "relevance_score": "0.477606",
        "ticker_sentiment_score": "0.309363",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.051003",
        "ticker_sentiment_score": "0.086006",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Warren Buffett's Unique Formula To Success Unveiled By Harvard Expert: 'You Can't Just Correct Your Weaknesses'",
    "url": "https://www.benzinga.com/news/24/05/38863691/warren-buffetts-unique-formula-to-success-unveiled-by-harvard-expert-you-cant-just-correct-your-weak",
    "time_published": "20240516T041841",
    "authors": [
      "Benzinga Neuro"
    ],
    "summary": "Warren Buffett's enduring success secret has been revealed by a Harvard University expert, offering a unique insight into the legendary investor's approach. What Happened: Bill George, a leadership expert at Harvard University, has identified a crucial factor that has contributed to Buffett's ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/16/Warren-Buffett.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.51485,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.093289",
        "ticker_sentiment_score": "0.353837",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.093289",
        "ticker_sentiment_score": "0.330323",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Jim Cramer's week ahead: Earnings from Nvidia, Target, Macy's",
    "url": "https://www.cnbc.com/2024/05/17/jim-cramers-week-ahead-earnings-from-nvidia-target-macys.html",
    "time_published": "20240517T223845",
    "authors": [
      "Julie Coleman"
    ],
    "summary": "CNBC's Jim Cramer highlighted earnings reports from Palo Alto Networks, Toll Brothers, Ross Stores and Deckers Outdoor.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107416859-1715985273MM-A-051724-short.jpg?v=1715985272&w=750&h=422&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.30181,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TOL",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.147395",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WSM",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.106893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "-0.092261",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.397517",
        "ticker_sentiment_score": "0.457557",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ADI",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.106893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DECK",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.197884",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ROST",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.197884",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RL",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.197884",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.197884",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "M",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.147395",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.165031",
        "ticker_sentiment_score": "0.320629",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.106893",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Nvidia Headlines Earnings News, As Market Keeps An Ear On The Fed",
    "url": "https://www.investors.com/research/investing-action-plan/nvidia-headlines-earnings-news-as-stock-market-keeps-an-ear-on-the-fed/",
    "time_published": "20240517T214000",
    "authors": [
      "Investor's Business Daily",
      "ALAN R. ELLIOTT"
    ],
    "summary": "Nvidia ( NVDA ) leads the charge as the earnings season quiets down, but still holds potential for some action. China-based Temu owner PDD Holdings ( PDD ) , homebuilder Toll Brothers ( TOL ) and Target ( TGT ) are all due to report.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2019/01/stock-NYSE-05-adobe.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.142857"
      }
    ],
    "overall_sentiment_score": 0.054834,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "SCVL",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "0.097082",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TGT",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.065479",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.19117",
        "ticker_sentiment_score": "0.108218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LPG",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "-0.066125",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MOD",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.017276",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "-0.018042",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "APOS",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "-0.017021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "M",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "-0.133427",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "URBN",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "0.123131",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "-0.019109",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOL",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "-0.02347",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PDD",
        "relevance_score": "0.159781",
        "ticker_sentiment_score": "0.018893",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZO",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.129588",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DECK",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "-0.004041",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNPS",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.047218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.026667",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "-0.056208",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BKNG",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "-0.019109",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "-0.019109",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "news",
    "url": "https://www.newswire.ca/news/heart-rhythm-society-%28hrs%29-2024-annual-meeting/",
    "time_published": "20240517T203100",
    "authors": [],
    "summary": "heart rhythm society ( hrs ) 2024 annual meeting Press Releases | Cision Canada ...",
    "banner_image": "https://www.newswire.ca/content/dam/prnewswire/common/JournalistsBloggers.jpg",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.585808,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.817578",
        "ticker_sentiment_score": "0.82337",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment",
    "url": "https://www.newswire.ca/news-releases/medtronic-affera-tm-mapping-and-ablation-system-with-sphere-9-tm-catheter-achieves-endpoints-for-safety-and-efficacy-providing-promising-evidence-for-the-future-of-atrial-fibrillation-treatment-893155359.html",
    "time_published": "20240517T203100",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Medtronic Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter achieves endpoints for safety and efficacy ... Canada ...",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.250961,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.203827",
        "ticker_sentiment_score": "0.255625",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Unusual Options Activity - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/options/24/05/38902120/medtronic-unusual-options-activity",
    "time_published": "20240517T200056",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bullish move on Medtronic. Our analysis of options history for Medtronic MDT revealed 23 unusual trades. Delving into the details, we found 47% of traders were bullish, while 34% showed bearish tendencies.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.25029,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.671304",
        "ticker_sentiment_score": "0.266915",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "news",
    "url": "https://www.newswire.ca/news/heart-rhythm-2024/",
    "time_published": "20240517T153500",
    "authors": [],
    "summary": "heart rhythm 2024 Press Releases | Cision Canada ...",
    "banner_image": "https://www.newswire.ca/content/dam/prnewswire/common/JournalistsBloggers.jpg",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.545563,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.837089",
        "ticker_sentiment_score": "0.729832",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure\u2122",
    "url": "https://www.newswire.ca/news-releases/late-breaking-data-show-reliable-performance-of-small-diameter-defibrillation-lead-the-medtronic-omniasecure-tm--846000112.html",
    "time_published": "20240517T153500",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.340166,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.472048",
        "ticker_sentiment_score": "0.462303",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Investors Heavily Search Medtronic PLC  ( MDT ) : Here is What You Need to Know",
    "url": "https://www.zacks.com/stock/news/2275276/investors-heavily-search-medtronic-plc-mdt-here-is-what-you-need-to-know",
    "time_published": "20240517T130009",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default248.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      }
    ],
    "overall_sentiment_score": 0.221804,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.490323",
        "ticker_sentiment_score": "0.120283",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wealthy Americans are starting to spend more carefully | Business",
    "url": "https://www.cnn.com/2024/05/19/economy/stocks-week-ahead-wealthy-americans-spending/index.html",
    "time_published": "20240519T113000",
    "authors": [
      "Bryan Mena"
    ],
    "summary": "Wealthy Americans are starting to spend more carefully ...",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1197716194-copy.jpg?q=w_1110,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "www.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.9545"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.839681"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.067529,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BIG",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "-0.065876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GETY",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DLTR",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WOOF",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "-0.065876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAH",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "M",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "URBN",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZO",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BBW",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ME",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.099752",
        "ticker_sentiment_score": "-0.019551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RCL",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.091961",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RL",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLCE",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "-0.065876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.004813",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wealthy Americans are starting to spend more carefully | Business",
    "url": "https://edition.cnn.com/2024/05/19/economy/stocks-week-ahead-wealthy-americans-spending/index.html",
    "time_published": "20240519T113000",
    "authors": [
      "Bryan Mena"
    ],
    "summary": "Wealthy Americans are starting to spend more carefully CNN International ...",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1197716194-copy.jpg?q=w_1110,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "edition.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.9545"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.839681"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.067529,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BIG",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "-0.065876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GETY",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DLTR",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WOOF",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "-0.065876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAH",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "M",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "URBN",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZO",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BBW",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ME",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.099752",
        "ticker_sentiment_score": "-0.019551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RCL",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.091961",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RL",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLCE",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "-0.065876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.010465",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.033328",
        "ticker_sentiment_score": "0.004813",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/05/38924573/medtronics-heart-catheter-achieves-safety-and-efficacy-goals-in-patients-with-irregular-heartbeat",
    "time_published": "20240520T182212",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Friday, Medtronic plc MDT released results from the SPHERE Per-AF study comparing Sphere-9 to the conventional Thermocool SmartTouch SF radiofrequency ablation catheter with the Carto 3 System.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/20/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.250849,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.316168",
        "ticker_sentiment_score": "0.118129",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "MiniMed\u2122 780G system recognized among Fast Company's 2024 World Changing Ideas",
    "url": "https://www.prnewswire.com/news-releases/minimed-780g-system-recognized-among-fast-companys-2024-world-changing-ideas-302150225.html",
    "time_published": "20240520T145400",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Award recognizes the commitment of Medtronic to revolutionizing diabetes care DUBLIN, May 20, 2024 /PRNewswire/ -- Fast Company announced that the Medtronic MiniMed\u2122 780G automated insulin delivery system has been recognized in the Best World-Changing Idea, North America category as part of the ...",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.417026,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.496597",
        "ticker_sentiment_score": "0.493398",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "THNOF",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.065508",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Reports Favorable SPHERE Per-AF Trial Outcome",
    "url": "https://www.zacks.com/stock/news/2276100/medtronic-mdt-reports-favorable-sphere-per-af-trial-outcome",
    "time_published": "20240520T135700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.247896,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.083541",
        "ticker_sentiment_score": "0.054123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.246999",
        "ticker_sentiment_score": "0.29052",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.125025",
        "ticker_sentiment_score": "0.060545",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HITI",
        "relevance_score": "0.083541",
        "ticker_sentiment_score": "0.054123",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Unlocking Q4 Potential of Medtronic  ( MDT ) : Exploring Wall Street Estimates for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2275937/unlocking-q4-potential-of-medtronic-mdt-exploring-wall-street-estimates-for-key-metrics",
    "time_published": "20240520T131507",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default354.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999986"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.095232,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.332658",
        "ticker_sentiment_score": "0.082379",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Urinary Catheters Market size is set to grow by USD 2.44 bn from 2024-2028, rising geriatric population with urinary ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/urinary-catheters-market-size-is-set-to-grow-by-usd-2-44-bn-from-2024-2028--rising-geriatric-population-with-urinary-incontinence-to-boost-the-market-growth-technavio-302149616.html",
    "time_published": "20240520T053000",
    "authors": [],
    "summary": "Urinary Catheters Market size is set to grow by USD 2.44 bn from 2024-2028, rising geriatric population with urinary ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": -0.004828,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BSX",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLPBY",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNVVF",
        "relevance_score": "0.028456",
        "ticker_sentiment_score": "0.035541",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "IBM Unveils Next Chapter of watsonx with Open Source, Product & Ecosystem Innovations to Drive Enterprise AI at Scale - Canada NewsWire",
    "url": "https://www.newswire.ca/news-releases/ibm-unveils-next-chapter-of-watsonx-with-open-source-product-amp-ecosystem-innovations-to-drive-enterprise-ai-at-scale-897043184.html",
    "time_published": "20240521T040100",
    "authors": [],
    "summary": "IBM Unveils Next Chapter of watsonx with Open Source, Product & Ecosystem Innovations to Drive Enterprise AI at Scale Canada ...",
    "banner_image": null,
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Blockchain",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.335919,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BR",
        "relevance_score": "0.013297",
        "ticker_sentiment_score": "0.279936",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.039878",
        "ticker_sentiment_score": "0.280799",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.039878",
        "ticker_sentiment_score": "0.138243",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRMNF",
        "relevance_score": "0.013297",
        "ticker_sentiment_score": "0.077404",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCP",
        "relevance_score": "0.026591",
        "ticker_sentiment_score": "0.08507",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.039878",
        "ticker_sentiment_score": "0.2048",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ELV",
        "relevance_score": "0.026591",
        "ticker_sentiment_score": "0.2153",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "IBM Unveils Next Chapter of watsonx with Open Source, Product & Ecosystem Innovations to Drive Enterprise AI at Scale - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/ibm-unveils-next-chapter-of-watsonx-with-open-source-product--ecosystem-innovations-to-drive-enterprise-ai-at-scale-302150775.html",
    "time_published": "20240521T040100",
    "authors": [],
    "summary": "IBM Unveils Next Chapter of watsonx with Open Source, Product & Ecosystem Innovations to Drive Enterprise AI at Scale PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Blockchain",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.335845,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BR",
        "relevance_score": "0.01303",
        "ticker_sentiment_score": "0.279584",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.039075",
        "ticker_sentiment_score": "0.277402",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.039075",
        "ticker_sentiment_score": "0.137965",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRMNF",
        "relevance_score": "0.01303",
        "ticker_sentiment_score": "0.077248",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCP",
        "relevance_score": "0.026056",
        "ticker_sentiment_score": "0.084849",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.039075",
        "ticker_sentiment_score": "0.202488",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ELV",
        "relevance_score": "0.026056",
        "ticker_sentiment_score": "0.21288",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic's  ( MDT )  MiniMed 780G AID System Wins New Accolade",
    "url": "https://www.zacks.com/stock/news/2277130/medtronics-mdt-minimed-780g-aid-system-wins-new-accolade",
    "time_published": "20240522T130600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99237"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.285443,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.054068",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.082963",
        "ticker_sentiment_score": "0.054068",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.323078",
        "ticker_sentiment_score": "0.32901",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.124164",
        "ticker_sentiment_score": "0.06035",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Orchestra BioMed to Participate in Jefferies Global Healthcare Conference",
    "url": "https://www.globenewswire.com/news-release/2024/05/22/2886510/0/en/Orchestra-BioMed-to-Participate-in-Jefferies-Global-Healthcare-Conference.html",
    "time_published": "20240522T124300",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., May 22, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.209982,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.138464",
        "ticker_sentiment_score": "0.104215",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.138464",
        "ticker_sentiment_score": "0.114789",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.883531",
        "ticker_sentiment_score": "0.358058",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.138464",
        "ticker_sentiment_score": "0.114789",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024",
    "url": "https://www.newswire.ca/news-releases/clarivate-identifies-five-breakthrough-medical-technologies-set-to-transform-patient-care-in-2024-828102854.html",
    "time_published": "20240522T070000",
    "authors": [
      "Clarivate Plc"
    ],
    "summary": "New report highlights innovations poised to drive significant clinical and market impact LONDON, May 22, 2024 /CNW/ -- Clarivate Plc ( NYSE:CLVT ) , a leading global provider of transformative intelligence, today announced the release of the Medical Technologies to Watch in 2024 report.",
    "banner_image": "https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg?p=facebook",
    "source": "Canada Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.newswire.ca",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.387364,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CLVT",
        "relevance_score": "0.388276",
        "ticker_sentiment_score": "0.460184",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.040484",
        "ticker_sentiment_score": "0.12175",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q4 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/05/23/medtronic-mdt-q4-2024-earnings-call-transcript/",
    "time_published": "20240523T180013",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "MDT earnings call for the period ending March 31, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.614606"
      }
    ],
    "overall_sentiment_score": 0.336344,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.004421",
        "ticker_sentiment_score": "0.129496",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004421",
        "ticker_sentiment_score": "0.119959",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.004421",
        "ticker_sentiment_score": "0.079475",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004421",
        "ticker_sentiment_score": "0.119959",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.004421",
        "ticker_sentiment_score": "0.129496",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.088244",
        "ticker_sentiment_score": "0.18508",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.004421",
        "ticker_sentiment_score": "0.107107",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Medtronic Stock Slumped Today",
    "url": "https://www.fool.com/investing/2024/05/23/why-medtronic-stock-slumped-today/",
    "time_published": "20240523T155035",
    "authors": [
      "Rich Smith"
    ],
    "summary": "A 27x earnings valuation and single-digit growth rate means Medtronic stock is probably going down.",
    "banner_image": "https://g.foolcdn.com/editorial/images/778429/1-simple-red-arrow-declining-stock-chart-on-a-white-checked-background.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.997335"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.387143,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.967875",
        "ticker_sentiment_score": "0.603459",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic's Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/05/38988743/medtronics-q4-earnings-medical-device-giant-clocks-strong-sales-from-neurology-devices-hikes-divide",
    "time_published": "20240523T151411",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Medtronic Plc MDT reported fourth-quarter 2024 sales of $8.59 billion, beating the consensus of $8.44 billion. Revenue increased 0.5%, as reported, and 5.4% organic. The company's organic revenue results reflect broad-based growth across the company, with mid-single-digit or higher organic ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/23/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995077"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.363748,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.43789",
        "ticker_sentiment_score": "0.064349",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q4 Earnings Beat Estimates, Margins Down",
    "url": "https://www.zacks.com/stock/news/2278165/medtronic-mdt-q4-earnings-beat-estimates-margins-down",
    "time_published": "20240523T150300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.19972,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.16117",
        "ticker_sentiment_score": "0.056533",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.16117",
        "ticker_sentiment_score": "0.066155",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.081001",
        "ticker_sentiment_score": "0.176631",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EHC",
        "relevance_score": "0.16117",
        "ticker_sentiment_score": "0.096741",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.31583",
        "ticker_sentiment_score": "0.387587",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q4 Earnings and Revenues Surpass Estimates",
    "url": "https://www.zacks.com/stock/news/2277693/medtronic-mdt-q4-earnings-and-revenues-surpass-estimates",
    "time_published": "20240523T115505",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) delivered earnings and revenue surprises of 0.69% and 1.80%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default118.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.139307,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.401331",
        "ticker_sentiment_score": "0.140756",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CGC",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Nasdaq, S&P 500 Futures Ride Higher On Nvidia Boost: More Economic Data Keeps Traders Wary - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",
    "url": "https://www.benzinga.com/news/earnings/24/05/38982267/wall-street-braces-for-strong-open-on-nvidia-cheer-but-traders-wary-of-key-data-why-this-analyst-se",
    "time_published": "20240523T110700",
    "authors": [
      "Shanthi Rexaline"
    ],
    "summary": "Major U.S. index futures jumped early Thursday as Nvidia Corp.'s NVDA earnings provided a shot in the arm for the market. A couple of market-moving economic data on the job market and the manufacturing sector and a Federal Reserve official's speech could also affect the day's trading.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/23/Close-Up-Of-Stock-Market-Trader-Looking-_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.996023"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.0,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "SCVL",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.136888",
        "ticker_sentiment_score": "0.013329",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTU",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNOW",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BJ",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WB",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WDAY",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LGF-A",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTES",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZUO",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROST",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RL",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BILI",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "-0.20456",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase",
    "url": "https://www.prnewswire.com/news-releases/medtronic-reports-full-year-and-fourth-quarter-fiscal-2024-financial-results-announces-dividend-increase-302153592.html",
    "time_published": "20240523T104500",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "Medtronic reports full year and fourth quarter fiscal 2024 financial results. announces dividend increase PR ...",
    "banner_image": "https://mma.prnewswire.com/media/2419996/Medtronic_FY24_Q4_Earnings_Social_Video_Draft_V4.mp4?p=medium",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      }
    ],
    "overall_sentiment_score": 0.288468,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.25444",
        "ticker_sentiment_score": "0.228276",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.051746",
        "ticker_sentiment_score": "0.080834",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Investor Sentiment Falls Further After Fed Minutes, Dow Tumbles 200 Points - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/05/38978768/investor-sentiment-falls-further-after-fed-minutes-dow-tumbles-200-points",
    "time_published": "20240523T061629",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "The CNN Money Fear and Greed index showed another decline in the overall market sentiment, but the index remained in the \"Greed\" zone on Wednesday. U.S. stocks settled lower on Wednesday following the release of Fed minutes, with the Dow Jones index falling over 200 points during the session.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/23/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      }
    ],
    "overall_sentiment_score": -0.211462,
    "overall_sentiment_label": "Somewhat-Bearish",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.390022",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WSM",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.390022",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.390022",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BJ",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROST",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.104683",
        "ticker_sentiment_score": "-0.304855",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Nvidia, BJ's Wholesale Club And 3 Stocks To Watch Heading Into Thursday - NVIDIA  ( NASDAQ:NVDA ) ",
    "url": "https://www.benzinga.com/news/earnings/24/05/38978690/nvidia-bjs-wholesale-club-and-3-stocks-to-watch-heading-into-thursday",
    "time_published": "20240523T060224",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street expects BJ's Wholesale Club Holdings, Inc. BJ to report quarterly earnings at 83 cents per share on revenue of $4.83 billion before the opening bell, ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/23/King-County--Washington--United-States--.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      }
    ],
    "overall_sentiment_score": 0.297631,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BJ",
        "relevance_score": "0.258351",
        "ticker_sentiment_score": "0.150339",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DD",
        "relevance_score": "0.490323",
        "ticker_sentiment_score": "0.544633",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ROST",
        "relevance_score": "0.379051",
        "ticker_sentiment_score": "0.110155",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.379051",
        "ticker_sentiment_score": "0.454789",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.379051",
        "ticker_sentiment_score": "0.289579",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Flywheel Announces Hooman Hakami to Interim CEO Appointment",
    "url": "https://www.prnewswire.com/news-releases/flywheel-announces-hooman-hakami-to-interim-ceo-appointment-302155357.html",
    "time_published": "20240524T180000",
    "authors": [
      "Flywheel"
    ],
    "summary": "MINNEAPOLIS, May 24, 2024 /PRNewswire/ -- Flywheel Exchange, Inc, the leading medical imaging data management and AI enablement company, today announced the appointment of Hooman Hakami as Interim CEO, effective immediately. Hooman will serve as Interim CEO until a long-term CEO is hired and ...",
    "banner_image": "https://mma.prnewswire.com/media/2387275/Flywheel.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.382414,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.088472",
        "ticker_sentiment_score": "-0.012444",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.",
    "url": "https://www.globenewswire.com/news-release/2024/05/24/2888081/0/en/Guerbet-Hugues-Lecat-appointed-Chairman-of-the-Board-of-Directors-of-Guerbet.html",
    "time_published": "20240524T154500",
    "authors": [
      "GUERBET"
    ],
    "summary": "Hugues Lecat appointed Chairman of the Board of Directors of ...",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/c4731c25-21f2-47d1-910e-edbaeb4de604",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.173603,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "-0.003057",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "-0.003057",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Edward Lifesciences  ( EW )  for Now",
    "url": "https://www.zacks.com/stock/news/2278839/heres-why-you-should-retain-edward-lifesciences-ew-for-now",
    "time_published": "20240524T145700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999483"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.241167,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.199859",
        "ticker_sentiment_score": "0.065974",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EHC",
        "relevance_score": "0.199859",
        "ticker_sentiment_score": "0.112734",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.387374",
        "ticker_sentiment_score": "0.358704",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.050465",
        "ticker_sentiment_score": "0.146287",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.050465",
        "ticker_sentiment_score": "0.146287",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.199859",
        "ticker_sentiment_score": "0.077141",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.050465",
        "ticker_sentiment_score": "0.146287",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic's  ( MDT )  OmniaSecure Lead Favored in the LEADR Trial",
    "url": "https://www.zacks.com/stock/news/2278636/medtronics-mdt-omniasecure-lead-favored-in-the-leadr-trial",
    "time_published": "20240524T140000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.231505,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.117486",
        "ticker_sentiment_score": "0.048085",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.117486",
        "ticker_sentiment_score": "0.048085",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.342487",
        "ticker_sentiment_score": "0.355402",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.156207",
        "ticker_sentiment_score": "0.061779",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Stocks Hit A Wall Despite Booming Nvidia: Weekly Review",
    "url": "https://www.investors.com/news/stock-market-hits-wall-despite-nvidia/",
    "time_published": "20240524T135600",
    "authors": [
      "Investor's Business Daily",
      "IBD STAFF"
    ],
    "summary": "Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2020/04/Stock-BullAndMarket-07-shutt.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.996023"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.048906,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.098984",
        "ticker_sentiment_score": "0.029132",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LPG",
        "relevance_score": "0.059488",
        "ticker_sentiment_score": "-0.051036",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTU",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.029637",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ADI",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.029375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AWON",
        "relevance_score": "0.019846",
        "ticker_sentiment_score": "-0.030649",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "M",
        "relevance_score": "0.019846",
        "ticker_sentiment_score": "0.176327",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "URBN",
        "relevance_score": "0.098984",
        "ticker_sentiment_score": "0.09459",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.079261",
        "ticker_sentiment_score": "0.021451",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PDD",
        "relevance_score": "0.079261",
        "ticker_sentiment_score": "0.07713",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QCOM",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.020469",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.037332",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.019846",
        "ticker_sentiment_score": "0.003706",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "-0.143801",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.001969",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.196451",
        "ticker_sentiment_score": "-0.004959",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MOD",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "-0.129767",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNOW",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "-0.070546",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SBLK",
        "relevance_score": "0.059488",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAH",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.113589",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOL",
        "relevance_score": "0.079261",
        "ticker_sentiment_score": "0.047708",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WSM",
        "relevance_score": "0.059488",
        "ticker_sentiment_score": "0.004071",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DECK",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.043392",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.020469",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROST",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "0.153264",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNPS",
        "relevance_score": "0.059488",
        "ticker_sentiment_score": "0.071995",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EXP",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "-0.113268",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.039679",
        "ticker_sentiment_score": "-0.032794",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?",
    "url": "https://www.fool.com/investing/2024/05/26/medtronic-stock-could-soar-29-according-to-a-wall/",
    "time_published": "20240526T085100",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "The medical device manufacturer has raised its dividend payout for 47 consecutive years.",
    "banner_image": "https://g.foolcdn.com/editorial/images/778531/happy-investor-stock-chart-getty.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.318331,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.739837",
        "ticker_sentiment_score": "0.490038",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.148182",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.229481",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "With FDA Clearance, Intuitive Surgical Operates On New Breakout",
    "url": "https://www.investors.com/research/breakout-stocks-technical-analysis/intuittive-surgical-isrg-stock-da-vinci-robotic-surgery/",
    "time_published": "20240529T120100",
    "authors": [
      "MATTHEW GALGANI",
      "Investor's Business Daily"
    ],
    "summary": "In March, robotic surgery leader Intuitive Surgical ( ISRG ) received clearance from the U.S. Federal Drug Administration for the da Vinci 5 next-generation multiport robotic system.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2024/05/Stock-AIdocs-Adobe.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      }
    ],
    "overall_sentiment_score": 0.156921,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.123209",
        "ticker_sentiment_score": "-0.045783",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.785139",
        "ticker_sentiment_score": "0.336537",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.183895",
        "ticker_sentiment_score": "0.027727",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Globus Medical  ( GMED )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2282069/heres-why-you-should-retain-globus-medical-gmed-stock-now",
    "time_published": "20240531T132900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors are optimistic about Globus Medical (GMED) led by strong musculoskeletal prospects and raised guidance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999953"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.223622,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.197011",
        "ticker_sentiment_score": "0.065254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EHC",
        "relevance_score": "0.197011",
        "ticker_sentiment_score": "0.113042",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.1848",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.1848",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.29176",
        "ticker_sentiment_score": "0.245843",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.1848",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.197011",
        "ticker_sentiment_score": "0.0763",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.1848",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Watch These 5 Stocks That Recently Hiked Dividends",
    "url": "https://www.zacks.com/stock/news/2281891/watch-these-5-stocks-that-recently-hiked-dividends",
    "time_published": "20240531T120700",
    "authors": [
      "Santanu Roy"
    ],
    "summary": "Investors may keep a tab on stocks like HLNE, RL, SPTN, EQH and MDT, which have lately hiked their dividend payments.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.990678"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      }
    ],
    "overall_sentiment_score": 0.149686,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "SPTN",
        "relevance_score": "0.332883",
        "ticker_sentiment_score": "0.198638",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HLNE",
        "relevance_score": "0.332883",
        "ticker_sentiment_score": "0.122993",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RL",
        "relevance_score": "0.332883",
        "ticker_sentiment_score": "0.102172",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.332883",
        "ticker_sentiment_score": "0.104488",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EQH",
        "relevance_score": "0.371523",
        "ticker_sentiment_score": "0.146207",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic appoints Mandeep Singh Kumar as Vice President of India business",
    "url": "https://www.business-standard.com/companies/news/medtronic-appoints-mandeep-singh-kumar-as-vice-president-of-india-business-124053101352_1.html",
    "time_published": "20240531T110457",
    "authors": [
      "Anjali Singh"
    ],
    "summary": "India Medtronic, a subsidiary of Medtronic plc, announced the appointment of Mandeep Singh Kumar as the new vice president and managing director of the company, effective May 2024. He replaces Michael Blackwell, who has returned to the United States to pursue new opportunities.",
    "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2024-05/31/full/1717153387-7358.jpg?im=FitAndFill=(826,465)",
    "source": "Business Standard",
    "category_within_source": "GoogleRSS",
    "source_domain": "www.business-standard.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.40543,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.718897",
        "ticker_sentiment_score": "0.600602",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "FOREX:VND",
        "relevance_score": "0.280615",
        "ticker_sentiment_score": "0.012619",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "S&P 500 Giants Lead Five Healthy Stocks Near Buy Points",
    "url": "https://www.investors.com/news/sp-500-giants-stocks-near-buy-points/",
    "time_published": "20240601T120000",
    "authors": [
      "Investor's Business Daily",
      "HARRISON MILLER"
    ],
    "summary": "With many leading stocks in need of some repair, investors may want to seek medical attention. Eli Lilly ( LLY ) , Novo Nordisk ( NVO ) , Vertex Pharmaceuticals ( VRTX ) , Intuitive Surgical ( ISRG ) and Universal Health ( UHS ) are all trading in or near buy zones.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2018/05/Stock-HealthCloud-01-adobe.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.94762"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.124906,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "CTLT",
        "relevance_score": "0.064018",
        "ticker_sentiment_score": "-0.132137",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.312026",
        "ticker_sentiment_score": "0.139665",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCA",
        "relevance_score": "0.064018",
        "ticker_sentiment_score": "-0.408769",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.064018",
        "ticker_sentiment_score": "0.094068",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.252006",
        "ticker_sentiment_score": "0.092848",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VRTX",
        "relevance_score": "0.159148",
        "ticker_sentiment_score": "0.132957",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.064018",
        "ticker_sentiment_score": "0.094068",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.312026",
        "ticker_sentiment_score": "0.136597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.032035",
        "ticker_sentiment_score": "-0.073241",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Medtronic Stock a Buy?",
    "url": "https://www.fool.com/investing/2024/06/01/is-medtronic-stock-a-buy/",
    "time_published": "20240601T074000",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Medtronic has a strong, diverse business and it provides investors with a growing dividend.",
    "banner_image": "https://g.foolcdn.com/editorial/images/778647/medical-professional-smiling.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      }
    ],
    "overall_sentiment_score": 0.301527,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.717348",
        "ticker_sentiment_score": "0.482108",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan - NVIDIA  ( NASDAQ:NVDA ) ",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39126902/nvidia-enables-real-time-healthcare-industrial-and-scientific-ai-applications-at-the-edge-with-ent",
    "time_published": "20240602T125650",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "TAIPEI, Taiwan, June 02, 2024 ( GLOBE NEWSWIRE ) -- COMPUTEX -- To address the increasing need for real-time AI computing at the industrial edge, NVIDIA today announced the general software availability of NVIDIA AI Enterprise-IGX with NVIDIA Holoscan on the NVIDIA IGX\u2122 platform.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.311114,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.075318",
        "ticker_sentiment_score": "0.224901",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.911185",
        "ticker_sentiment_score": "0.543285",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.050254",
        "ticker_sentiment_score": "0.160253",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations",
    "url": "https://www.globenewswire.com/news-release/2024/06/03/2892163/9622/en/EDAP-Appoints-New-Executive-Leaders-to-Strengthen-Europe-and-Middle-East-Commercial-Operations.html",
    "time_published": "20240603T120000",
    "authors": [
      "EDAP TMS S.A."
    ],
    "summary": "New appointments bring significant commercial experience with a focus on growing key strategic markets ...",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/3e934184-5c25-44fd-880b-e10deb63e6e1",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.092676,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.104228",
        "ticker_sentiment_score": "0.108785",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.138663",
        "ticker_sentiment_score": "0.12328",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EDAP",
        "relevance_score": "0.30569",
        "ticker_sentiment_score": "0.118482",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "TELA Bio Appoints Jeffrey Blizard to its Board of Directors",
    "url": "https://www.globenewswire.com/news-release/2024/06/04/2893425/0/en/TELA-Bio-Appoints-Jeffrey-Blizard-to-its-Board-of-Directors.html",
    "time_published": "20240604T200500",
    "authors": [
      "Tela Bio Inc"
    ],
    "summary": "MALVERN, Pa., June 04, 2024 ( GLOBE NEWSWIRE ) -- TELA Bio, Inc. ( \"TELA Bio\" ) ( Nasdaq: TELA ) , a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that it has appointed Jeffrey Blizard, the Global Head of ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/62aad9be-813a-415e-990b-f27442cbec50",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.2113,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TELA",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "0.356609",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.030218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNWV",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.030218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.030218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.030218",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "TELA Bio Appoints Jeffrey Blizard to its Board of Directors - TELA Bio  ( NASDAQ:TELA ) ",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39170247/tela-bio-appoints-jeffrey-blizard-to-its-board-of-directors",
    "time_published": "20240604T200500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MALVERN, Pa., June 04, 2024 ( GLOBE NEWSWIRE ) -- TELA Bio, Inc. ( \"TELA Bio\" ) TELA, a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.220393,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TELA",
        "relevance_score": "0.513494",
        "ticker_sentiment_score": "0.341908",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.030087",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNWV",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.030087",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.030087",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.061631",
        "ticker_sentiment_score": "0.030087",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Recalls Some Versions Of Software Used For Cranial Surgery - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/06/39192592/medtronic-recalls-some-versions-of-software-used-for-cranial-surgery",
    "time_published": "20240605T192347",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Medtronic Plc MDT has initiated a recall for some versions of its StealthStation S8 application. The FDA deemed software recall as Class I, the most serious kind.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/05/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.165478,
    "overall_sentiment_label": "Somewhat-Bearish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.533481",
        "ticker_sentiment_score": "-0.044251",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Raised Its Dividend for a 47th Straight Year, But Here's Why It Isn't a Great Dividend Growth Stock",
    "url": "https://www.fool.com/investing/2024/06/06/medtronic-raised-its-dividend-for-a-47th-straight/",
    "time_published": "20240606T120000",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Medtronic is keeping its dividend streak going, but the recent increase isn't likely to be a meaningful one for many dividend investors.",
    "banner_image": "https://g.foolcdn.com/editorial/images/779298/person-with-a-headache-tracking-charts.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.238233,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.678673",
        "ticker_sentiment_score": "0.357839",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/06/39236547/looking-into-medtronics-recent-short-interest",
    "time_published": "20240607T203015",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has risen 10.38% since its last report. The company recently reported that it has 15.33 million shares sold short, which is 1.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.1 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Cardiovascular Business Expands Amid Macro Woes",
    "url": "https://www.zacks.com/stock/news/2285427/medtronic-mdt-cardiovascular-business-expands-amid-macro-woes",
    "time_published": "20240607T151400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "For Hugo surgical robot, Medtronic (MDT) is scaling manufacturing production, expanding regulatory approvals and ramping up installations to see continued progress internationally.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/27/3804.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      }
    ],
    "overall_sentiment_score": 0.227224,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.090989",
        "ticker_sentiment_score": "0.057016",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.090989",
        "ticker_sentiment_score": "0.057016",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.507107",
        "ticker_sentiment_score": "0.394351",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.064422",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, And Company Appoints CEO and President",
    "url": "https://www.prnewswire.com/news-releases/cala-taps-therapy-is-now-covered-by-medicare-for-essential-tremor-patients-and-company-appoints-ceo-and-president-302167845.html",
    "time_published": "20240610T130000",
    "authors": [
      "Cala Health"
    ],
    "summary": "Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, And Company Appoints CEO and ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/2256949/CALA_Wordmark_Logo_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.353117,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.141754",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.141754",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.04406",
        "ticker_sentiment_score": "0.141754",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BNY Mellon Mutual Funds for Strong Returns",
    "url": "https://www.zacks.com/stock/news/2285784/3-bny-mellon-mutual-funds-for-strong-returns",
    "time_published": "20240610T114100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Consider investing in BNY Mellon mutual funds like DREVX, MPISX and DLDRX for stable returns.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.329186,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.050005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.050005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OXY",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.049005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.050005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.045004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FCX",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.049005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.062434",
        "ticker_sentiment_score": "0.045004",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Olympic athletes turn to diabetes tech in pursuit of medals",
    "url": "https://www.cnn.com/2024/06/10/sport/paris-olympics-diabetes-tech-spt-intl/index.html",
    "time_published": "20240610T091900",
    "authors": [],
    "summary": "Olympians, including Dutch marathon runner Abdi Nageeye, are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels.",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1711050504.jpg?c=16x9&q=h_144,w_256,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "www.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.245539,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GLDAF",
        "relevance_score": "0.03853",
        "ticker_sentiment_score": "0.094574",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HESG",
        "relevance_score": "0.03853",
        "ticker_sentiment_score": "0.04517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03853",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.202623",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Council Post: 14 Emerging Wearable Health Technologies Transforming Remote Care",
    "url": "https://www.forbes.com/sites/forbestechcouncil/2024/06/11/14-emerging-wearable-health-technologies-transforming-remote-care/",
    "time_published": "20240611T171541",
    "authors": [
      "Expert Panel\u00ae"
    ],
    "summary": "14 Emerging Wearable Health Technologies Transforming Remote Care Forbes ...",
    "banner_image": "https://blogs-images.forbes.com/assets/images/avatars/blog-3949_400_6d18078e84d93600baaf18165a1394f8.jpg",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.523892,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.373505",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WLDS",
        "relevance_score": "0.072217",
        "ticker_sentiment_score": "0.273965",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FJTSF",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.424385",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "1 Medical Device Stock Perfectly Positioned to Benefit From AI",
    "url": "https://www.fool.com/investing/2024/06/11/1-medical-device-stock-perfectly-positioned-to-ben/",
    "time_published": "20240611T113000",
    "authors": [
      "George Budwell"
    ],
    "summary": "Medtronic is an undervalued AI stock with an elite dividend program.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F780165%2Finnovation.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.384305,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.664",
        "ticker_sentiment_score": "0.532959",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "V",
        "relevance_score": "0.069697",
        "ticker_sentiment_score": "0.04135",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Royalty Pharma  ( NASDAQ:RPRX ) ",
    "url": "https://www.benzinga.com/news/24/06/39291315/wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yield",
    "time_published": "20240612T131552",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/12/Interest-Rate-And-Dividend-Yield-Concept.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      }
    ],
    "overall_sentiment_score": 0.066874,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "RPRX",
        "relevance_score": "0.199037",
        "ticker_sentiment_score": "-0.157069",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "-0.014167",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "-0.076473",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "66% of Americans give companies a failing grade for CEO pay | Business",
    "url": "https://www.cnn.com/2024/06/12/business/ceo-pay-poll-gallup/index.html",
    "time_published": "20240612T103000",
    "authors": [
      "Matt Egan"
    ],
    "summary": "66% of Americans give companies a failing grade for CEO pay ...",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1417454673.jpg?c=16x9&q=w_800,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "www.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": -0.159022,
    "overall_sentiment_label": "Somewhat-Bearish",
    "ticker_sentiment": [
      {
        "ticker": "WBD",
        "relevance_score": "0.105914",
        "ticker_sentiment_score": "-0.060619",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AVGO",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.051826",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.108023",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "-0.087825",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.035397",
        "ticker_sentiment_score": "0.041834",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Ipsos wins ANA B2 award for The Path insights series",
    "url": "https://www.prnewswire.com/news-releases/ipsos-wins-ana-b2-award-for-the-path-insights-series-302173355.html",
    "time_published": "20240614T194400",
    "authors": [
      "Ipsos"
    ],
    "summary": "Ipsos recognized for excellence in business-to-business marketing with prestigious bronze GEM award from the Association of National Advertisers",
    "banner_image": "https://mma.prnewswire.com/media/1821113/Ipsos_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.442711,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KMB",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDLZ",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDNDF",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KHC",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CL",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UBER",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DEO",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.026424",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Got $200? 2 Healthcare Stocks to Buy and Hold Forever.",
    "url": "https://www.fool.com/investing/2024/06/14/got-200-2-healthcare-stocks-to-buy-and-hold/",
    "time_published": "20240614T101500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "They aren't the flashiest stocks, but they get the job done.",
    "banner_image": "https://g.foolcdn.com/editorial/images/780015/physician-talking-to-patient.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.233304,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.395012",
        "ticker_sentiment_score": "0.273199",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.301933",
        "ticker_sentiment_score": "0.236217",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cardiex Sales and Operations Update",
    "url": "https://investingnews.com/cardiex-sales-and-operations-update/",
    "time_published": "20240618T002629",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Jane Muthoni faced frequent illness during her childhood before she was diagnosed with diabetes. Knowing that over half the world's population can't access essential health services - she now travels around Africa to help others live healthier lives through her work with Medtronic LABS",
    "banner_image": "https://investingnews.com/media-library/cardiex-limited.png?id=52080630&width=1200&height=600&coordinates=0%2C100%2C0%2C100",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.097591,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.699089",
        "ticker_sentiment_score": "0.155285",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Sempra Appoints Jennifer M. Kirk to Board of Directors",
    "url": "https://investingnews.com/sempra-appoints-jennifer-m-kirk-to-board-of-directors/",
    "time_published": "20240620T212507",
    "authors": [
      "Investing News Network"
    ],
    "summary": "Sempra ( NYSE: SRE ) ( BMV: SRE ) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20 2024.",
    "banner_image": "https://images.newsfilecorp.com/files/7417/207678_55f74e59a4f1a9ac_logo.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.403707,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "OXY",
        "relevance_score": "0.089129",
        "ticker_sentiment_score": "-0.040694",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.262994",
        "ticker_sentiment_score": "0.069856",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSG",
        "relevance_score": "0.089129",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SRE",
        "relevance_score": "0.781806",
        "ticker_sentiment_score": "0.706492",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Wyoming Philanthropist and Rotarian Donates $1 million to Project C.U.R.E. for Work in Ukraine.",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39417108/wyoming-philanthropist-and-rotarian-donates-1-million-to-project-c-u-r-e-for-work-in-ukraine",
    "time_published": "20240620T161831",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Denver, Colorado, June 20, 2024 ( GLOBE NEWSWIRE ) -- FOR IMMEDIATE RELEASE - Project C.U.R.E., the nation's leading provider of donated medical supplies and equipment to underserved communities worldwide, received a $1 million donation from Wyoming philanthropist and Rotarian, John Evans.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.312358,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.025164",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KMB",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.099987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.099987",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STE",
        "relevance_score": "0.058472",
        "ticker_sentiment_score": "0.099987",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Generative AI-Based MedTech Stocks to Keep an Eye On",
    "url": "https://www.zacks.com/stock/news/2290746/3-generative-ai-based-medtech-stocks-to-keep-an-eye-on",
    "time_published": "20240620T125600",
    "authors": [
      "Moumi Mondal"
    ],
    "summary": "With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a9/50722.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.744043"
      }
    ],
    "overall_sentiment_score": 0.399799,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.0367",
        "ticker_sentiment_score": "0.149756",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QEBR",
        "relevance_score": "0.0367",
        "ticker_sentiment_score": "0.341543",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.146025",
        "ticker_sentiment_score": "0.203667",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.146025",
        "ticker_sentiment_score": "0.209095",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "One Cardiac Surgeon's Dream To Bring Robotic Surgery To The Masses Is Becoming A Reality - SS Innovations  ( OTC:SSII ) ",
    "url": "https://www.benzinga.com/partner/general/24/06/39409632/one-cardiac-surgeons-dream-to-bring-robotic-surgery-to-the-masses-is-becoming-a-reality",
    "time_published": "20240620T120845",
    "authors": [
      "Kimberly Adams"
    ],
    "summary": "According to the Mayo Clinic, Robotic surgery allows doctors to perform many types of complex procedures with more precision, flexibility and control than is possible with traditional procedures. Most often, a robotic surgery system includes a camera arm and mechanical arms with surgical ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/20/image1-1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.224211,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.028056",
        "ticker_sentiment_score": "0.138203",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.028056",
        "ticker_sentiment_score": "0.336845",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SSII",
        "relevance_score": "0.274937",
        "ticker_sentiment_score": "0.165223",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "New MiniMed\u2122 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes",
    "url": "https://www.prnewswire.com/news-releases/new-minimed-780g-system-data-demonstrates-ability-to-address-persistent-blood-sugar-challenges-for-people-with-type-1-diabetes-302179448.html",
    "time_published": "20240621T223000",
    "authors": [
      "Medtronic plc"
    ],
    "summary": "New MiniMed\u2122 780G system data demonstrates ability to address persistent blood sugar challenges for people with ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.113562,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.207374",
        "ticker_sentiment_score": "0.159373",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "All Public Company News from PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/all-public-company-news/",
    "time_published": "20240621T214040",
    "authors": [],
    "summary": "All Public Company PR ...",
    "banner_image": "https://www.prnewswire.com/content/dam/prnewswire/common/JournalistsBloggers.jpg",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.905476"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.185027,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ENPH",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.107088",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAND",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.356288",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "RNA",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.152404",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GL",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAFE",
        "relevance_score": "0.210274",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UA",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.24477",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PTCT",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.146314",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXTI",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.094042",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KORE",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TM",
        "relevance_score": "0.053153",
        "ticker_sentiment_score": "-0.086679",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRSN",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "-0.0195",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARGX",
        "relevance_score": "0.053153",
        "ticker_sentiment_score": "0.146676",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.098389",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HALO",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.159415",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EC",
        "relevance_score": "0.210274",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRVL",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "0.107088",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top 10 Companies Dominating the Global Drug Delivery Systems Market",
    "url": "https://www.prnewswire.com/news-releases/top-10-companies-dominating-the-global-drug-delivery-systems-market-302178938.html",
    "time_published": "20240621T085300",
    "authors": [
      "BCC Research LLC"
    ],
    "summary": "\"Revolutionizing Healthcare Horizons: Delving Deep into Advanced Drug Delivery Systems ( ADDS ) and Forecasting an Explosive $359.1 Billion Market Growth by 2028, BCC Research Study\" BOSTON, June 21, 2024 /PRNewswire/ -- Demand for effective solutions has never been so urgent to prevent global ...",
    "banner_image": "https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.368737,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BSX",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.139046",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.139046",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.139046",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.116067",
        "ticker_sentiment_score": "0.157812",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TEVA",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.139046",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.116067",
        "ticker_sentiment_score": "0.157812",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.116067",
        "ticker_sentiment_score": "0.157812",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.116067",
        "ticker_sentiment_score": "0.157812",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cleo Commences U.S. Regulatory Process with FDA",
    "url": "https://investingnews.com/cleo-commences-us-regulatory-process-with-fda/",
    "time_published": "20240625T231824",
    "authors": [
      "Investing News Network"
    ],
    "summary": "With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed\u2122 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep",
    "banner_image": "https://mma.prnewswire.com/media/1657690/Medtronic_Logo.jpg",
    "source": "Investing News Network",
    "category_within_source": "n/a",
    "source_domain": "investingnews.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.213245,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.541149",
        "ticker_sentiment_score": "0.182399",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Shares Positive Data for MiniMed 780G System",
    "url": "https://www.zacks.com/stock/news/2292779/medtronic-mdt-shares-positive-data-for-minimed-780g-system",
    "time_published": "20240625T130600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/06/667.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.193975,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MEDP",
        "relevance_score": "0.125679",
        "ticker_sentiment_score": "0.049497",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.125679",
        "ticker_sentiment_score": "0.049497",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.248259",
        "ticker_sentiment_score": "0.216704",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.167032",
        "ticker_sentiment_score": "0.064563",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer",
    "url": "https://www.globenewswire.com/news-release/2024/06/25/2903625/0/en/CVRx-Announces-Appointment-of-Robert-Allen-John-as-Chief-Revenue-Officer.html",
    "time_published": "20240625T105000",
    "authors": [
      "Inc.",
      "CVRx"
    ],
    "summary": "MINNEAPOLIS, June 25, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( \"CVRx\" ) , a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer effective June 27. In this role, John will lead the Company's US sales team with the ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/04c4feba-7841-4ac8-8ca5-6c03be383a0e",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.35402,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.058442",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVRX",
        "relevance_score": "0.543935",
        "ticker_sentiment_score": "0.577546",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.058442",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer - CVRx  ( NASDAQ:CVRX ) ",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39474109/cvrx-announces-appointment-of-robert-allen-john-as-chief-revenue-officer",
    "time_published": "20240625T105000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MINNEAPOLIS, June 25, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc. CVRX ( \"CVRx\" ) , a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer effective June 27.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.351136,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.067727",
        "ticker_sentiment_score": "0.057787",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVRX",
        "relevance_score": "0.503424",
        "ticker_sentiment_score": "0.553385",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.067727",
        "ticker_sentiment_score": "0.057787",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "HP Inc. Appoints Karen Parkhill as Chief Financial Officer - HP  ( NYSE:HPQ ) ",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39501153/hp-inc-appoints-karen-parkhill-as-chief-financial-officer",
    "time_published": "20240626T130002",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "PALO ALTO, Calif., June 26, 2024 ( GLOBE NEWSWIRE ) -- HP Inc. HPQ today announced that Karen Parkhill will join the company as Chief Financial Officer on August 5, 2024. Tim Brown, who has been serving as interim Chief Financial Officer, will return to his role as the head of Print Finance.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.336134,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HPQ",
        "relevance_score": "0.354572",
        "ticker_sentiment_score": "0.456497",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "AXP",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "-0.001009",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.073321",
        "ticker_sentiment_score": "0.017248",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CMA",
        "relevance_score": "0.146025",
        "ticker_sentiment_score": "0.153347",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "HP Inc. Appoints Karen Parkhill as Chief Financial Officer",
    "url": "https://www.globenewswire.com/news-release/2024/06/26/2904524/0/en/HP-Inc-Appoints-Karen-Parkhill-as-Chief-Financial-Officer.html",
    "time_published": "20240626T130000",
    "authors": [
      "HP Inc."
    ],
    "summary": "PALO ALTO, Calif., June 26, 2024 ( GLOBE NEWSWIRE ) -- HP Inc. ( NYSE: HPQ ) today announced that Karen Parkhill will join the company as Chief Financial Officer on August 5, 2024. Tim Brown, who has been serving as interim Chief Financial Officer, will return to his role as the head of Print ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/37c4d49c-63cd-4ba2-9a1a-c89d07424eb9",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.333655,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HPQ",
        "relevance_score": "0.382925",
        "ticker_sentiment_score": "0.487321",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "AXP",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "-0.001018",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.01744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CMA",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.161275",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "url": "https://www.zacks.com/stock/news/2293474/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings",
    "time_published": "20240626T125006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default301.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99989"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.380269,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.253646",
        "ticker_sentiment_score": "0.23017",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ELV",
        "relevance_score": "0.314017",
        "ticker_sentiment_score": "0.340694",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Loses 5% in a Month: What's Next for MDT Investors?",
    "url": "https://www.zacks.com/stock/news/2296266/medtronic-loses-5-in-a-month-whats-next-for-mdt-investors",
    "time_published": "20240702T154700",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.082921,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.644527",
        "ticker_sentiment_score": "0.018763",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.194632",
        "ticker_sentiment_score": "0.001634",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Intuitive Surgical  ( ISRG )  Rises 10% in a Month: What's Next?",
    "url": "https://www.zacks.com/stock/news/2296101/intuitive-surgical-isrg-rises-10-in-a-month-whats-next",
    "time_published": "20240702T130500",
    "authors": [
      "Indrajit Bandyopadhyay"
    ],
    "summary": "Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/40/1670.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.299852,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.282448",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.403913",
        "ticker_sentiment_score": "0.453487",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.282448",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Medical Equipment Maintenance Market: From $54.0B in 2024 to $88.9B by 2029 at 10.5% CAGR | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39616068/global-medical-equipment-maintenance-market-from-54-0b-in-2024-to-88-9b-by-2029-at-10-5-cagr-marke",
    "time_published": "20240703T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, July 03, 2024 ( GLOBE NEWSWIRE ) -- The global Medical Equipment Maintenance Market, valued at $54.0 billion in 2024 and projected to reach $88.9 billion by 2029 with a CAGR of 10.5%, is driven by increasing adoption of preventive maintenance programs in healthcare facilities to ensure ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.411886,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.10863",
        "ticker_sentiment_score": "0.176846",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.03631",
        "ticker_sentiment_score": "0.059027",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GPC",
        "relevance_score": "0.03631",
        "ticker_sentiment_score": "0.156825",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.144491",
        "ticker_sentiment_score": "0.244097",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.03631",
        "ticker_sentiment_score": "0.059027",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cryotherapy Market to be Worth USD 885.7 million by 2034, Growing a CAGR 9.3% - Exclusive Report by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39615062/cryotherapy-market-to-be-worth-usd-885-7-million-by-2034-growing-a-cagr-9-3-exclusive-report-by-tr",
    "time_published": "20240703T113300",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. - , July 03, 2024 ( GLOBE NEWSWIRE ) -- The global cryotherapy market stood at US$ 331.4 million in 2023, and the global market is projected to reach US$ 885.7 million in 2034.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.339504,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.03916",
        "ticker_sentiment_score": "0.292631",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.03916",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.117104",
        "ticker_sentiment_score": "0.077729",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Pediatric Medical Devices Market on Track to Reach USD 47.4 Billion by 2031: Driven by Advancements in Medical Devices and Digital Solutions at 6.3% CAGR: Analysis by TMR",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39647701/pediatric-medical-devices-market-on-track-to-reach-usd-47-4-billion-by-2031-driven-by-advancements",
    "time_published": "20240705T143457",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research. Inc. , July 05, 2024 ( GLOBE NEWSWIRE ) -- The global pediatric medical devices market was projected to attain US$ 27.6 billion in 2022. It is anticipated to garner a 6.3% CAGR from 2023 to 2031 and by 2031, the market is likely ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.208062,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAX",
        "relevance_score": "0.038284",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.038284",
        "ticker_sentiment_score": "0.050787",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.038284",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.038284",
        "ticker_sentiment_score": "0.073514",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.1145",
        "ticker_sentiment_score": "0.050134",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.038284",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2299569/medtronic-mdt-rises-yet-lags-behind-market-some-facts-worth-knowing",
    "time_published": "20240710T215019",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Medtronic (MDT) settling at $77.06, representing a +0.23% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default274.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.165014,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.484191",
        "ticker_sentiment_score": "0.19592",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "2 Healthcare Stocks to Buy at a Discount",
    "url": "https://www.fool.com/investing/2024/07/14/2-healthcare-stocks-to-buy-at-a-discount/",
    "time_published": "20240714T140000",
    "authors": [
      "Rachel Warren"
    ],
    "summary": "Beaten-down stocks can sometimes present an opportunity.",
    "banner_image": "https://g.foolcdn.com/editorial/images/783034/investing-woman-wall-street-suit-stocks-finance.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.98396"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.658903"
      }
    ],
    "overall_sentiment_score": 0.260259,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.038969",
        "ticker_sentiment_score": "0.119066",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AWON",
        "relevance_score": "0.038969",
        "ticker_sentiment_score": "0.178542",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TDOC",
        "relevance_score": "0.077845",
        "ticker_sentiment_score": "0.101704",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.038969",
        "ticker_sentiment_score": "0.119066",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.267664",
        "ticker_sentiment_score": "0.23861",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "2 Healthcare Stocks to Buy Hand Over Fist This Month",
    "url": "https://www.fool.com/investing/2024/07/14/2-healthcare-stocks-to-buy-hand-over-fist-this-mon/",
    "time_published": "20240714T133100",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "They don't have the most exciting businesses, but they have a lot to offer nonetheless.",
    "banner_image": "https://g.foolcdn.com/editorial/images/782612/doctor-and-patient-in-a-hospital-room.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.891286"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.343957,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.454714",
        "ticker_sentiment_score": "0.511875",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.04823",
        "ticker_sentiment_score": "0.155387",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.413803",
        "ticker_sentiment_score": "0.452836",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "2 Top Growth Stocks That Could Turn $1,000 Into $4,000 in 10 Years",
    "url": "https://www.fool.com/investing/2024/07/14/2-top-growth-stocks-that-could-turn-1000-into-4000/",
    "time_published": "20240714T110000",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "These two companies have done it before -- and can do it again.",
    "banner_image": "https://media.ycharts.com/charts/1651f3c2b6c48a88627f0195fc368b58.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.136494,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.105836",
        "ticker_sentiment_score": "0.078686",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VEEV",
        "relevance_score": "0.405378",
        "ticker_sentiment_score": "0.089547",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.260559",
        "ticker_sentiment_score": "0.112821",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields - Pfizer  ( NYSE:PFE ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/07/39779339/wall-streets-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-divid",
    "time_published": "20240715T180821",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/15/GE-Healthcare-Amersham-radiopharmaceutic.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.127007,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "CVS",
        "relevance_score": "0.199037",
        "ticker_sentiment_score": "0.118551",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "-0.144941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "-0.090347",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.100308",
        "ticker_sentiment_score": "0.078606",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade",
    "url": "https://www.fool.com/investing/2024/07/15/3-high-yield-dividend-stocks-to-buy-in-the-second/",
    "time_published": "20240715T094400",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "These three stocks boast an average yield that is more than three times the average dividend payer in the benchmark S&P 500 index.",
    "banner_image": "https://g.foolcdn.com/editorial/images/783355/investor-sofa-laptop-getty.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.34091,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ADC",
        "relevance_score": "0.368383",
        "ticker_sentiment_score": "0.354062",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MCO",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.230925",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.205906",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "O",
        "relevance_score": "0.215894",
        "ticker_sentiment_score": "0.294378",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Surpasses Market Returns: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2302984/medtronic-mdt-surpasses-market-returns-some-facts-worth-knowing",
    "time_published": "20240716T215018",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) closed the most recent trading day at $78.10, moving +1.32% from the previous trading session.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default185.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.194654,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.543535",
        "ticker_sentiment_score": "0.310927",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Spinal Implants and Devices Market Poised for Significant Growth, Expected to Reach USD 22.39 Billion by 2032, According to Straits Research",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39796798/spinal-implants-and-devices-market-poised-for-significant-growth-expected-to-reach-usd-22-39-billi",
    "time_published": "20240716T144000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, July 16, 2024 ( GLOBE NEWSWIRE ) -- As per the Latest Report by Straits Research, the global spinal implants and devices market size was valued at USD 13.97 billion in 2023. It is projected to reach USD 22.39 billion by 2032, growing at a CAGR of 5.5% during the forecast ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.038565,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.029292",
        "ticker_sentiment_score": "0.204197",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "META",
        "relevance_score": "0.029292",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research - Medtronic  ( NYSE:MDT ) , DaVita  ( NYSE:DVA ) ",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39796337/renal-denervation-devices-market-expected-to-reach-usd-387-million-by-2032-with-a-remarkable-37-2-",
    "time_published": "20240716T142000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, July 16, 2024 ( GLOBE NEWSWIRE ) -- As per the Latest Report by Straits Research, the global renal denervation devices market size was valued at USD 54.26 million in 2023.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.209626,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.125789",
        "ticker_sentiment_score": "0.156339",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "META",
        "relevance_score": "0.03157",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "0.175181",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How Much Will Medtronic Pay Out in Dividends This Year?",
    "url": "https://www.fool.com/investing/2024/07/16/how-much-will-medtronic-pay-out-in-dividends-this/",
    "time_published": "20240716T122600",
    "authors": [
      "Eric Volkman"
    ],
    "summary": "The short answer: More than many of its peers, at least in terms of yield.",
    "banner_image": "https://g.foolcdn.com/editorial/images/783445/medical-professional-holding-dollar-sign-paperweight.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.151066,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.555911",
        "ticker_sentiment_score": "0.26709",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medical Devices Market to Surpass $756.59 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39836904/medical-devices-market-to-surpass-756-59-billion-by-2031-skyquest-technology",
    "time_published": "20240718T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, July 18, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Medical Devices market will attain a value of $756.59 Billion by 2031, with a CAGR of 5.8% over the forecast period ( 2024-2031 ) . Medical devices are essential tools used in the healthcare sector to diagnose and ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.305725,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.153954",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ESLOF",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XRAY",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.078515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.044885",
        "ticker_sentiment_score": "0.153954",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers - Abbott Laboratories  ( NYSE:ABT ) ",
    "url": "https://www.benzinga.com/general/biotech/24/07/39861919/abbott-labs-makes-marketing-push-for-new-glucose-monitors-targets-health-conscious-consumers",
    "time_published": "20240719T151041",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Abbott Laboratories ABT CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device. This device targets consumers without diabetes, aiming to personalize health data and enhance understanding of ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/19/abbott-shutter.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.308181,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.194242",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.194242",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.287762",
        "ticker_sentiment_score": "0.117819",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Sinks As Market Gains: Here's Why",
    "url": "https://www.zacks.com/stock/news/2306411/medtronic-mdt-stock-sinks-as-market-gains-heres-why",
    "time_published": "20240722T215027",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) closed at $79.30 in the latest trading session, marking a -0.23% move from the prior day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default298.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.206931,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.454174",
        "ticker_sentiment_score": "0.277024",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  is a Top-Ranked Value Stock: Should You Buy?",
    "url": "https://www.zacks.com/stock/news/2306838/medtronic-mdt-is-a-top-ranked-value-stock-should-you-buy",
    "time_published": "20240723T134012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default192.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.401384,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.479683",
        "ticker_sentiment_score": "0.169975",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 BlackRock Mutual Funds to Buy for Long-Term Gains",
    "url": "https://www.zacks.com/stock/news/2307603/3-blackrock-mutual-funds-to-buy-for-long-term-gains",
    "time_published": "20240724T115900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BlackRock mutual funds like BMCAX, BIRAX and MDBAX that have given impressive returns in the past and are expected to do the same in 2024 and beyond.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8a/52792.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.972193"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.998356"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.218208,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.331765",
        "ticker_sentiment_score": "0.381251",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.085324",
        "ticker_sentiment_score": "0.050193",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.042723",
        "ticker_sentiment_score": "0.048639",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.042723",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.042723",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.042723",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BlackRock Mutual Funds to Buy With Rate Cuts on the Horizon",
    "url": "https://www.zacks.com/stock/news/2309655/3-blackrock-mutual-funds-to-buy-with-rate-cuts-on-the-horizon",
    "time_published": "20240726T093200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BlackRock mutual funds like BMCAX, BATPX and MRBVX for high returns and risk reduction as the first rate cut appears on the horizon.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f8/614.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999896"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.309338,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.503831",
        "ticker_sentiment_score": "0.454759",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.157046",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.11723",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.11723",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.11723",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.090304",
        "ticker_sentiment_score": "0.13776",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Better Buy: Abbott Laboratories vs. Intuitive Surgical",
    "url": "https://www.fool.com/investing/2024/07/26/better-buy-abbott-laboratories-vs-intuitive-surgic/",
    "time_published": "20240726T092700",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "The medical technology business has been good for both companies, but which is right for your portfolio?",
    "banner_image": "https://g.foolcdn.com/editorial/images/784235/investor-calculator-getty.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      }
    ],
    "overall_sentiment_score": 0.207029,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.268",
        "ticker_sentiment_score": "0.309649",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.049981",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.368383",
        "ticker_sentiment_score": "0.271892",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.049981",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "DexCom  ( DXCM )  Q2 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/07/25/dexcom-dxcm-q2-2024-earnings-call-transcript/",
    "time_published": "20240726T030017",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "DXCM earnings call for the period ending June 30, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.211592,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BCS",
        "relevance_score": "0.004134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.004134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CCORF",
        "relevance_score": "0.004134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.004134",
        "ticker_sentiment_score": "0.027326",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.057827",
        "ticker_sentiment_score": "0.099",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BNXYF",
        "relevance_score": "0.004134",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Surpasses Market Returns: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2311368/medtronic-mdt-surpasses-market-returns-some-facts-worth-knowing",
    "time_published": "20240729T215017",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $80, signifying a +1.65% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default98.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.197114,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.466609",
        "ticker_sentiment_score": "0.276341",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Dips While Market Gains: Key Facts",
    "url": "https://www.zacks.com/stock/news/2313497/medtronic-mdt-stock-dips-while-market-gains-key-facts",
    "time_published": "20240731T214517",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) closed at $80.32 in the latest trading session, marking a -0.61% move from the prior day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default327.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.995921"
      }
    ],
    "overall_sentiment_score": 0.19632,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.517534",
        "ticker_sentiment_score": "0.26653",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Stock Moves Above 50-Day SMA: Should You Buy MDT?",
    "url": "https://www.zacks.com/stock/news/2314430/medtronic-stock-moves-above-50-day-sma-should-you-buy-mdt",
    "time_published": "20240801T152300",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "Medtronic's (MDT) stock finally breaking above its 50-day SMA can be a piece of good news for investors, signaling an uptrend.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/27/3804.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.9545"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.5855"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.183286,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.565345",
        "ticker_sentiment_score": "0.118867",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.124164",
        "ticker_sentiment_score": "0.14156",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2317384/medtronic-mdt-rises-yet-lags-behind-market-some-facts-worth-knowing",
    "time_published": "20240806T214522",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Medtronic (MDT) settling at $80.78, representing a +0.56% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default244.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99246"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.180968,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.535653",
        "ticker_sentiment_score": "0.272806",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Intuitive Surgical  ( ISRG )  Rises 5% Post Earnings: What's Next?",
    "url": "https://www.zacks.com/stock/news/2316780/intuitive-surgical-isrg-rises-5-post-earnings-whats-next",
    "time_published": "20240806T115500",
    "authors": [
      "Indrajit Bandyopadhyay"
    ],
    "summary": "Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.337937,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.078482",
        "ticker_sentiment_score": "0.280407",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.377712",
        "ticker_sentiment_score": "0.468537",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.078482",
        "ticker_sentiment_score": "0.280407",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "2 Dividend Stocks to Buy and Never Sell",
    "url": "https://www.fool.com/investing/2024/08/06/2-dividend-stocks-to-buy-and-never-sell/",
    "time_published": "20240806T110700",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "These two are rock-solid businesses with strong dividend programs.",
    "banner_image": "https://g.foolcdn.com/editorial/images/785381/physicians-in-an-operating-room.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.839681"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.350209,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.34974",
        "ticker_sentiment_score": "0.476524",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.060236",
        "ticker_sentiment_score": "0.189296",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Chips, Glorious Chips!",
    "url": "https://www.fool.com/investing/2024/08/07/chips-glorious-chips/",
    "time_published": "20240807T205700",
    "authors": [
      "Motley Fool Staff"
    ],
    "summary": "Someone's gotta make 'em, and someone's gotta buy 'em.",
    "banner_image": "https://g.foolcdn.com/editorial/images/785851/mfm_01.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999956"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.157733,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.041394",
        "ticker_sentiment_score": "0.068626",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNEJF",
        "relevance_score": "0.008282",
        "ticker_sentiment_score": "0.041735",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.140076",
        "ticker_sentiment_score": "0.10708",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVCR",
        "relevance_score": "0.008282",
        "ticker_sentiment_score": "0.158451",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.024844",
        "ticker_sentiment_score": "0.134517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HPNN",
        "relevance_score": "0.008282",
        "ticker_sentiment_score": "0.075637",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.008282",
        "ticker_sentiment_score": "0.059376",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033121",
        "ticker_sentiment_score": "0.069044",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.024844",
        "ticker_sentiment_score": "0.173496",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.008282",
        "ticker_sentiment_score": "-0.010183",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.107347",
        "ticker_sentiment_score": "0.080039",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/08/40228865/looking-into-medtronics-recent-short-interest",
    "time_published": "20240807T173028",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has fallen 10.08% since its last report. The company recently reported that it has 13.68 million shares sold short, which is 1.07% of all regular shares that are available for trading.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1723051825_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results",
    "url": "https://www.globenewswire.com/news-release/2024/08/08/2927435/0/en/Acutus-Medical-Reports-Second-Quarter-and-Year-To-Date-2024-Financial-Results.html",
    "time_published": "20240808T205600",
    "authors": [
      "Inc.",
      "Acutus Medical"
    ],
    "summary": "CARLSBAD, Calif., Aug. 08, 2024 ( GLOBE NEWSWIRE ) -- Acutus Medical, Inc. ( \"Acutus\" or the \"Company\" ) ( OTC: AFIB ) today reported results for the second quarter and year-to-date of 2024.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/2e6d1769-86af-4321-8203-7b0211a44f8b",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.988915"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.12681,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.134968",
        "ticker_sentiment_score": "0.142095",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Veru Inc.  ( VERU )  Reports Q3 Loss, Tops Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2318836/veru-inc-veru-reports-q3-loss-tops-revenue-estimates",
    "time_published": "20240808T114509",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Veru (VERU) delivered earnings and revenue surprises of -16.67% and 12.97%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default335.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.142298,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.14131",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VERU",
        "relevance_score": "0.406745",
        "ticker_sentiment_score": "0.174765",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "mHealth market to Reach USD 176.69 Billion by 2031, Growing at 13.8% CAGR | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40281810/mhealth-market-to-reach-usd-176-69-billion-by-2031-growing-at-13-8-cagr-skyquest-technology",
    "time_published": "20240809T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Aug. 09, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that Global mHealth Market will attain a value of USD 176.69 Billion by 2031, with a CAGR of 13.8% over the forecast period ( 2024-2031 ) . There will be a significant increase in the global market over the next few years.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.320878,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "OMRNF",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.051772",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.049322",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Spectral Medical Announces Second Quarter Results and Provides Corporate Update",
    "url": "https://www.globenewswire.com/news-release/2024/08/09/2927742/0/en/Spectral-Medical-Announces-Second-Quarter-Results-and-Provides-Corporate-Update.html",
    "time_published": "20240809T120000",
    "authors": [
      "Spectral Medical Inc."
    ],
    "summary": "Tigris Trial Enrollment Reaches 126 Patients ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/9516c02b-7f3b-41c0-bac1-a037af9a3240",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.995921"
      }
    ],
    "overall_sentiment_score": 0.217241,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.019813",
        "ticker_sentiment_score": "0.063086",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SOLV",
        "relevance_score": "0.019813",
        "ticker_sentiment_score": "0.063086",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EDTXF",
        "relevance_score": "0.039614",
        "ticker_sentiment_score": "0.142523",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Moves -1.04%: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2320983/medtronic-mdt-stock-moves--104-what-you-should-know",
    "time_published": "20240812T220009",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $81.19, denoting a -1.04% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default158.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.167375,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.538782",
        "ticker_sentiment_score": "0.1603",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update",
    "url": "https://www.globenewswire.com/news-release/2024/08/12/2928789/0/en/Orchestra-BioMed-Reports-Second-Quarter-2024-Financial-Results-and-Provides-a-Business-Update.html",
    "time_published": "20240812T202000",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., Aug. 12, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its second quarter ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.203668,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.019846",
        "ticker_sentiment_score": "0.112686",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.079261",
        "ticker_sentiment_score": "0.101251",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.253595",
        "ticker_sentiment_score": "0.27537",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.138236",
        "ticker_sentiment_score": "0.108903",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSOI",
        "relevance_score": "0.019846",
        "ticker_sentiment_score": "0.222437",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "SEALSQ is Leading the Charge in Helping Clients Transition from Digitalization to Robotization Setting the Stage for the Future with Its Cutting-edge Post-Quantum Chips",
    "url": "https://www.globenewswire.com/news-release/2024/08/12/2928490/0/en/SEALSQ-is-Leading-the-Charge-in-Helping-Clients-Transition-from-Digitalization-to-Robotization-Setting-the-Stage-for-the-Future-with-Its-Cutting-edge-Post-Quantum-Chips.html",
    "time_published": "20240812T131700",
    "authors": [
      "SEAL Semiconductors"
    ],
    "summary": "Geneva, Switzerland, Aug. 12, 2024 ( GLOBE NEWSWIRE ) -- Following the design phase and production, and test of the first proof-of-concept, the QS7001 engineering samples are being produced and expected to be ready to order as soon as Q4 2024, while the TPM version should be ready by end of ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/4071513d-3f7c-4a38-a055-8da38cfb60df",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.323317,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LAES",
        "relevance_score": "0.356682",
        "ticker_sentiment_score": "0.28187",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.052743",
        "ticker_sentiment_score": "0.257182",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.026386",
        "ticker_sentiment_score": "0.083061",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:ECC",
        "relevance_score": "0.026386",
        "ticker_sentiment_score": "0.081792",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Increases Yet Falls Behind Market: What Investors Need to Know",
    "url": "https://www.zacks.com/stock/news/2321630/medtronic-mdt-increases-yet-falls-behind-market-what-investors-need-to-know",
    "time_published": "20240813T214511",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $82.27, denoting a +1.33% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default40.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      }
    ],
    "overall_sentiment_score": 0.149793,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.540358",
        "ticker_sentiment_score": "0.180576",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Abbott Up 7.7% Post Q2 Earnings: Should You Buy ABT Stock?",
    "url": "https://www.zacks.com/stock/news/2321482/abbott-up-77-post-q2-earnings-should-you-buy-abt-stock",
    "time_published": "20240813T154600",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "Abbott's (ABT) strong growth projection for 2024 is an indication that the stock will be able to sustain the positive momentum through the rest of the year.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.976671"
      }
    ],
    "overall_sentiment_score": 0.324262,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.138773",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.138773",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "EEG-EMG Equipment Market Size is on Track to Achieve USD 2.6 Billion by 2034 with 6.1% CAGR | Strategic Insights Report by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40342216/eeg-emg-equipment-market-size-is-on-track-to-achieve-usd-2-6-billion-by-2034-with-6-1-cagr-strateg",
    "time_published": "20240813T150711",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc, Aug. 13, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global EEG-EMG equipment market ( EEG-EMG \uc7a5\ube44 \uc2dc\uc7a5 ) was worth US$ 1.3 Billion in 2023 and is expected to reach US$ 2.6 ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/47b1b6b7-1556-4563-b3c2-7e58ce5ee03f/eeg-emg-equipment-market.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.225023,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.036365",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.036365",
        "ticker_sentiment_score": "-0.058078",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NHNKF",
        "relevance_score": "0.072655",
        "ticker_sentiment_score": "0.036123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZYXI",
        "relevance_score": "0.036365",
        "ticker_sentiment_score": "-0.058078",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.036365",
        "ticker_sentiment_score": "-0.058078",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.108794",
        "ticker_sentiment_score": "0.07008",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?",
    "url": "https://www.fool.com/investing/2024/08/12/abbott-laboratories-stock-could-soar-to-143-accord/",
    "time_published": "20240813T002900",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver.",
    "banner_image": "https://g.foolcdn.com/editorial/images/786808/investment-presentation2-getty.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.818451"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.247093,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CURN",
        "relevance_score": "0.050786",
        "ticker_sentiment_score": "-0.109967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.249873",
        "ticker_sentiment_score": "0.221881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.050786",
        "ticker_sentiment_score": "0.217437",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.201105",
        "ticker_sentiment_score": "0.176356",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.050786",
        "ticker_sentiment_score": "0.040944",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "IM Cannabis Corp.  ( IMCC )  Reports Q2 Loss, Tops Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2321881/im-cannabis-corp-imcc-reports-q2-loss-tops-revenue-estimates",
    "time_published": "20240814T131504",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "IM Cannabis (IMCC) delivered earnings and revenue surprises of 79.76% and 12.07%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default36.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.116963,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.138066",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IMCC",
        "relevance_score": "0.398148",
        "ticker_sentiment_score": "0.132197",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday - TJX Companies  ( NYSE:TJX ) ",
    "url": "https://www.benzinga.com/news/24/08/40363474/tjx-to-rally-over-15-here-are-10-top-analyst-forecasts-for-wednesday",
    "time_published": "20240814T114304",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs raised the price target for nCino, Inc. NCNO from $34 to $42.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/14073919/image-99-1024x583.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.274475,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "WULF",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "-0.038458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NCNO",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.303403",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.163516",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IBTA",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.155634",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INTU",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.016915",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SBUX",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.448639",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SRAD",
        "relevance_score": "0.159043",
        "ticker_sentiment_score": "0.144568",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.159043",
        "ticker_sentiment_score": "0.012572",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRIX",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.33677",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DPRO",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.103629",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.159043",
        "ticker_sentiment_score": "0.229204",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.236588",
        "ticker_sentiment_score": "0.136759",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Progresses in CGM With New Approval, Alliance",
    "url": "https://www.zacks.com/stock/news/2322671/medtronic-mdt-progresses-in-cgm-with-new-approval-alliance",
    "time_published": "20240815T142000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The FDA approval for Medtronic's (MDT) Simplera CGM sets the stage for further regulatory submissions of the updated InPen smart insulin pen app.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.41947,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.263942",
        "ticker_sentiment_score": "0.40673",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.160277",
        "ticker_sentiment_score": "0.264574",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.263942",
        "ticker_sentiment_score": "0.295159",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Seeking Clues to Medtronic  ( MDT )  Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2322493/seeking-clues-to-medtronic-mdt-q1-earnings-a-peek-into-wall-street-projections-for-key-metrics",
    "time_published": "20240815T131509",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default7.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999862"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.147941,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.326499",
        "ticker_sentiment_score": "0.163521",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Masimo's  ( MASI )  W1 Watch Gains FDA Nod for SafetyNet Connectivity",
    "url": "https://www.zacks.com/stock/news/2322505/masimos-masi-w1-watch-gains-fda-nod-for-safetynet-connectivity",
    "time_published": "20240815T131500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest FDA clearance of Masimo's (MASI) W1 medical watch is likely to provide a continuous and accurate view of patients' health data.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ca/2974.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.33542,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MASI",
        "relevance_score": "0.76191",
        "ticker_sentiment_score": "0.520444",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TDOC",
        "relevance_score": "0.133841",
        "ticker_sentiment_score": "0.181553",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.305871",
        "ticker_sentiment_score": "0.422825",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.177802",
        "ticker_sentiment_score": "0.136126",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday - Robinhood Markets  ( NASDAQ:HOOD ) ",
    "url": "https://www.benzinga.com/news/24/08/40392583/robinhood-to-rally-around-29-here-are-10-top-analyst-forecasts-for-thursday",
    "time_published": "20240815T121134",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Rosenblatt raised the price target for Lumentum Holdings Inc. LITE from $65 to $69.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/15080944/image-115-1024x571.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.658903"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.250236,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ALL",
        "relevance_score": "0.080458",
        "ticker_sentiment_score": "0.180568",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.094419",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSCO",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "0.32506",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNOW",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "0.009467",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "0.338393",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.234108",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "LITE",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "-0.036744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IPSC",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "-0.117248",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.007031",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PGR",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "0.178186",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.238133",
        "ticker_sentiment_score": "0.171986",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HOOD",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.293152",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DELL",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.094419",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Bariatric Surgery Devices Market to Reach USD 3.1 billion by 2034, Growth at CAGR 6.6% | Report by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40411565/bariatric-surgery-devices-market-to-reach-usd-3-1-billion-by-2034-growth-at-cagr-6-6-report-by-tra",
    "time_published": "20240816T084400",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 16, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global bariatric surgical devices market ( \ube44\ub9cc \uc218\uc220 \uc7a5\uce58 \uc2dc\uc7a5 ) was worth US$ 1.5 Bn in 2023 and is expected to reach US$ 3.1 Bn ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/3c1e2a41-0b2c-4a86-9155-07a8c8a96c9d/bariatric-surgical-devices-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.196826,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.029113",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.029113",
        "ticker_sentiment_score": "0.095645",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.029113",
        "ticker_sentiment_score": "0.095645",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.087185",
        "ticker_sentiment_score": "0.065041",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Dividend Stocks to Double Up On Right Now",
    "url": "https://www.fool.com/investing/2024/08/17/3-dividend-stocks-to-double-up-on-right-now/",
    "time_published": "20240817T130500",
    "authors": [
      "Selena Maranjian"
    ],
    "summary": "How does a 5.7% dividend yield sound?",
    "banner_image": "https://g.foolcdn.com/editorial/images/786403/getty-smiling-happy-with-dog-yoga-pants.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.875462"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.288498,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.060541",
        "ticker_sentiment_score": "0.109004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.060541",
        "ticker_sentiment_score": "0.006061",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.238718",
        "ticker_sentiment_score": "0.283349",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.180236",
        "ticker_sentiment_score": "0.099287",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Buy, Sell or Hold Medtronic  ( MDT )  Before Q1 Earnings?",
    "url": "https://www.zacks.com/stock/news/2323880/should-you-buy-sell-or-hold-medtronic-mdt-before-q1-earnings",
    "time_published": "20240819T151800",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "Medtronic's (MDT) first-quarter profits might have been dented by higher costs and expenses originating from macro issues and geopolitical complexities. However, innovations may have boosted the top line.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      }
    ],
    "overall_sentiment_score": 0.322216,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.41849",
        "ticker_sentiment_score": "0.346615",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.062761",
        "ticker_sentiment_score": "0.03506",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "5 Dividend Growth Stocks to Buy and Hold Forever",
    "url": "https://www.fool.com/investing/2024/08/19/5-dividend-growth-stocks-to-buy-and-hold-forever/",
    "time_published": "20240819T133000",
    "authors": [
      "George Budwell"
    ],
    "summary": "Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F787696%2Fgetty-dividend-stocks-growing-money-income-cash.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.601843,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AAPL",
        "relevance_score": "0.088964",
        "ticker_sentiment_score": "0.369158",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "KO",
        "relevance_score": "0.1331",
        "ticker_sentiment_score": "0.25762",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.1331",
        "ticker_sentiment_score": "0.193958",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.088964",
        "ticker_sentiment_score": "0.329279",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.1331",
        "ticker_sentiment_score": "0.3017",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medical Education Market is Projected to Expand at 5.1% CAGR, Reaching US$ 57.95 Billion by 2034 | Fact.MR",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40436837/medical-education-market-is-projected-to-expand-at-5-1-cagr-reaching-us-57-95-billion-by-2034-fact",
    "time_published": "20240819T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Aug. 19, 2024 ( GLOBE NEWSWIRE ) -- Revenue from medical education is estimated to reach US$ 35.11 billion in 2024, as revealed in a study recently updated by Fact.MR, a market research and competitive intelligence provider.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/96fecbea-1805-4e9a-b6a1-89f981093e6f/medical-education-market.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.37,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.039811",
        "ticker_sentiment_score": "0.082112",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.039811",
        "ticker_sentiment_score": "0.082112",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.039811",
        "ticker_sentiment_score": "0.082112",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.039811",
        "ticker_sentiment_score": "0.082112",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAE",
        "relevance_score": "0.039811",
        "ticker_sentiment_score": "0.082112",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.039811",
        "ticker_sentiment_score": "0.082112",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Varicose Veins Treatment Market to Attract Revenues Worth USD 2.4 Billion by 2031 at 4.8% CAGR - Report by Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40436375/varicose-veins-treatment-market-to-attract-revenues-worth-usd-2-4-billion-by-2031-at-4-8-cagr-repo",
    "time_published": "20240819T101822",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 19, 2024 ( GLOBE NEWSWIRE ) -- The varicose veins treatment market size ( \uc815\ub9e5\ub958 \uce58\ub8cc \uc2dc\uc7a5 ) is expected to reach US$ 2.4 Bn by the end of 2031 during the forecast period, as per Transparency Market Research ( TMR ) , a ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.148981,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ENOV",
        "relevance_score": "0.032251",
        "ticker_sentiment_score": "0.086517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ETTYF",
        "relevance_score": "0.032251",
        "ticker_sentiment_score": "0.086517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.032251",
        "ticker_sentiment_score": "0.057961",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.032251",
        "ticker_sentiment_score": "0.086517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.032251",
        "ticker_sentiment_score": "0.086517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VTRS",
        "relevance_score": "0.032251",
        "ticker_sentiment_score": "0.086517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.096542",
        "ticker_sentiment_score": "0.08579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.096542",
        "ticker_sentiment_score": "0.068653",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Buy, Sell or Hold Medtronic Before Q1 Earnings? - Abbott Laboratories  ( NYSE:ABT ) , Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/08/40444564/should-you-buy-sell-or-hold-medtronic-before-q1-earnings",
    "time_published": "20240820T174349",
    "authors": [
      "Zacks"
    ],
    "summary": "Medtronic plc MDT is scheduled to report first-quarter fiscal 2025 results on Aug 20, before the opening bell. In the last reported quarter, the company's adjusted earnings of $1.46 exceeded the Zacks Consensus Estimate by 0.69%.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/charts/32/74604.jpg?v=757625008",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999953"
      }
    ],
    "overall_sentiment_score": 0.331023,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.408791",
        "ticker_sentiment_score": "0.336825",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.030602",
        "ticker_sentiment_score": "0.042671",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/08/40467533/nasdaq-moves-lower-medtronic-posts-upbeat-earnings",
    "time_published": "20240820T160204",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.10% to 40,854.31 while the NASDAQ fell 0.15% to 17,850.34. The S&P 500 also fell, dropping, 0.06% to 5,604.70. Health care shares climbed by 0.5% on Tuesday.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/20/Le-2-azioni-finanziarie-da-scaricare-ad-.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.94762"
      }
    ],
    "overall_sentiment_score": 0.113871,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "RERE",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.20598",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BACHY",
        "relevance_score": "0.071357",
        "ticker_sentiment_score": "-0.028402",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TTNP",
        "relevance_score": "0.211806",
        "ticker_sentiment_score": "0.549422",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "INM",
        "relevance_score": "0.211806",
        "ticker_sentiment_score": "0.140522",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BTBT",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.314302",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MYNA",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.152496",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.211806",
        "ticker_sentiment_score": "0.31202",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VIPS",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "-0.183701",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q1 Earnings Beat, Fiscal 2025 View Narrowed",
    "url": "https://www.zacks.com/stock/news/2324518/medtronic-mdt-q1-earnings-beat-fiscal-2025-view-narrowed",
    "time_published": "20240820T154500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reports broad-based growth across all major segments, with strong gains in Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, Cranial & Spinal Technologies and Diabetes businesses.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/27/3804.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.184179,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CURN",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.173155",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.197413",
        "ticker_sentiment_score": "0.111684",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.197413",
        "ticker_sentiment_score": "0.091749",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.382925",
        "ticker_sentiment_score": "0.292144",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.197413",
        "ticker_sentiment_score": "0.090216",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Markets Wait for Fed's July FOMC Minutes",
    "url": "https://www.zacks.com/stock/news/2324435/markets-wait-for-feds-july-fomc-minutes",
    "time_published": "20240820T144300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Today, we achieve peak late-August trading. Not in terms of stock market highs - we're still off mid-June levels - but in terms of low volume, low activity. We remain in the final stages of Q2 earnings season, but aside from a couple speeches by Fed members later today, we have a dearth of ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/467.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      }
    ],
    "overall_sentiment_score": 0.066551,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "HD",
        "relevance_score": "0.142565",
        "ticker_sentiment_score": "0.133153",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.212425",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.142565",
        "ticker_sentiment_score": "0.145553",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Dog Day of Summer: Right Now in the Stock Market",
    "url": "https://www.zacks.com/stock/news/2324413/dog-day-of-summer-right-now-in-the-stock-market",
    "time_published": "20240820T140900",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "It's this week -- today, precisely -- that best represents a typical late-summer stock market environment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d7/48913.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      }
    ],
    "overall_sentiment_score": 0.066492,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "HD",
        "relevance_score": "0.139265",
        "ticker_sentiment_score": "0.12778",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.139265",
        "ticker_sentiment_score": "0.143639",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/08/40462317/medical-devices-giant-medtronic-q1-earnings-revenue-and-eps-beat-lifts-annual-guidance-marginally-o",
    "time_published": "20240820T130511",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Tuesday, Medtronic Plc MDT reported first-quarter 2025 sales of $7.92 billion, beating the consensus of $7.89 billion. The medical device maker reported adjusted EPS of $1.23, beating the consensus of $1.20. Revenue increased 2.8% year over year, as reported, and 5.3% organic.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/20/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.995077"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.383917,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.388879",
        "ticker_sentiment_score": "0.229262",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Surpasses Q1 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2324169/medtronic-mdt-surpasses-q1-earnings-and-revenue-estimates",
    "time_published": "20240820T115502",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) delivered earnings and revenue surprises of 2.50% and 0.22%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default165.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.161878,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.406745",
        "ticker_sentiment_score": "0.175906",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HITI",
        "relevance_score": "0.210579",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BNY Mellon Mutual Funds to Invest in for Solid Returns",
    "url": "https://www.zacks.com/stock/news/2324137/3-bny-mellon-mutual-funds-to-invest-in-for-solid-returns",
    "time_published": "20240820T105000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BNY Mellon mutual funds like DREVX, MPISX and DLDRX for a diversified investment approach.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ad/591.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.284691,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PSX",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.045093",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EQT",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FCX",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.067919",
        "ticker_sentiment_score": "0.045093",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Nasdaq, S&P 500 Futures Climb After 8-Session Market Rally: What's Going On - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",
    "url": "https://www.benzinga.com/news/earnings/24/08/40457537/us-stocks-may-take-a-breather-after-s-p-500s-impressive-8-session-winning-streak-strategist-says-ma",
    "time_published": "20240820T104809",
    "authors": [
      "Shanthi Rexaline"
    ],
    "summary": "The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/20/Stocks-Watch--Shutterstock.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Blockchain",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.142857"
      }
    ],
    "overall_sentiment_score": 0.041002,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MSTR",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDNDF",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.157502",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.167371",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.208016",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.164391",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COIN",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COTY",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCD",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.164391",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TOL",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTO",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LZB",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.164391",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "-0.172491",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "WT",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.004793",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VIPS",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "-0.172491",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:JPY",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "-0.025413",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "-0.073515",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "-0.046629",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone - ZIM Integrated Shipping  ( NYSE:ZIM ) ",
    "url": "https://www.benzinga.com/news/24/08/40454461/s-p-500-nasdaq-extend-gains-for-8th-consecutive-session-investor-sentiment-improves-but-greed-index",
    "time_published": "20240820T064041",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, but the index remained in the \"Fear\" zone on Monday. U.S. stocks settled higher on Monday, with the S&P 500 and Nasdaq recording gains for the eighth straight day.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/20/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.014789,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ALC",
        "relevance_score": "0.24289",
        "ticker_sentiment_score": "-0.283679",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.122894",
        "ticker_sentiment_score": "-0.184804",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.24289",
        "ticker_sentiment_score": "-0.283679",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "ZIM",
        "relevance_score": "0.24289",
        "ticker_sentiment_score": "0.302911",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Analysts Boost Their Forecasts After Upbeat Earnings - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/08/40485522/medtronic-analysts-boost-their-forecasts-after-upbeat-earnings",
    "time_published": "20240821T132507",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Medtronic Plc MDT reported better-than-expected results for its first quarter on Tuesday. The company posted first-quarter 2025 sales of $7.92 billion, beating the consensus of $7.89 billion. The medical device maker reported adjusted EPS of $1.23, beating the consensus of $1.20.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21091928/image-184-1024x425.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972756"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.32909,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.805127",
        "ticker_sentiment_score": "0.564395",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday - Texas Instruments  ( NASDAQ:TXN ) ",
    "url": "https://www.benzinga.com/news/24/08/40484349/texas-instruments-to-rally-around-16-here-are-10-top-analyst-forecasts-for-wednesday",
    "time_published": "20240821T125853",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Jefferies raised the price target for BrightView Holdings, Inc. BV from $13 to $17.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-1024x514.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.199829,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ADC",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.185617",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ENPH",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "-0.036135",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DRMA",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "-0.111761",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.146916",
        "ticker_sentiment_score": "0.228689",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CCOI",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "-0.126104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.146916",
        "ticker_sentiment_score": "-0.027176",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TXN",
        "relevance_score": "0.288893",
        "ticker_sentiment_score": "0.380454",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GLW",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.432823",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SON",
        "relevance_score": "0.146916",
        "ticker_sentiment_score": "-0.083991",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BV",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.084957",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.146916",
        "ticker_sentiment_score": "-0.083991",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.290942",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VIPS",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "0.049309",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Company News for Aug 21, 2024",
    "url": "https://www.zacks.com/stock/news/2324719/company-news-for-aug-21-2024",
    "time_published": "20240821T091500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Companies In The News Are: LLY, BA, AS, MDT.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.084125,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.558244",
        "ticker_sentiment_score": "0.010179",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AS",
        "relevance_score": "0.299478",
        "ticker_sentiment_score": "0.071662",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.558244",
        "ticker_sentiment_score": "0.404103",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.558244",
        "ticker_sentiment_score": "-0.095961",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Compared to Estimates, Medtronic  ( MDT )  Q1 Earnings: A Look at Key Metrics  ( Revised ) ",
    "url": "https://www.zacks.com/stock/news/2324698/compared-to-estimates-medtronic-mdt-q1-earnings-a-look-at-key-metrics-revised",
    "time_published": "20240821T080400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default152.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.929393"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.153989,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.346884",
        "ticker_sentiment_score": "0.117423",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Abbott  ( ABT )  Gets FDA Approval for Aspirin-Free HeartMate 3 Regimen",
    "url": "https://www.zacks.com/stock/news/2326206/abbott-abt-gets-fda-approval-for-aspirin-free-heartmate-3-regimen",
    "time_published": "20240823T131200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Abbott's (ABT) labeling update, exclusively for patients with a HeartMate 3 heart pump, secures the FDA's approval.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/1871.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.9545"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.223099,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MASI",
        "relevance_score": "0.179121",
        "ticker_sentiment_score": "0.09968",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.090134",
        "ticker_sentiment_score": "0.250226",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.179121",
        "ticker_sentiment_score": "0.106826",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.134841",
        "ticker_sentiment_score": "0.135251",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.134841",
        "ticker_sentiment_score": "0.052418",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why This 1 Value Stock Could Be a Great Addition to Your Portfolio",
    "url": "https://www.zacks.com/stock/news/2326978/why-this-1-value-stock-could-be-a-great-addition-to-your-portfolio",
    "time_published": "20240826T134012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default148.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.378663,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.74841",
        "ticker_sentiment_score": "0.214082",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "This Is Great News for Medtronic, but Is It Time to Buy the Stock?",
    "url": "https://www.fool.com/investing/2024/08/26/great-news-for-medtronic-investors-time-to-buy/",
    "time_published": "20240826T130000",
    "authors": [
      "Dan Victor"
    ],
    "summary": "This MedTech leader is back on track with profitable growth.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F788089%2Fgettyimages-2150701511-1200x800-5b2df79.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.993856"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      }
    ],
    "overall_sentiment_score": 0.400165,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.657331",
        "ticker_sentiment_score": "0.541866",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.058188",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ABT Expands Pure Bliss Line of Products for Advanced Infant Nutrition",
    "url": "https://www.zacks.com/stock/news/2328328/abt-expands-pure-bliss-line-of-products-for-advanced-infant-nutrition",
    "time_published": "20240828T134100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Abbott announces the expansion of its Pure Bliss by Similac line of products for infant nutrition with Organic and Organic A2 Milk infant formulas.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.980509"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.448968,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TMDX",
        "relevance_score": "0.219312",
        "ticker_sentiment_score": "0.152684",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.219312",
        "ticker_sentiment_score": "0.225107",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.120871",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.165409",
        "ticker_sentiment_score": "0.060544",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.272181",
        "ticker_sentiment_score": "0.208561",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.485272",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Is It Apt to Hold Globus Medical Stock in Your Portfolio Now?",
    "url": "https://www.zacks.com/stock/news/2328189/is-it-apt-to-hold-globus-medical-stock-in-your-portfolio-now",
    "time_published": "20240828T123800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "GMED's robust prospects in the musculoskeletal field and the synergies from the NuVasive merger bode well. Yet, macroeconomic issues can affect performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.983605"
      }
    ],
    "overall_sentiment_score": 0.295877,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VCYT",
        "relevance_score": "0.176825",
        "ticker_sentiment_score": "0.105853",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.044551",
        "ticker_sentiment_score": "0.196014",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.423606",
        "ticker_sentiment_score": "0.381464",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.044551",
        "ticker_sentiment_score": "0.196014",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.176825",
        "ticker_sentiment_score": "0.105853",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "New Launches Support Tandem Diabetes Stock Despite Macro Concerns",
    "url": "https://www.zacks.com/stock/news/2329688/new-launches-support-tandem-diabetes-stock-despite-macro-concerns",
    "time_published": "20240830T152300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest addition to TNDM's pump platform portfolio, Tandem Mobi, is leading the way in creating a whole new category of devices for insulin therapy.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.980509"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.221704,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TNDM",
        "relevance_score": "0.132855",
        "ticker_sentiment_score": "0.019548",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.21961",
        "ticker_sentiment_score": "0.176015",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.121004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.176502",
        "ticker_sentiment_score": "0.129767",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.044469",
        "ticker_sentiment_score": "0.121004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.132855",
        "ticker_sentiment_score": "0.053209",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.262052",
        "ticker_sentiment_score": "0.277114",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Is Medtronic Stock a Buy?",
    "url": "https://www.fool.com/investing/2024/09/01/is-medtronic-stock-a-buy/",
    "time_published": "20240901T124500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "It might not be the most exciting business, but it has other things going its way.",
    "banner_image": "https://g.foolcdn.com/editorial/images/788711/diabetes-patient-adjusting-device.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.988915"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.255659,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.523784",
        "ticker_sentiment_score": "0.29039",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "0.136098",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
    "url": "https://www.zacks.com/stock/news/2331386/why-this-1-momentum-stock-could-be-a-great-addition-to-your-portfolio",
    "time_published": "20240904T135013",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default190.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      }
    ],
    "overall_sentiment_score": 0.348434,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.543535",
        "ticker_sentiment_score": "0.150684",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion - Baxter Intl  ( NYSE:BAX ) , Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/markets/equities/24/09/40737587/medtronic-recalls-some-video-laryngoscopes-due-to-increased-risk-for-battery-overheat-explosion",
    "time_published": "20240905T174541",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Thursday, Medtronic Plc MDT said it is recalling certain devices and updating use instructions for another due to the possibility that the battery may deplete below its designed threshold. If this happens, it increases the risk of battery instability and may lead to increased battery temperature ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/05/Nationwide-Recall.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": -0.099371,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.288893",
        "ticker_sentiment_score": "0.006397",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.195025",
        "ticker_sentiment_score": "0.08331",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BlackRock Mutual Funds to Keep an Eye On",
    "url": "https://www.zacks.com/stock/news/2331905/3-blackrock-mutual-funds-to-keep-an-eye-on",
    "time_published": "20240905T112900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BlackRock mutual funds like MDGRX, MDBAX and BMCAX that have given impressive returns in the past and are expected to do the same in 2024 and beyond.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f8/614.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.983605"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999186"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.340212,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.431287",
        "ticker_sentiment_score": "0.525124",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.04842",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRHI",
        "relevance_score": "0.082535",
        "ticker_sentiment_score": "0.343546",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.04842",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.047446",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.047446",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.04842",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.047446",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RYDAF",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.04842",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tympanostomy Products Market Size to See 3.4% Annual Growth, Surpassing USD 139.7 Million by 2031| Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40726947/tympanostomy-products-market-size-to-see-3-4-annual-growth-surpassing-usd-139-7-million-by-2031-tr",
    "time_published": "20240905T112009",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc. , Sept. 05, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global tympanostomy products market ( \uace0\ub9c9\uc808\uac1c\uc220 \uc81c\ud488 \uc2dc\uc7a5 ) was worth US$ 103.6 Mn in 2022 and is expected to reach US$ 139.7 Mn ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/41f86746-d538-47c8-a197-24d612aed91f/tympanostomy-products-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.150517,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.034087",
        "ticker_sentiment_score": "0.050843",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.034087",
        "ticker_sentiment_score": "0.172986",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.034087",
        "ticker_sentiment_score": "0.172986",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AEXAF",
        "relevance_score": "0.034087",
        "ticker_sentiment_score": "0.172986",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.102013",
        "ticker_sentiment_score": "0.064306",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?",
    "url": "https://www.fool.com/investing/2024/09/05/billionaire-ray-dalios-former-hedge-fund-is-buying/",
    "time_published": "20240905T100000",
    "authors": [
      "George Budwell"
    ],
    "summary": "Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F789676%2Fgrowth.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.623304"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.260598,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.463792",
        "ticker_sentiment_score": "0.414388",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.357293",
        "ticker_sentiment_score": "0.288695",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BNXYF",
        "relevance_score": "0.04111",
        "ticker_sentiment_score": "0.215412",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.463792",
        "ticker_sentiment_score": "0.363547",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "3 Stocks Offering a \"Golden Opportunity\"",
    "url": "https://moneymorning.com/2024/09/06/3-stocks-offering-a-golden-opportunity/",
    "time_published": "20240906T163213",
    "authors": [
      "Chris Johnson"
    ],
    "summary": "In the sometimes complicated world of technical analysis it often pays to just keep things simple. Part of my daily analysis of the market includes checking the list of companies that are making technical moves as their patterns grow stronger.",
    "banner_image": "https://moneymorning.com/wp-content/blogs.dir/1/files/2024/09/EQIX.png",
    "source": "Money Morning",
    "category_within_source": "RSS",
    "source_domain": "moneymorning.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.82617"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.319689,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EQIX",
        "relevance_score": "0.091162",
        "ticker_sentiment_score": "0.063501",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.13637",
        "ticker_sentiment_score": "0.185727",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CLX",
        "relevance_score": "0.091162",
        "ticker_sentiment_score": "0.090363",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.225321",
        "ticker_sentiment_score": "0.285832",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain?",
    "url": "https://www.zacks.com/stock/news/2332712/abbotts-lingo-cgm-system-gains-us-availability-stock-to-gain",
    "time_published": "20240906T133700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who are not on insulin.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b8/1573.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.980509"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.293906,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TMDX",
        "relevance_score": "0.204072",
        "ticker_sentiment_score": "0.144392",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.253514",
        "ticker_sentiment_score": "0.293932",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.051551",
        "ticker_sentiment_score": "0.12946",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.153797",
        "ticker_sentiment_score": "0.057773",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.253514",
        "ticker_sentiment_score": "0.197138",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BodyBilt Continues Innovation Trend with New LabPro Stool",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40794517/bodybilt-continues-innovation-trend-with-new-labpro-stool",
    "time_published": "20240910T134148",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NAVASOTA, Texas, Sept. 10, 2024 ( GLOBE NEWSWIRE ) -- ErgoGenesis Workplace Solutions, LLC, the manufacturer of BodyBilt seating solutions for laboratory, office, home, and intensive-use environments, is announcing the release of its latest innovation, the LabPro Stool.",
    "banner_image": "https://ml.globenewswire.com/media/e63f94d4-8fa2-4a49-b5d1-ce624a02dfbb/small/bodybilt-logo-stacked-large-emblem-black-png.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.307068,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DGX",
        "relevance_score": "0.065866",
        "ticker_sentiment_score": "-0.038268",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.065866",
        "ticker_sentiment_score": "-0.038268",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.065866",
        "ticker_sentiment_score": "-0.038268",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources",
    "url": "https://www.globenewswire.com/news-release/2024/09/10/2943525/23089/en/Lifecore-Biomedical-Appoints-Brikkelle-Thompson-as-Senior-Vice-President-of-Human-Resources.html",
    "time_published": "20240910T110000",
    "authors": [
      "Lifecore Biomedical",
      "Inc."
    ],
    "summary": "Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/ca940278-cc18-4a3f-93b7-d8a034c998c9",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.319522,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.086556",
        "ticker_sentiment_score": "0.125388",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LFCR",
        "relevance_score": "0.33628",
        "ticker_sentiment_score": "0.218174",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.086556",
        "ticker_sentiment_score": "0.125388",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings - Entero Therapeutics  ( NASDAQ:ENTO ) ",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40789141/entero-therapeutics-signs-letter-of-intent-to-license-and-commercialize-remote-patient-and-machine",
    "time_published": "20240910T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "BOCA RATON, Fla., Sept. 10, 2024 ( GLOBE NEWSWIRE ) -- Entero Therapeutics, Inc., ENTO, ( \"Entero Therapeutics\" or the \"Company\" ) , a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal ( GI ) diseases, today ...",
    "banner_image": "https://ml.globenewswire.com/media/5d254ae4-e3a0-4b37-b825-033bda51dfe6/small/entero-logo-options-final-png.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.220407,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ENTO",
        "relevance_score": "0.530508",
        "ticker_sentiment_score": "0.246091",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.027476",
        "ticker_sentiment_score": "0.064271",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WISA",
        "relevance_score": "0.05492",
        "ticker_sentiment_score": "0.203913",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?",
    "url": "https://www.zacks.com/stock/news/2334726/medtronic-keeps-capturing-high-growth-markets-time-to-buy-mdt-stock",
    "time_published": "20240911T152100",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "MDT stock breaking above its 200 and 50-day SMAs can be a piece of good news for investors, signaling an uptrend.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.682689"
      }
    ],
    "overall_sentiment_score": 0.221426,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.58463",
        "ticker_sentiment_score": "0.307575",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.107978",
        "ticker_sentiment_score": "0.155061",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.072108",
        "ticker_sentiment_score": "0.199697",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
    "url": "https://www.zacks.com/stock/news/2334585/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick",
    "time_published": "20240911T134012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default175.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      }
    ],
    "overall_sentiment_score": 0.448606,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.428632",
        "ticker_sentiment_score": "0.160736",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3M, Visa, Medtronic And More On CNBC's 'Final Trades' - 3M  ( NYSE:MMM ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/09/40812333/3m-visa-medtronic-and-more-on-cnbcs-final-trades",
    "time_published": "20240911T121652",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Halftime Report Final Trades,\" Joshua Brown of Ritholtz Wealth Management named 3M Company MMM, which recorded gains on Tuesday. On Sept. 6, Morgan Stanley analyst Chris Snyder initiated coverage on 3M with an Underweight rating and announced a price target of $125.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/11/stock-traders-shutter.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.146192,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "IVZ",
        "relevance_score": "0.29234",
        "ticker_sentiment_score": "-0.463519",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "0.148007",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.29234",
        "ticker_sentiment_score": "0.470497",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.148731",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "V",
        "relevance_score": "0.546745",
        "ticker_sentiment_score": "0.329424",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/09/40841282/looking-into-medtronics-recent-short-interest",
    "time_published": "20240912T184514",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has risen 22.86% since its last report. The company recently reported that it has 16.50 million shares sold short, which is 1.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.39 days to cover ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1726166710_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Nearly 70% of Leaders Prioritize GenAI for Data and Analytics, Almost Half Anticipate Doubling ROI in Three Years, New Study Finds",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40837789/nearly-70-of-leaders-prioritize-genai-for-data-and-analytics-almost-half-anticipate-doubling-roi-i",
    "time_published": "20240912T160000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MOUNTAIN VIEW, Calif., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- A new MIT SMR Connections report sponsored by ThoughtSpot, the AI-Powered Analytics company, explores how early adopters of generative AI for analytics are gaining a significant competitive edge, with many already experiencing positive ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/863ad690-137a-40ea-9de8-50d257994214/mit-press-release-pr-graphic-v3-1200x628-1-.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.342724,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CVS",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.157698",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.157698",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RBCPF",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.157698",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.157698",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 BNY Mellon Mutual Funds for Steady Returns",
    "url": "https://www.zacks.com/stock/news/2335034/3-bny-mellon-mutual-funds-for-steady-returns",
    "time_published": "20240912T110100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Consider investing in BNY Mellon mutual funds like DREVX, MPISX and DLDRX for strategic investment opportunities.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6a/353.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99793"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.298544,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.043151",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.043151",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PSX",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.053195",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.045159",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EQT",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.053195",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FCX",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.053195",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.045159",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Reasons Medtronic's Stock Can Continue Rallying Higher",
    "url": "https://www.fool.com/investing/2024/09/12/3-reasons-medtronics-stock-can-continue-rallying/",
    "time_published": "20240912T110000",
    "authors": [
      "David Jagielski"
    ],
    "summary": "Medtronic's stock has been rising higher in recent weeks after another solid quarterly performance.",
    "banner_image": "https://media.ycharts.com/charts/771f4130aa9994e51b31a0fcf44cbf79.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.77141"
      }
    ],
    "overall_sentiment_score": 0.287494,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.533481",
        "ticker_sentiment_score": "0.420911",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BNXYF",
        "relevance_score": "0.058047",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top Stock Reports for Verizon, Prologis & Medtronic",
    "url": "https://www.zacks.com/research-daily/2335722/top-stock-reports-for-verizon-prologis-medtronic",
    "time_published": "20240913T202600",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Prologis, Inc. (PLD) and Medtronic plc (MDT), as well as a micro-cap stock Crimson Wine Group, Ltd. (CWGL).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/32/22529.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.344266,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.24847",
        "ticker_sentiment_score": "0.500932",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "0.29869",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PLD",
        "relevance_score": "0.063091",
        "ticker_sentiment_score": "0.277574",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Pacemaker Devices Market Size to Reach USD 6.9 Billion by 2034, Driven by Minimally Invasive Techniques and Personalized Medicine | Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40856519/pacemaker-devices-market-size-to-reach-usd-6-9-billion-by-2034-driven-by-minimally-invasive-techni",
    "time_published": "20240913T151357",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc., Sept. 13, 2024 ( GLOBE NEWSWIRE ) -- The global pacemaker devices market ( \uc2ec\uc7a5\ubc15\ub3d9\uae30 \uc7a5\uce58 \uc2dc\uc7a5 ) is estimated to surge at a CAGR of 3.8% from 2024 to 2034.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/fb2838b8-05ab-488b-80d2-737a1c2b815c/pacemaker-devices-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.431268,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.032961",
        "ticker_sentiment_score": "0.050574",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.065866",
        "ticker_sentiment_score": "0.197897",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.065866",
        "ticker_sentiment_score": "0.197897",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.098659",
        "ticker_sentiment_score": "0.053052",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.098659",
        "ticker_sentiment_score": "0.110089",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Hologram Doctor-Patient Visits Launched by West Cancer Center",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40853865/hologram-doctor-patient-visits-launched-by-west-cancer-center",
    "time_published": "20240913T132054",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Berkeley, CA, Sept. 13, 2024 ( GLOBE NEWSWIRE ) -- West Cancer Center & Research Institute and Proto Inc. announced the first holographic doctor-patient visits at UC Berkeley's forum on Global Healthcare Innovation.",
    "banner_image": "https://ml.globenewswire.com/media/db7f1d27-79ea-44c3-9ed3-db8a17e39287/small/logos-red-horizontal-light-mode-1-png.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.215212,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.037253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.037253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.04583",
        "ticker_sentiment_score": "0.037253",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Vident International Equity Strategy ETF  ( VIDI )  a Strong ETF Right Now?",
    "url": "https://www.zacks.com/stock/news/2335630/is-vident-international-equity-strategy-etf-vidi-a-strong-etf-right-now",
    "time_published": "20240913T102007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smart Beta ETF report for ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default17.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.209997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.118064",
        "ticker_sentiment_score": "0.067312",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JAZZ",
        "relevance_score": "0.118064",
        "ticker_sentiment_score": "0.067312",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200",
    "url": "https://www.fool.com/investing/2024/09/14/2-unstoppable-dividend-stocks-to-buy-right-now-for/",
    "time_published": "20240914T140500",
    "authors": [
      "Rachel Warren"
    ],
    "summary": "Dividend income can be a great way to boost your portfolio growth.",
    "banner_image": "https://g.foolcdn.com/editorial/images/790293/getty-happy-person-sign-language-laptop-1.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.918141"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      }
    ],
    "overall_sentiment_score": 0.362387,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.223659",
        "ticker_sentiment_score": "0.273287",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TGT",
        "relevance_score": "0.350564",
        "ticker_sentiment_score": "0.398767",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "3 American Century Mutual Funds to Buy for Exceptional Returns",
    "url": "https://www.zacks.com/stock/news/2336297/3-american-century-mutual-funds-to-buy-for-exceptional-returns",
    "time_published": "20240916T121600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in American Century mutual funds like BGEIX, AGYWX and ALVDX for strong returns ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.260095,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.053221",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.053221",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.051211",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZIJMY",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.047191",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.053221",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KGC",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.047191",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.051211",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AEM",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.047191",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.070725",
        "ticker_sentiment_score": "0.051211",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Verizon, Prologis, Medtronic and Crimson",
    "url": "https://www.zacks.com/stock/news/2336244/the-zacks-analyst-blog-verizon-prologis-medtronic-and-crimson",
    "time_published": "20240916T102000",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Verizon, Prologis, Medtronic and Crimson are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cd/401.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.300087,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.340245",
        "ticker_sentiment_score": "0.358917",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.198628",
        "ticker_sentiment_score": "0.17371",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PLD",
        "relevance_score": "0.198628",
        "ticker_sentiment_score": "0.176776",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Mark Cuban Foundation and ThoughtSpot Bring Free AI Bootcamp to Palo Alto Area Teens",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40903454/mark-cuban-foundation-and-thoughtspot-bring-free-ai-bootcamp-to-palo-alto-area-teens",
    "time_published": "20240917T154208",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MOUNTAIN VIEW, Calif., Sept. 17, 2024 ( GLOBE NEWSWIRE ) -- Time is running out to apply to participate in the Mark Cuban Foundation Artificial Intelligence ( AI ) Bootcamp hosted by ThoughtSpot in Mountain View. Applications for the no-cost bootcamp are closing September 30.",
    "banner_image": "https://ml.globenewswire.com/media/ee50c305-fad0-4c90-acea-07a6212af029/small/mark-cuban-foundation-png.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.321241,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.040212",
        "ticker_sentiment_score": "0.15879",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.040212",
        "ticker_sentiment_score": "0.15879",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.040212",
        "ticker_sentiment_score": "0.15879",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Boeing, union negotiators to resume talks as striking workers dig in",
    "url": "https://www.business-standard.com/world-news/boeing-union-negotiators-to-resume-talks-as-striking-workers-dig-in-124091701255_1.html",
    "time_published": "20240917T150619",
    "authors": [
      "Reuters"
    ],
    "summary": "The top negotiators at Boeing and the International Association of Machinists and Aerospace Workers (IAM) will meet with federal mediators in Seattle on Tuesday for preliminary talks, as per reports ...",
    "banner_image": null,
    "source": "Business Standard",
    "category_within_source": "Companies",
    "source_domain": "www.business-standard.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": -0.145022,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.065685",
        "ticker_sentiment_score": "0.122212",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.751437",
        "ticker_sentiment_score": "-0.272731",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "ISRG Stock Rallies 14% in 3 Months: Is It Still Worth Buying?",
    "url": "https://www.zacks.com/stock/news/2337049/isrg-stock-rallies-14-in-3-months-is-it-still-worth-buying",
    "time_published": "20240917T121200",
    "authors": [
      "Indrajit Bandyopadhyay"
    ],
    "summary": "Intuitive Surgical is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.33291,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.070002",
        "ticker_sentiment_score": "0.277151",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.37102",
        "ticker_sentiment_score": "0.445384",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.070002",
        "ticker_sentiment_score": "0.277151",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?",
    "url": "https://www.zacks.com/stock/news/2338744/bioventus-surges-103-in-six-months-is-the-stock-worth-a-buy",
    "time_published": "20240919T164800",
    "authors": [
      "Sundeep Ganoria"
    ],
    "summary": "BVS' stock generates phenomenal returns, driven by double-digit revenue growth across the Pain Treatments and Surgical Solutions franchises.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.996718"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.998356"
      }
    ],
    "overall_sentiment_score": 0.356029,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.123526",
        "ticker_sentiment_score": "0.29853",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BVS",
        "relevance_score": "0.607406",
        "ticker_sentiment_score": "0.50559",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Up 0.7% Since Last Earnings Report: Can It Continue?",
    "url": "https://www.zacks.com/stock/news/2338632/medtronic-mdt-up-07-since-last-earnings-report-can-it-continue",
    "time_published": "20240919T153008",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default195.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      }
    ],
    "overall_sentiment_score": 0.164226,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.269776",
        "ticker_sentiment_score": "0.166187",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.091509",
        "ticker_sentiment_score": "0.181564",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Heart Failure Monitoring Systems Market Growth to Reach US$ 24,612.2 Million at a CAGR of 5.7% by 2034 | Fact.MR",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40934283/heart-failure-monitoring-systems-market-growth-to-reach-us-24-612-2-million-at-a-cagr-of-5-7-by-20",
    "time_published": "20240919T100000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Sept. 19, 2024 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global heart failure monitoring systems market is estimated to reach a valuation of US$ 14,079.6 million in 2024 and is expected to grow at a CAGR of 5.7% during ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/c968a57a-0435-4f6e-bade-03aac87495ef/heart-failure-monitoring-systems-market.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.362841,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.059711",
        "ticker_sentiment_score": "0.016026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.089462",
        "ticker_sentiment_score": "0.031098",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.089462",
        "ticker_sentiment_score": "0.08166",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.119088",
        "ticker_sentiment_score": "0.018556",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.029876",
        "ticker_sentiment_score": "0.105544",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.059711",
        "ticker_sentiment_score": "0.016026",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick",
    "url": "https://www.zacks.com/stock/news/2339203/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick",
    "time_published": "20240920T135012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default239.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.218855,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.610572",
        "ticker_sentiment_score": "0.160524",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Unusual Options Activity For September 23 - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/options/24/09/40990663/medtronic-unusual-options-activity-for-september-23",
    "time_published": "20240923T200121",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bearish stance on Medtronic MDT. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1727121678_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.21092,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.574748",
        "ticker_sentiment_score": "0.231835",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "TNDM Stock Likely to Gain From Innovation Amid Competition",
    "url": "https://www.zacks.com/stock/news/2339800/tndm-stock-likely-to-gain-from-innovation-amid-competition",
    "time_published": "20240923T132900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for people living with the condition.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b8/1573.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.976671"
      }
    ],
    "overall_sentiment_score": 0.158537,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AXGN",
        "relevance_score": "0.123526",
        "ticker_sentiment_score": "0.05026",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.123526",
        "ticker_sentiment_score": "0.111185",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.120059",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.164188",
        "ticker_sentiment_score": "0.135668",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "0.120059",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.244109",
        "ticker_sentiment_score": "0.226697",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "KIDS",
        "relevance_score": "0.244109",
        "ticker_sentiment_score": "0.086257",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "AI healthcare firm Qure.ai completes $65 mn Series D funding round",
    "url": "https://www.business-standard.com/companies/start-ups/ai-healthcare-firm-qure-ai-completes-65-mn-series-d-funding-round-124092501368_1.html",
    "time_published": "20240925T173353",
    "authors": [
      "Peerzada Abrar"
    ],
    "summary": "The investment will expedite expansion into the US market and other geographies, increase investment into foundational AI models and enable complementary med-tech company acquisitions ...",
    "banner_image": null,
    "source": "Business Standard",
    "category_within_source": "Companies",
    "source_domain": "www.business-standard.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.212064,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "0.162268",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "0.162268",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global healthcare AI innovator Qure.ai completes $65 million Series D funding round led by Lightspeed and 360One Asset",
    "url": "https://www.benzinga.com/pressreleases/24/09/g41028996/global-healthcare-ai-innovator-qure-ai-completes-65-million-series-d-funding-round-led-by-lightspe",
    "time_published": "20240925T160000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, Sept. 25, 2024 ( GLOBE NEWSWIRE ) -- Qure.ai, a global healthcare AI innovator, has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the US market and other geographies, increase investment into foundational AI models and ...",
    "banner_image": "https://ml-eu.globenewswire.com/media/8d8e70c1-877d-4d23-a559-3051d91c46e8/small/image-5-png.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.271616,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.069697",
        "ticker_sentiment_score": "0.108863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.069697",
        "ticker_sentiment_score": "0.108863",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Infusion Pump Market to Surpass Market Valuation of USD 31.41 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/09/g41022248/infusion-pump-market-to-surpass-market-valuation-of-usd-31-41-billion-by-2031-skyquest-technology",
    "time_published": "20240925T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Sept. 25, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Infusion Pump Market will reach a value of USD 31.41 Billion by 2031, with a CAGR of 8.2% during the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "Mergers",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.339478,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CODAF",
        "relevance_score": "0.042647",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.042647",
        "ticker_sentiment_score": "0.113171",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SZIHF",
        "relevance_score": "0.085173",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.042647",
        "ticker_sentiment_score": "0.113171",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic",
    "url": "https://www.zacks.com/stock/news/2341071/axonics-stock-rises-on-favorable-verdict-in-patent-case-with-medtronic",
    "time_published": "20240925T115200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "AXNX stock continues to gain following a favorable court ruling last week in a patent litigation with Medtronic.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      }
    ],
    "overall_sentiment_score": 0.222118,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.399506",
        "ticker_sentiment_score": "-0.098251",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.235252",
        "ticker_sentiment_score": "0.299832",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.844813",
        "ticker_sentiment_score": "0.30002",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Gains But Lags Market: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2342264/medtronic-mdt-gains-but-lags-market-what-you-should-know",
    "time_published": "20240926T215018",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reachead $89.45 at the closing of the latest trading day, reflecting a +0.07% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default356.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.928769"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.169928,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.582526",
        "ticker_sentiment_score": "0.25651",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Smartest Dividend Stocks to Buy With $10,000 Right Now",
    "url": "https://www.fool.com/investing/2024/09/26/the-smartest-dividend-stocks-to-buy-with-10000-now/",
    "time_published": "20240926T152300",
    "authors": [
      "Reuben Gregg Brewer"
    ],
    "summary": "If you have $10k today, while the market is at all-time highs, think about diversification and downside risk.",
    "banner_image": "https://g.foolcdn.com/editorial/images/791819/23_11_08-a-line-of-100-dollar-bills-planted-in-the-ground-_mf-dloadgetty-dividend-stocks-growing-money-income-cash.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999822"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.295175,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.294093",
        "ticker_sentiment_score": "0.22177",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BKH",
        "relevance_score": "0.385137",
        "ticker_sentiment_score": "0.317892",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "O",
        "relevance_score": "0.246832",
        "ticker_sentiment_score": "0.203007",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership",
    "url": "https://www.zacks.com/stock/news/2342002/mdt-stock-might-gain-from-expanded-aible-ecosystem-and-new-partnership",
    "time_published": "20240926T140500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2297.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.990678"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.288046,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AXGN",
        "relevance_score": "0.097259",
        "ticker_sentiment_score": "0.053665",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.097259",
        "ticker_sentiment_score": "0.053665",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.458799",
        "ticker_sentiment_score": "0.205623",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.097259",
        "ticker_sentiment_score": "0.053665",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Phibro  ( PAHC )  Up 2.9% Since Last Earnings Report: Can It Continue?",
    "url": "https://www.zacks.com/stock/news/2342791/phibro-pahc-up-29-since-last-earnings-report-can-it-continue",
    "time_published": "20240927T153017",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default195.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99986"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.980922"
      }
    ],
    "overall_sentiment_score": 0.075192,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.193852",
        "ticker_sentiment_score": "0.024398",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.146025",
        "ticker_sentiment_score": "0.062341",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Medtronic  ( MDT )  is a Top Value Stock for the Long-Term",
    "url": "https://www.zacks.com/stock/news/2342593/why-medtronic-mdt-is-a-top-value-stock-for-the-long-term",
    "time_published": "20240927T134012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default270.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.464024,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.627119",
        "ticker_sentiment_score": "0.204547",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock",
    "url": "https://www.zacks.com/stock/news/2343146/positive-trial-outcome-for-pulseselect-pfa-likely-to-boost-mdt-stock",
    "time_published": "20240930T121500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.990678"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.234402,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AXGN",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "0.054852",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "0.054852",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.402941",
        "ticker_sentiment_score": "0.366823",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "0.054852",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "How Cosmos Health's Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit - AstraZeneca  ( NASDAQ:AZN ) , Cosmos Health  ( NASDAQ:COSM ) ",
    "url": "https://www.benzinga.com/partner/biotech/24/09/41091217/how-cosmos-healths-acquisition-of-almost-100-year-old-company-adding-to-capabilities-like-contrac",
    "time_published": "20240930T121301",
    "authors": [
      "James Blacker"
    ],
    "summary": "Global healthcare group Cosmos Health COSM has potentially positioned itself for growth through its acquisition last year of Cana Laboratories, a Greek pharmaceutical company with nearly a century of expertise.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.5"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.309033,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.037707",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.037707",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PG",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.037707",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UL",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.037707",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VTRS",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.037707",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COSM",
        "relevance_score": "0.172097",
        "ticker_sentiment_score": "0.321616",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.115232",
        "ticker_sentiment_score": "0.037707",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NSRGF",
        "relevance_score": "0.057767",
        "ticker_sentiment_score": "0.033966",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Reasons to Retain Medtronic Stock in Your Portfolio Now",
    "url": "https://www.zacks.com/stock/news/2344173/reasons-to-retain-medtronic-stock-in-your-portfolio-now",
    "time_published": "20241001T141800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      }
    ],
    "overall_sentiment_score": 0.286553,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AXGN",
        "relevance_score": "0.149966",
        "ticker_sentiment_score": "0.098853",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.294682",
        "ticker_sentiment_score": "0.26915",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.199037",
        "ticker_sentiment_score": "0.158608",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Trocars Market is expected to generate a revenue of USD 1.19 Billion by 2031, Globally, at 6.1% CAGR: Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41120048/trocars-market-is-expected-to-generate-a-revenue-of-usd-1-19-billion-by-2031-globally-at-6-1-cagr-",
    "time_published": "20241001T141500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Lewes, Delaware, Oct. 01, 2024 ( GLOBE NEWSWIRE ) -- The Global Trocars Market Size is projected to grow at a CAGR of 6.1% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/f0603937-7e17-4165-961f-053ff56023b5/trocars-market-1024x576.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.254192,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "COO",
        "relevance_score": "0.025219",
        "ticker_sentiment_score": "0.055766",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.025219",
        "ticker_sentiment_score": "0.055766",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.025219",
        "ticker_sentiment_score": "0.055766",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.025219",
        "ticker_sentiment_score": "0.055766",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.025219",
        "ticker_sentiment_score": "0.166446",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.025219",
        "ticker_sentiment_score": "0.055766",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer's top 10 things to watch in the stock market Tuesday",
    "url": "https://www.cnbc.com/2024/10/01/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html",
    "time_published": "20241001T131030",
    "authors": [],
    "summary": "Wall Street is heading for a lower open on the first day of October.",
    "banner_image": null,
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.196035,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BUD",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.08686",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NFLX",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.131001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.194938",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COST",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "-0.035999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "-0.083007",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.110717",
        "ticker_sentiment_score": "0.135051",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SBUX",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "-0.251986",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.046",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STZ",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.08686",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HD",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "-0.035999",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.055492",
        "ticker_sentiment_score": "0.148102",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.165409",
        "ticker_sentiment_score": "0.063848",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Peering Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/10/41148899/peering-into-medtronics-recent-short-interest",
    "time_published": "20241002T183017",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has fallen 23.26% since its last report. The company recently reported that it has 12.70 million shares sold short, which is 0.99% of all regular shares that are available for trading.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1727893813_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "RTI Announces its Second Annual Medical Technology Forum Featuring Speakers from NVIDIA, Medtronic, and Asensus Surgical",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41138916/rti-announces-its-second-annual-medical-technology-forum-featuring-speakers-from-nvidia-medtronic-",
    "time_published": "20241002T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SUNNYVALE, Calif., Oct. 02, 2024 ( GLOBE NEWSWIRE ) -- Real-Time Innovations ( RTI ) , the infrastructure software company for smart-world systems, announced its second annual virtual Medical Technology Forum to be held on October 24.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.399086,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.032702",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.032702",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QEBR",
        "relevance_score": "0.084423",
        "ticker_sentiment_score": "0.032702",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Down More Than 50%, Is DexCom Stock a Bargain Now?",
    "url": "https://www.fool.com/investing/2024/10/02/down-more-than-50-is-dexcom-stock-a-bargain-now/",
    "time_published": "20241002T081100",
    "authors": [
      "Cory Renauer"
    ],
    "summary": "Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.",
    "banner_image": "https://g.foolcdn.com/editorial/images/792566/investor-calculator-getty.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.162949,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.104228",
        "ticker_sentiment_score": "0.162878",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.605524",
        "ticker_sentiment_score": "0.209756",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.104228",
        "ticker_sentiment_score": "0.03257",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology - Abbott Laboratories  ( NYSE:ABT ) , DexCom  ( NASDAQ:DXCM ) ",
    "url": "https://www.benzinga.com/partner/health-care/24/10/41162090/expanding-continuous-glucose-monitoring-options-how-glucotrack-is-helping-usher-in-the-next-g",
    "time_published": "20241003T120306",
    "authors": [
      "Joshenomoto@benzinga.com"
    ],
    "summary": "Introduced in the late 1990s, continuous glucose monitoring ( CGM ) revolutionized diabetes care. Prior to CGM, home blood glucose monitoring ( BGM ) methodologies - which involve patients using a lancet to prick their fingers and apply a drop of blood to a test strip - represented the norm.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/03/Screenshot-2024-10-03-at-5-30-47PM.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.1396,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GCTK",
        "relevance_score": "0.307603",
        "ticker_sentiment_score": "0.116885",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.130596",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.078783",
        "ticker_sentiment_score": "0.107187",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.078783",
        "ticker_sentiment_score": "-0.003077",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Spine Surgery Robots Market Size to Hit USD 525.3 million by 2031, at a CAGR of 14.0%, Boosting Precision in Spinal Procedures | Exclusive Report by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41194185/spine-surgery-robots-market-size-to-hit-usd-525-3-million-by-2031-at-a-cagr-of-14-0-boosting-preci",
    "time_published": "20241004T223000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 04, 2024 ( GLOBE NEWSWIRE ) -- According to a report published by Transparency Market Research, the global spine surgery robots market was worth US$ 158.4 Mn in 2022 and is expected to reach US$ 525.3 Mn by 2031, at a ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/51260806-7524-4e86-95a0-fa1272c8f653/spine-surgery-robots-market-1-.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.304463,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.055701",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.055701",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.055701",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.103183",
        "ticker_sentiment_score": "0.067863",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Advances But Underperforms Market: Key Facts",
    "url": "https://www.zacks.com/stock/news/2346368/medtronic-mdt-advances-but-underperforms-market-key-facts",
    "time_published": "20241004T215021",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default274.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.19858,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.590482",
        "ticker_sentiment_score": "0.347256",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Recalls MiniMed Pump Due To Battery Life Concerns - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/10/41184951/medtronic-recalls-minimed-pump-due-to-battery-life-concerns",
    "time_published": "20241004T132129",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Medtronic plc MDT initiated a recall Friday to address potential battery life issues with its insulin pumps. As of July 31, the company has advised customers to pay close attention to their pumps' battery alerts and alarms.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/04/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": -0.14508,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.724687",
        "ticker_sentiment_score": "-0.003885",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BlackRock Mutual Funds That Stand Out as Must-Buy",
    "url": "https://www.zacks.com/stock/news/2345842/3-blackrock-mutual-funds-that-stand-out-as-must-buy",
    "time_published": "20241004T121900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BlackRock mutual funds like MDBAX, PCBAX and MDRFX for diverse investment strategies and global market exposure.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a8/346.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.284733,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.654246",
        "ticker_sentiment_score": "0.477967",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.051121",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.051121",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.049115",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.049115",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CZBS",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.050118",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FIZN",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.050118",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KHC",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.050118",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.049115",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LDOS",
        "relevance_score": "0.068306",
        "ticker_sentiment_score": "0.050118",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Catheter Introducer Sheaths Market Size on Track to Expand at 6.1% CAGR, Reaching USD 1.7 Billion by 2031| States Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41210402/catheter-introducer-sheaths-market-size-on-track-to-expand-at-6-1-cagr-reaching-usd-1-7-billion-by",
    "time_published": "20241007T152349",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 07, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global catheter introducer sheaths market was worth US$ 1.0 Bn in 2022 and is expected to reach US$ 1.7 Bn by the year ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/fa6daee5-7880-4e70-9bdb-14179c7a7852/catheter-introducer-sheaths-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.351199,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "0.415984",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ICUI",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.091162",
        "ticker_sentiment_score": "0.063597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "0.392608",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MMSI",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.030446",
        "ticker_sentiment_score": "-0.014104",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top Research Reports for JPMorgan Chase, Medtronic & Shopify",
    "url": "https://www.zacks.com/research-daily/2347553/top-research-reports-for-jpmorgan-chase-medtronic-shopify",
    "time_published": "20241008T202300",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Medtronic plc (MDT) and Shopify Inc. (SHOP), as well as a micro-cap stock Perma-Pipe International Holdings, Inc. (PPIH).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/3927.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.408457,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SHOP",
        "relevance_score": "0.059785",
        "ticker_sentiment_score": "0.28151",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PPIH",
        "relevance_score": "0.059785",
        "ticker_sentiment_score": "0.23809",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PINS",
        "relevance_score": "0.059785",
        "ticker_sentiment_score": "-0.011075",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.178021",
        "ticker_sentiment_score": "0.354121",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "CRTO",
        "relevance_score": "0.059785",
        "ticker_sentiment_score": "-0.011075",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?",
    "url": "https://www.zacks.com/stock/news/2348495/mdt-stock-trades-near-52-week-high-is-it-a-smart-buy-now",
    "time_published": "20241009T163000",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.998356"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.162974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.509589",
        "ticker_sentiment_score": "0.218469",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.078482",
        "ticker_sentiment_score": "0.196345",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.078482",
        "ticker_sentiment_score": "0.196345",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why You Should Retain Penumbra Stock in Your Portfolio Now",
    "url": "https://www.zacks.com/stock/news/2348251/heres-why-you-should-retain-penumbra-stock-in-your-portfolio-now",
    "time_published": "20241009T124300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors feel optimistic about PEN's strong growth prospects in the Thrombectomy business. Yet, unfavorable forex impacts are concerning.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.993781"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.304571,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AXGN",
        "relevance_score": "0.1437",
        "ticker_sentiment_score": "0.095184",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.493299",
        "ticker_sentiment_score": "0.483365",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.190793",
        "ticker_sentiment_score": "0.162639",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "0.04872",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "0.04872",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:JPY",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:USD",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Intuitive Surgical Stock Declines 0.7% in a Month: Is It Losing Steam?",
    "url": "https://www.zacks.com/stock/news/2348252/intuitive-surgical-stock-declines-07-in-a-month-is-it-losing-steam",
    "time_published": "20241009T124200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ISRG stock has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. However, the stock has declined in the past month. Let's see if the trend might change.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.267399,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.068404",
        "ticker_sentiment_score": "0.276696",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.363147",
        "ticker_sentiment_score": "0.387017",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.068404",
        "ticker_sentiment_score": "0.276696",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International",
    "url": "https://www.zacks.com/stock/news/2347920/the-zacks-analyst-blog-jpmorgan-medtronic-shopify-and-perma-pipe-international",
    "time_published": "20241009T071500",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5a/2120.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.360515,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SHOP",
        "relevance_score": "0.190793",
        "ticker_sentiment_score": "0.17837",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PPIH",
        "relevance_score": "0.190793",
        "ticker_sentiment_score": "0.161147",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PINS",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "-0.011",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.282777",
        "ticker_sentiment_score": "0.257434",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CRTO",
        "relevance_score": "0.048133",
        "ticker_sentiment_score": "-0.011",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent",
    "url": "https://www.zacks.com/stock/news/2348833/inspiremd-gains-fda-premarket-approval-for-cguard-prime-carotid-stent",
    "time_published": "20241010T134500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "NSPR gains premarket approval for its CGuard Prime carotid stent system for use in United States for treating carotid artery stenosis.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/06/667.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.338816,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.075234",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NSPR",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.198735",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "0.266557",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "0.182281",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica",
    "url": "https://www.zacks.com/stock/news/2348747/crl-to-aid-lundbecks-neurological-drug-research-with-ai-backed-logica",
    "time_published": "20241010T131000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Charles River and Lundbeck sign an agreement to use Logica to advance the discovery of novel neurological drugs.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/eb/4111.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.203416,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CRL",
        "relevance_score": "0.092036",
        "ticker_sentiment_score": "0.065385",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.137671",
        "ticker_sentiment_score": "0.154988",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.137671",
        "ticker_sentiment_score": "0.019068",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Surgical Navigation Systems Market to Surpass Market Valuation of USD 25.95 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41269446/surgical-navigation-systems-market-to-surpass-market-valuation-of-usd-25-95-billion-by-2031-skyque",
    "time_published": "20241010T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the global surgical navigation systems market will reach a value of USD 25.95 Billion by 2031, with a CAGR of 14% during the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "Mergers",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.253747,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IART",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.000975",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.041755",
        "ticker_sentiment_score": "0.052032",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2349523/medtronic-mdt-rises-yet-lags-behind-market-some-facts-worth-knowing",
    "time_published": "20241011T215019",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default195.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.137593,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.5341",
        "ticker_sentiment_score": "0.228176",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Stryker's Acquisition Spree: Double-Digit Growth on the Horizon - Medtronic  ( NYSE:MDT ) , Intuitive Surgical  ( NASDAQ:ISRG ) ",
    "url": "https://www.benzinga.com/news/earnings/24/10/41291842/strykers-acquisition-spree-double-digit-growth-on-the-horizon",
    "time_published": "20241011T192518",
    "authors": [
      "MarketBeat"
    ],
    "summary": "Stryker SYK is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to boost its competitiveness and add capabilities.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/11/national-cancer-institute-l8twzt4ccvq-unsplash.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.875462"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.309342,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.09347",
        "ticker_sentiment_score": "0.2353",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.442853",
        "ticker_sentiment_score": "0.339186",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe",
    "url": "https://www.zacks.com/stock/news/2349401/atricure-gets-ce-mark-for-encompass-clamp-expands-in-europe",
    "time_published": "20241011T143000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ca/2974.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.393057,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.076934",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATRC",
        "relevance_score": "0.347754",
        "ticker_sentiment_score": "0.465936",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.203215",
        "ticker_sentiment_score": "0.283121",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.203215",
        "ticker_sentiment_score": "0.173606",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business",
    "url": "https://www.zacks.com/stock/news/2349259/ge-healthcare-acquires-intelligent-ultrasounds-clinical-ai-business",
    "time_published": "20241011T133800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/1871.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.465443,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.201244",
        "ticker_sentiment_score": "0.223224",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.201244",
        "ticker_sentiment_score": "0.36879",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System",
    "url": "https://www.zacks.com/stock/news/2349243/snn-boosts-knee-revision-surgery-with-its-legion-hinged-knee-system",
    "time_published": "20241011T131500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/40/4066.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.286488,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.223866",
        "ticker_sentiment_score": "0.469047",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.168884",
        "ticker_sentiment_score": "0.082476",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.277748",
        "ticker_sentiment_score": "0.165594",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.277748",
        "ticker_sentiment_score": "0.295523",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.113062",
        "ticker_sentiment_score": "0.065461",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?",
    "url": "https://www.zacks.com/stock/news/2350984/should-isrg-stock-be-part-of-your-portfolio-ahead-of-q3-earnings",
    "time_published": "20241015T173300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.998917"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.317672,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.0699",
        "ticker_sentiment_score": "0.049169",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.570165",
        "ticker_sentiment_score": "0.376514",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.0699",
        "ticker_sentiment_score": "0.049169",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Abbott Stock Gains on Q3 Earnings Beat, Margins Expand",
    "url": "https://www.zacks.com/stock/news/2351773/abbott-stock-gains-on-q3-earnings-beat-margins-expand",
    "time_published": "20241016T175700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ABT delivers a strong underlying base business performance in the third quarter of 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/50/73256.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.261953,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AVIR",
        "relevance_score": "0.113956",
        "ticker_sentiment_score": "0.029633",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.188781",
        "ticker_sentiment_score": "0.13471",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.038101",
        "ticker_sentiment_score": "0.044002",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AHCO",
        "relevance_score": "0.113956",
        "ticker_sentiment_score": "-0.001115",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ADUS",
        "relevance_score": "0.151539",
        "ticker_sentiment_score": "0.100758",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Abbott Laboratories  ( ABT )  Q3 2024 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/10/16/abbott-laboratories-abt-q3-2024-earnings-call-tran/",
    "time_published": "20241016T174514",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "ABT earnings call for the period ending September 30, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.306555,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "0.107701",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "0.114561",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "0.114561",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "0.114561",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "0.076638",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "0.107701",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:USD",
        "relevance_score": "0.005061",
        "ticker_sentiment_score": "-0.032618",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Chest Drainage Devices Market on Track to Hit USD 1.3 Billion by 2031, Growing at a 5.4% CAGR with a Focus on Lung Re-expansion Solutions| Analysis by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41363851/chest-drainage-devices-market-on-track-to-hit-usd-1-3-billion-by-2031-growing-at-a-5-4-cagr-with-a",
    "time_published": "20241016T170019",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 16, 2024 ( GLOBE NEWSWIRE ) -- According to a report published by Transparency Market Research, the global chest drainage devices market was worth US$ 799.6 Mn in 2022 and is expected to reach US$ 1.3 Bn by 2031, at a ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/834ae5b4-8a32-42d8-8822-bcd32dab52c2/chest-drainage-devices-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.198808,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.421439",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UTMD",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TFX",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNGBY",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ICUI",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.035138",
        "ticker_sentiment_score": "0.04536",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "0.068269",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Global 3D Printing Medical Devices Market to Evolve at a Phenomenal 17.1% CAGR through 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41354311/global-3d-printing-medical-devices-market-to-evolve-at-a-phenomenal-17-1-cagr-through-2031-skyques",
    "time_published": "20241016T114500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Oct. 16, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the 3D Printing Medical Devices market will attain a value of USD 11.59 billion by 2031, with a CAGR of 17.1% over the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.247291,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DDD",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DM",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MKFG",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VJET",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSYS",
        "relevance_score": "0.07887",
        "ticker_sentiment_score": "0.021263",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ONVO",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RNSHF",
        "relevance_score": "0.039483",
        "ticker_sentiment_score": "0.020123",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BlackRock Mutual Funds to Add to Your Portfolio for Solid Gains",
    "url": "https://www.zacks.com/stock/news/2351203/3-blackrock-mutual-funds-to-add-to-your-portfolio-for-solid-gains",
    "time_published": "20241016T114200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BlackRock mutual funds like MCGRX, MRBVX and BMCRX that have given impressive returns in the past and are expected to do the same in 2024 and beyond.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/15/13491.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999186"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.314088,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.048593",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NRHI",
        "relevance_score": "0.084722",
        "ticker_sentiment_score": "0.358556",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.048593",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.047616",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.047616",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.048593",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.047616",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RYDAF",
        "relevance_score": "0.042421",
        "ticker_sentiment_score": "0.048593",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BlackRock Mutual Funds to Buy on Rate Cut Continuation",
    "url": "https://www.zacks.com/stock/news/2351155/3-blackrock-mutual-funds-to-buy-on-rate-cut-continuation",
    "time_published": "20241016T095300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BlackRock mutual funds like BREAX, BMCAX and MRBVX for high returns and risk reduction with more rate cuts on the horizon.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f8/614.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999975"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.289983,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.098659",
        "ticker_sentiment_score": "0.215989",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.115136",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.11813",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.111146",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.11813",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.111146",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.049424",
        "ticker_sentiment_score": "0.11813",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.098659",
        "ticker_sentiment_score": "0.141017",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "MDT vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://www.zacks.com/stock/news/2354144/mdt-vs-abt-which-stock-is-the-better-value-option",
    "time_published": "20241021T154013",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic ( MDT Quick QuoteMDT - ) or Abbott ( ABT Quick QuoteABT - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default203.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.485162,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.747404",
        "ticker_sentiment_score": "0.555429",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "ONWARD\u00ae Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41420913/onward-medical-announces-changes-to-board-of-directors-including-addition-of-medtech-leader-rob-te",
    "time_published": "20241021T053000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Ten Hoedt is a former Medtronic President and Executive Committee Member; also a former Chairman of MedTech Europe Commercial and digital health expert Rahma Samow will also join as Director Current Board Chairman Jan Ohrstrom and Director Fred Colen to retire from the Board at year-end after 8 ...",
    "banner_image": "https://ml.globenewswire.com/media/394fa020-511d-4331-9279-c835d2daf4d6/small/onward-logotype-red-png.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.216592,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.104341",
        "ticker_sentiment_score": "0.124513",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.026155",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Increases Despite Market Slip: Here's What You Need to Know",
    "url": "https://www.zacks.com/stock/news/2355338/medtronic-mdt-increases-despite-market-slip-heres-what-you-need-to-know",
    "time_published": "20241022T215021",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) closed the most recent trading day at $91.12, moving +0.1% from the previous trading session.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default245.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.186471,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.649828",
        "ticker_sentiment_score": "0.284987",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Bioventus Surges 73% in Three Months: Time to Buy the Stock?",
    "url": "https://www.zacks.com/stock/news/2355054/bioventus-surges-73-in-three-months-time-to-buy-the-stock",
    "time_published": "20241022T133500",
    "authors": [
      "Sundeep Ganoria"
    ],
    "summary": "BVS generates encouraging returns, driven by rapid sales growth across the Pain Treatments and Surgical Solutions franchises.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      }
    ],
    "overall_sentiment_score": 0.378858,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.130217",
        "ticker_sentiment_score": "0.277361",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BVS",
        "relevance_score": "0.674691",
        "ticker_sentiment_score": "0.560884",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt",
    "url": "https://www.zacks.com/stock/news/2356127/growing-biosimilars-business-supports-abt-stock-macro-issues-hurt",
    "time_published": "20241023T162000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      }
    ],
    "overall_sentiment_score": 0.224871,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAX",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.054426",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.054426",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.203215",
        "ticker_sentiment_score": "0.325366",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.157435",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.054426",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medical Devices Market to Surpass $756.59 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41513954/medical-devices-market-to-surpass-756-59-billion-by-2031-skyquest-technology",
    "time_published": "20241024T114500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Oct. 24, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Medical Devices market will attain a value of $756.59 Billion by 2031, with a CAGR of 5.8% over the forecast period ( 2024-2031 ) . Medical devices are essential tools used in the healthcare sector to diagnose and ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.263153,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.151177",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.151177",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Ascends But Remains Behind Market: Some Facts to Note",
    "url": "https://www.zacks.com/stock/news/2359071/medtronic-mdt-ascends-but-remains-behind-market-some-facts-to-note",
    "time_published": "20241028T215019",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the most recent trading session, Medtronic (MDT) closed at $90.60, indicating a +0.01% shift from the previous trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default44.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.213939,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.543535",
        "ticker_sentiment_score": "0.2936",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Peripheral Stent Implant Market is Projected to Climb to US$ 7.76 Billion by 2034 | Fact.MR Report",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41570484/peripheral-stent-implant-market-is-projected-to-climb-to-us-7-76-billion-by-2034-fact-mr-report",
    "time_published": "20241028T113000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Oct. 28, 2024 ( GLOBE NEWSWIRE ) -- The global peripheral stent implant market is set to be valued at US$ 4.11 billion in 2024 and is projected to expand at 6.6% CAGR from 2024 to 2034.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/c296590b-a5fe-4c76-8e3a-7c3910061684/peripheral-stent-implant-market.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.261751,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.072987",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.206091",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCRPF",
        "relevance_score": "0.036532",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock",
    "url": "https://www.zacks.com/stock/news/2359773/positive-trial-data-on-symplicity-rdn-system-likely-to-support-mdt-stock",
    "time_published": "20241029T142800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic announces new long-term favorable data for its Symplicity Spyral RDN system, which has undergone a SPYRAL HTN-ON MED clinical trial.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c3/648.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.990786"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.18238,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "RMD",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.052479",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.052479",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.371523",
        "ticker_sentiment_score": "0.173781",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.052479",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?",
    "url": "https://www.zacks.com/stock/news/2359687/should-bioventus-stock-be-in-your-portfolio-pre-q3-earnings",
    "time_published": "20241029T133500",
    "authors": [
      "Sundeep Ganoria"
    ],
    "summary": "Investors will likely focus on the sales performance of BVS across the Pain Treatments and Surgical Solutions franchises when it reports third-quarter results.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.998645"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999922"
      }
    ],
    "overall_sentiment_score": 0.311284,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.102231",
        "ticker_sentiment_score": "0.295113",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BVS",
        "relevance_score": "0.596349",
        "ticker_sentiment_score": "0.495877",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Why is Boston Scientific Stock Trading Lower On Wednesday? - Boston Scientific  ( NYSE:BSX ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/10/41634450/why-is-boston-scientific-stock-trading-lower-on-wednesday",
    "time_published": "20241030T190850",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Wednesday, Boston Scientific Corporation BSX released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe, symptomatic aortic stenosis at risk of open-heart surgery.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/30/BSX.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.063328,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.179121",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.349329",
        "ticker_sentiment_score": "0.012468",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.179121",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Outperforms Broader Market: What You Need to Know",
    "url": "https://www.zacks.com/stock/news/2362910/medtronic-mdt-outperforms-broader-market-what-you-need-to-know",
    "time_published": "20241101T214518",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) reachead $90.07 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default232.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.184536,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.601928",
        "ticker_sentiment_score": "0.33741",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "2 Dividend Stocks to Buy for a Lifetime of Passive Income",
    "url": "https://www.fool.com/investing/2024/11/02/2-dividend-stocks-to-buy-for-a-lifetime-of-passive/",
    "time_published": "20241102T155500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "These are the kinds of stocks that can allow investors to sleep easy at night.",
    "banner_image": "https://g.foolcdn.com/editorial/images/795680/pharmacist-talking-to-patient.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.21703,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.462395",
        "ticker_sentiment_score": "0.34079",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MRNA",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "0.019006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "-0.012046",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMMT",
        "relevance_score": "0.054607",
        "ticker_sentiment_score": "-0.12629",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer - Integra Lifesciences  ( NASDAQ:IART ) ",
    "url": "https://www.benzinga.com/pressreleases/24/11/g41708098/integra-lifesciences-announces-appointment-of-mojdeh-poul-as-president-and-chief-executive-officer",
    "time_published": "20241104T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "PRINCETON, N.J., Nov. 04, 2024 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART, a leading global medical technology company, today announced that its board of directors has appointed Mojdeh Poul as the new president and chief executive officer, effective January 6, 2025.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.440659,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "IART",
        "relevance_score": "0.202366",
        "ticker_sentiment_score": "0.258309",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IRTC",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.087456",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALGN",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.087456",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.056947",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.056947",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SWK",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.087456",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields - Johnson & Johnson  ( NYSE:JNJ ) ",
    "url": "https://www.benzinga.com/news/24/11/41773566/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yie",
    "time_published": "20241106T133908",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",
    "banner_image": null,
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.172048,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "RPRX",
        "relevance_score": "0.194242",
        "ticker_sentiment_score": "0.170844",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.287762",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.097854",
        "ticker_sentiment_score": "0.075969",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.097854",
        "ticker_sentiment_score": "-0.089749",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.194242",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNDX",
        "relevance_score": "0.097854",
        "ticker_sentiment_score": "0.177036",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.194242",
        "ticker_sentiment_score": "0.098207",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "National Vision  ( EYE )  Q3 Earnings Surpass Estimates",
    "url": "https://www.zacks.com/stock/news/2364920/national-vision-eye-q3-earnings-surpass-estimates",
    "time_published": "20241106T122502",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "National Vision (EYE) delivered earnings and revenue surprises of 140% and 0.03%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default90.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.162214,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EYE",
        "relevance_score": "0.401331",
        "ticker_sentiment_score": "0.122327",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.139265",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?",
    "url": "https://www.zacks.com/stock/news/2366596/medtronic-stock-trading-at-a-discount-before-q2-earnings-time-to-buy",
    "time_published": "20241107T161000",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.94762"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      }
    ],
    "overall_sentiment_score": 0.244691,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.444538",
        "ticker_sentiment_score": "0.242746",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.0553",
        "ticker_sentiment_score": "0.096973",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Sinks As Market Gains: Here's Why",
    "url": "https://www.zacks.com/stock/news/2367787/medtronic-mdt-stock-sinks-as-market-gains-heres-why",
    "time_published": "20241108T224511",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Medtronic (MDT) settling at $87.72, representing a -0.45% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default115.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.175013,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.540358",
        "ticker_sentiment_score": "0.259097",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Top Analyst Reports for Oracle, Micron Technology & Medtronic",
    "url": "https://www.zacks.com/research-daily/2367240/top-analyst-reports-for-oracle-micron-technology-medtronic",
    "time_published": "20241108T212700",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Micron Technology, Inc. (MU) and Medtronic plc (MDT), as well as a micro-cap stock The Cato Corporation (CATO).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/83/1947.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.350448,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.199037",
        "ticker_sentiment_score": "0.437393",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MU",
        "relevance_score": "0.06697",
        "ticker_sentiment_score": "0.359208",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ORCL",
        "relevance_score": "0.13347",
        "ticker_sentiment_score": "0.253441",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FOREX:AMD",
        "relevance_score": "0.13347",
        "ticker_sentiment_score": "0.018732",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo  ( CIIE )  - Ping An Healthcare  ( OTC:PIAHY ) ",
    "url": "https://www.benzinga.com/pressreleases/24/11/n41832483/ping-an-health-and-medtronic-form-strategic-partnership-at-the-china-international-import-expo-cii",
    "time_published": "20241108T020400",
    "authors": [
      "PRNewswire"
    ],
    "summary": "HONG KONG and SHANGHAI, Nov. 7, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ( \"Ping An Good Doctor\", \"Ping An Health\", or \"the Company\", Stock Code: 1833.HK ) established a strategic partnership with Medtronic ( Shanghai ) Management Co., Ltd. ( \"Medtronic\" ) at the ...",
    "banner_image": "https://mma.prnewswire.com/media/2551590/image.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.441545,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "WYCC",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.179841",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.496741",
        "ticker_sentiment_score": "0.564337",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PANHF",
        "relevance_score": "0.096866",
        "ticker_sentiment_score": "0.056974",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.096866",
        "ticker_sentiment_score": "0.184157",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Oracle, Micron Technology, Medtronic and The Cato",
    "url": "https://www.zacks.com/stock/news/2367922/the-zacks-analyst-blog-oracle-micron-technology-medtronic-and-the-cato",
    "time_published": "20241111T124700",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Oracle, Micron Technology, Medtronic and The Cato are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/09/1038.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.333706,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MU",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.249345",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ORCL",
        "relevance_score": "0.254042",
        "ticker_sentiment_score": "0.237802",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.254042",
        "ticker_sentiment_score": "0.333955",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CATO",
        "relevance_score": "0.103109",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:AMD",
        "relevance_score": "0.103109",
        "ticker_sentiment_score": "0.016664",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Clearside Biomedical, Inc.  ( CLSD )  Reports Q3 Loss, Tops Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2369273/clearside-biomedical-inc-clsd-reports-q3-loss-tops-revenue-estimates",
    "time_published": "20241112T230520",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Clearside Biomedical (CLSD) delivered earnings and revenue surprises of 28.57% and 310.28%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default213.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.119088,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.137278",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLSD",
        "relevance_score": "0.396052",
        "ticker_sentiment_score": "0.073091",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will ISRG Stock Continue Its Uptrend After Gaining 9.9% in a Month?",
    "url": "https://www.zacks.com/stock/news/2368614/will-isrg-stock-continue-its-uptrend-after-gaining-99-in-a-month",
    "time_published": "20241112T131000",
    "authors": [
      "Indrajit Bandyopadhyay"
    ],
    "summary": "Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock also gained during the past month. Let's see if the trend might change.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      }
    ],
    "overall_sentiment_score": 0.323918,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.056876",
        "ticker_sentiment_score": "0.297023",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.407404",
        "ticker_sentiment_score": "0.429664",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.056876",
        "ticker_sentiment_score": "0.297023",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Capricor Therapeutics  ( CAPR )  Reports Q3 Loss, Misses Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2370004/capricor-therapeutics-capr-reports-q3-loss-misses-revenue-estimates",
    "time_published": "20241113T221004",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Capricor (CAPR) delivered earnings and revenue surprises of -11.76% and 43.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default117.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.151547,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAPR",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "-0.064878",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Beverly Hills surgeon sues Medtronic for patent infringement",
    "url": "https://www.cnbc.com/2024/11/13/beverly-hills-surgeon-sues-medtronic-for-patent-infringement.html",
    "time_published": "20241113T185534",
    "authors": [],
    "summary": "The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against Medtronic.",
    "banner_image": null,
    "source": "CNBC",
    "category_within_source": "Business",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.009763,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.841981",
        "ticker_sentiment_score": "-0.062654",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EW",
        "relevance_score": "0.07031",
        "ticker_sentiment_score": "0.03202",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Expanding Global Market, NuVasive Benefits to Aid GMED Stock",
    "url": "https://www.zacks.com/stock/news/2369841/expanding-global-market-nuvasive-benefits-to-aid-gmed-stock",
    "time_published": "20241113T160500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.997335"
      }
    ],
    "overall_sentiment_score": 0.301013,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.158874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.158874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.35278",
        "ticker_sentiment_score": "0.330753",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.158874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.081001",
        "ticker_sentiment_score": "0.053892",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.081001",
        "ticker_sentiment_score": "0.053892",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.158874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.121241",
        "ticker_sentiment_score": "0.121696",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Precigen, Inc.  ( PGEN )  Reports Q3 Loss, Lags Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2370700/precigen-inc-pgen-reports-q3-loss-lags-revenue-estimates",
    "time_published": "20241114T224504",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Precigen (PGEN) delivered earnings and revenue surprises of -12.50% and 13.36%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default251.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.121632,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.139265",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PGEN",
        "relevance_score": "0.401331",
        "ticker_sentiment_score": "0.046684",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results",
    "url": "https://www.globenewswire.com/news-release/2024/11/14/2981648/0/en/Acutus-Medical-Reports-Third-Quarter-and-Year-To-Date-2024-Financial-Results.html",
    "time_published": "20241114T212600",
    "authors": [
      "Acutus Medical",
      "Inc."
    ],
    "summary": "CARLSBAD, Calif., Nov. 14, 2024 ( GLOBE NEWSWIRE ) -- Acutus Medical, Inc. ( \"Acutus\" or the \"Company\" ) ( OTC: AFIB ) today reported results for the third quarter and year-to-date of 2024.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/2e6d1769-86af-4321-8203-7b0211a44f8b",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.988915"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.154796,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.13459",
        "ticker_sentiment_score": "0.141881",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Insights Into Medtronic  ( MDT )  Q2: Wall Street Projections for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2370304/insights-into-medtronic-mdt-q2-wall-street-projections-for-key-metrics",
    "time_published": "20241114T141508",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Besides Wall Street's top -and-bottom-line estimates for Medtronic (MDT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default167.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999955"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.088283,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.322233",
        "ticker_sentiment_score": "0.09176",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer's week ahead: Earnings from Nvidia, TJX and Walmart",
    "url": "https://www.cnbc.com/2024/11/15/jim-cramer-nvidia-tjx-walmart-earnings.html",
    "time_published": "20241115T235048",
    "authors": [],
    "summary": "CNBC's Jim Cramer previews key earnings reports and investor days that could trigger Wall Street action for the week of November 18.",
    "banner_image": null,
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      }
    ],
    "overall_sentiment_score": 0.14069,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "WSM",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "-0.049175",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "-0.090668",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.220141",
        "ticker_sentiment_score": "0.029905",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PG",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.073862",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GEHC",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.073862",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VIK",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.214365",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VRT",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "-0.022398",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HD",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.306922",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.269716",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.070824",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.220141",
        "ticker_sentiment_score": "0.218387",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Increases Despite Market Slip: Here's What You Need to Know",
    "url": "https://www.zacks.com/stock/news/2371257/medtronic-mdt-increases-despite-market-slip-heres-what-you-need-to-know",
    "time_published": "20241115T224504",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Medtronic (MDT) settling at $87.53, representing a +1.78% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default224.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.163193,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.514619",
        "ticker_sentiment_score": "0.17819",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BellRing Brands  ( BRBR )  Q4 Earnings and Revenues Beat Estimates",
    "url": "https://www.zacks.com/stock/news/2371822/bellring-brands-brbr-q4-earnings-and-revenues-beat-estimates",
    "time_published": "20241118T231502",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "BellRing Brands (BRBR) delivered earnings and revenue surprises of 2% and 2.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      }
    ],
    "overall_sentiment_score": 0.193359,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRBR",
        "relevance_score": "0.400265",
        "ticker_sentiment_score": "0.27745",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Markets Wait for Last Significant Week of Q3 Earnings Season",
    "url": "https://www.zacks.com/stock/news/2371645/markets-wait-for-last-significant-week-of-q3-earnings-season",
    "time_published": "20241118T155500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "We expect another consequential week for the stock market, if for no other reason than Zacks Rank #1 ( Strong Buy ) -rated NVIDIA ( NVDA Quick QuoteNVDA - ) is scheduled to report Q3 earnings Wednesday after the closing bell.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/93/534.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      }
    ],
    "overall_sentiment_score": 0.108395,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.163909",
        "ticker_sentiment_score": "0.061199",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.243701",
        "ticker_sentiment_score": "0.082595",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.163909",
        "ticker_sentiment_score": "-0.038977",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.163909",
        "ticker_sentiment_score": "0.158878",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "M",
        "relevance_score": "0.082393",
        "ticker_sentiment_score": "-0.029595",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.163909",
        "ticker_sentiment_score": "0.158878",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.163909",
        "ticker_sentiment_score": "0.061199",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Big Week for NVDA, Retail Earnings and Housing",
    "url": "https://www.zacks.com/stock/news/2371636/big-week-for-nvda-retail-earnings-and-housing",
    "time_published": "20241118T152300",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "NVIDIA is the last of the Big Tech companies to report, joining Walmart (WMT), Target (TGT) and other retailers reporting this week.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/44/2713.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      }
    ],
    "overall_sentiment_score": 0.099005,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.155954",
        "ticker_sentiment_score": "0.059222",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.306007",
        "ticker_sentiment_score": "0.029097",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.155954",
        "ticker_sentiment_score": "-0.031356",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.155954",
        "ticker_sentiment_score": "0.118214",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "M",
        "relevance_score": "0.078354",
        "ticker_sentiment_score": "-0.024363",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.155954",
        "ticker_sentiment_score": "0.118214",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.155954",
        "ticker_sentiment_score": "0.059222",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Q2 2025 Earnings Call Transcript",
    "url": "https://www.fool.com/earnings/call-transcripts/2024/11/19/medtronic-mdt-q2-2025-earnings-call-transcript/",
    "time_published": "20241119T201510",
    "authors": [
      "Motley Fool Transcribing"
    ],
    "summary": "MDT earnings call for the period ending September 30, 2024.",
    "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.330332,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.004509",
        "ticker_sentiment_score": "0.120048",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.004509",
        "ticker_sentiment_score": "0.12959",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.004509",
        "ticker_sentiment_score": "0.12959",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.004509",
        "ticker_sentiment_score": "0.105488",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.004509",
        "ticker_sentiment_score": "0.120048",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.004509",
        "ticker_sentiment_score": "0.12959",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.022545",
        "ticker_sentiment_score": "0.208043",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.009019",
        "ticker_sentiment_score": "0.160754",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Gold Moves Higher; Medtronic Posts Upbeat Results - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/11/42071959/gold-moves-higher-medtronic-posts-upbeat-results",
    "time_published": "20241119T190920",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining by around 1% on Tuesday. The Dow traded down 0.03% to 43,374.79 while the NASDAQ rose 1.03% to 18,985.21. The S&P 500 also rose, gaining, 0.49% to 5,922.41. Information technology shares rose by 0.6% on Tuesday.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/19/Medtronic-Headquarters-Photo-by-Tony-Web_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.138984,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "CDRO",
        "relevance_score": "0.135729",
        "ticker_sentiment_score": "-0.085048",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.068112",
        "ticker_sentiment_score": "0.196883",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PRFX",
        "relevance_score": "0.135729",
        "ticker_sentiment_score": "0.161143",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRNR",
        "relevance_score": "0.135729",
        "ticker_sentiment_score": "0.188902",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SMCI",
        "relevance_score": "0.135729",
        "ticker_sentiment_score": "0.085048",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NWTN",
        "relevance_score": "0.202366",
        "ticker_sentiment_score": "0.27315",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "INCY",
        "relevance_score": "0.135729",
        "ticker_sentiment_score": "-0.002475",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.267559",
        "ticker_sentiment_score": "0.393338",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/general/health-care/24/11/42069216/medtronic-q2-earnings-diabetes-and-neuroscience-revenue-boost-growth-raises-annual-outlook",
    "time_published": "20241119T171305",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Tuesday, Medtronic Plc MDT reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion. The medical device maker reported adjusted EPS of $1.26, beating the consensus of $1.25. Revenue increased 5.3% year over year, as reported, and 5% on an organic basis.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/19/Medtronic-Headquarters-Photo-by-Tony-Web.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.989041"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.315892,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.568148",
        "ticker_sentiment_score": "0.248994",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.104228",
        "ticker_sentiment_score": "0.159619",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View",
    "url": "https://www.zacks.com/stock/news/2372098/medtronic-q2-earnings-and-revenues-top-stock-down-on-trimmed-25-view",
    "time_published": "20241119T143100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "MDT delivers diversified growth across all its segments in the second quarter of fiscal 2025.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/63046.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.192484,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CURN",
        "relevance_score": "0.087985",
        "ticker_sentiment_score": "0.071114",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.174903",
        "ticker_sentiment_score": "0.127539",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.341503",
        "ticker_sentiment_score": "0.315454",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.174903",
        "ticker_sentiment_score": "0.103638",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COR",
        "relevance_score": "0.174903",
        "ticker_sentiment_score": "0.082559",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Surpasses Q2 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2371958/medtronic-mdt-surpasses-q2-earnings-and-revenue-estimates",
    "time_published": "20241119T125502",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) delivered earnings and revenue surprises of 1.61% and 1.75%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default310.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.159581,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.406745",
        "ticker_sentiment_score": "0.175906",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VERU",
        "relevance_score": "0.210579",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why US Futures Are Down Tuesday - Bakkt Hldgs  ( NYSE:BKKT ) , Trump Media & Technology  ( NASDAQ:DJT ) ",
    "url": "https://www.benzinga.com/24/11/42058223/us-stocks-likely-to-open-in-red-as-geopolitical-tension-weigh-on-investor-sentiment-wharton-economist-says-market",
    "time_published": "20241119T113559",
    "authors": [
      "Rounak Jain"
    ],
    "summary": "U.S. stocks could open on a negative note on Tuesday after the averages maintained a cautious stance last week. Futures of all three major indices were slightly down on Tuesday, pointing to a cautious sentiment on Wall Street.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/19/Wall-Street.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Blockchain",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999499"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.053034,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "-0.019952",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "0.306771",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMCI",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "0.090086",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "-0.019001",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "-0.165153",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "BKKT",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "0.098406",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WT",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DJT",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "0.098406",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "-0.165153",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Nasdaq Gains Over 100 Points As Tesla Surges: Investor Sentiment Declines, Fear & Greed Index Remains In 'Neutral' Zone - Tesla  ( NASDAQ:TSLA ) ",
    "url": "https://www.benzinga.com/news/earnings/24/11/42055772/nasdaq-gains-over-100-points-as-tesla-surges-investor-sentiment-declines-fear-greed-index-remains-i",
    "time_published": "20241119T083138",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "The CNN Money Fear and Greed index showed a further decline in the overall market sentiment, while the index remained in the \"Neutral\" zone on Monday. U.S. stocks settled mixed on Monday, with the Nasdaq gaining more than 100 points during the session as the Tesla, Inc.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/19/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": -0.079874,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "WBD",
        "relevance_score": "0.104683",
        "ticker_sentiment_score": "-0.302673",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "0.192242",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "-0.251886",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.104683",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.207571",
        "ticker_sentiment_score": "-0.251886",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Walmart, Lowe's And 3 Stocks To Watch Heading Into Tuesday - Walmart  ( NYSE:WMT ) ",
    "url": "https://www.benzinga.com/news/earnings/24/11/42054723/walmart-lowes-and-3-stocks-to-watch-heading-into-tuesday",
    "time_published": "20241119T063233",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Walmart Inc. WMT to report quarterly earnings at 53 cents per share on revenue of $167.72 billion before the opening bell, according to data ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/19/Walmarts-Thanksgiving-Day-Shutdown-Could.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999483"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.320046,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ACM",
        "relevance_score": "0.373378",
        "ticker_sentiment_score": "0.300783",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.373378",
        "ticker_sentiment_score": "0.487974",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SYM",
        "relevance_score": "0.254307",
        "ticker_sentiment_score": "0.20499",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.373378",
        "ticker_sentiment_score": "0.379129",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Nasdaq Gains 1% Ahead Of Nvidia Earnings: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone - NVIDIA  ( NASDAQ:NVDA ) ",
    "url": "https://www.benzinga.com/news/earnings/24/11/42081160/nasdaq-gains-1-ahead-of-nvidia-earnings-investor-sentiment-improves-fear-greed-index-remains-in-neu",
    "time_published": "20241120T070452",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the \"Neutral\" zone on Tuesday. U.S. stocks settled mixed on Tuesday, with the Nasdaq gaining around 1% during the session as investors shrugged off rising geopolitical concerns ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/20/Market-Sentiment--Fear-And-Greed-Index--.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      }
    ],
    "overall_sentiment_score": 0.063131,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "TGT",
        "relevance_score": "0.18046",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.351807",
        "ticker_sentiment_score": "0.437978",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.18046",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.18046",
        "ticker_sentiment_score": "0.391813",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.090816",
        "ticker_sentiment_score": "-0.101243",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.18046",
        "ticker_sentiment_score": "0.334451",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.18046",
        "ticker_sentiment_score": "0.334451",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 Dividend Stocks I'll Never Sell",
    "url": "https://www.fool.com/investing/2024/11/21/3-dividend-stocks-ill-never-sell/",
    "time_published": "20241121T120000",
    "authors": [
      "George Budwell"
    ],
    "summary": "As a long-term dividend investor, I've learned that the hardest part of investing isn't finding great companies -- it's having the discipline to hold them forever. After years of portfolio optimization, I've identified three dividend stocks with such powerful competitive advantages and consistent ...",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F798471%2Fpassive-income-alternate.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.995077"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.457898,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.181591",
        "ticker_sentiment_score": "0.35786",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "COST",
        "relevance_score": "0.240489",
        "ticker_sentiment_score": "0.360339",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "V",
        "relevance_score": "0.298023",
        "ticker_sentiment_score": "0.317095",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/11/42145869/looking-into-medtronics-recent-short-interest",
    "time_published": "20241122T191527",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has fallen 4.76% since its last report. The company recently reported that it has 10.18 million shares sold short, which is 0.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.93 days to cover their ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1732302924_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "MDT Stock Gains From FDA Approval for Its InPen App",
    "url": "https://www.zacks.com/stock/news/2373906/mdt-stock-gains-from-fda-approval-for-its-inpen-app",
    "time_published": "20241122T141400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic receives an FDA nod for its InPen app, which will help launch the company's Smart MDI system.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.972476"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.207015,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "RMD",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.056559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.056559",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.482982",
        "ticker_sentiment_score": "0.180941",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.254042",
        "ticker_sentiment_score": "0.138195",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors - Abbott Laboratories  ( NYSE:ABT ) , InspireMD  ( NASDAQ:NSPR ) ",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42174671/inspiremd-announces-appointment-of-accomplished-medical-technology-executive-scott-r-ward-to-its-b",
    "time_published": "20241125T210500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "MIAMI, Nov. 25, 2024 ( GLOBE NEWSWIRE ) -- InspireMD, Inc. NSPR, developer of the CGuard\u2122 Embolic Prevention Stent System ( EPS ) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.113022,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.031949",
        "ticker_sentiment_score": "0.009406",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CURN",
        "relevance_score": "0.031949",
        "ticker_sentiment_score": "-0.011736",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NSPR",
        "relevance_score": "0.369228",
        "ticker_sentiment_score": "0.112969",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wearable Patch Market to Expand at a High 7.9% CAGR through 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42158479/wearable-patch-market-to-expand-at-a-high-7-9-cagr-through-2031-skyquest-technology",
    "time_published": "20241125T101001",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Nov. 25, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the wearable patch market size will attain a value of USD 17.09 billion by 2031, with a CAGR of 7.9% over the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.333709,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IRTC",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.057301",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "International Expansion Supports BSX Stock Amid Macroeconomic Woes",
    "url": "https://www.zacks.com/stock/news/2375415/international-expansion-supports-bsx-stock-amid-macroeconomic-woes",
    "time_published": "20241126T145000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "BSX's Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal (GI) and pulmonary treatment options.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.928769"
      }
    ],
    "overall_sentiment_score": 0.220036,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EW",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.060863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.060863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.060863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.47037",
        "ticker_sentiment_score": "0.198467",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.060863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.052674",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.052674",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.060863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.224903",
        "ticker_sentiment_score": "0.125312",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.045569",
        "ticker_sentiment_score": "0.142193",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday - Allstate  ( NYSE:ALL ) , GitLab  ( NASDAQ:GTLB ) ",
    "url": "https://www.benzinga.com/24/11/42190113/starbucks-to-rally-around-13-here-are-10-top-analyst-forecasts-for-tuesday",
    "time_published": "20241126T140736",
    "authors": [],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stifel raised the price target for Semtech Corporation SMTC from $58 to $65.",
    "banner_image": "https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26090422/image-281-1024x583.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99999"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.223893,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ALL",
        "relevance_score": "0.078354",
        "ticker_sentiment_score": "0.059675",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GTLB",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.101556",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.155954",
        "ticker_sentiment_score": "0.082863",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZM",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.22833",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SBUX",
        "relevance_score": "0.306007",
        "ticker_sentiment_score": "0.183342",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.306007",
        "ticker_sentiment_score": "0.194322",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WWD",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.287376",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.21639",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.111012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCAT",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "-0.014433",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HUBB",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.003584",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMTC",
        "relevance_score": "0.232069",
        "ticker_sentiment_score": "0.107668",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Very Healthy Dividend Stocks to Hold for Decades of Income",
    "url": "https://www.fool.com/investing/2024/11/26/2-very-healthy-dividend-stocks-to-hold-for-decades/",
    "time_published": "20241126T111800",
    "authors": [
      "Matt DiLallo"
    ],
    "summary": "Checking a company's vital signs before investing in its stock for dividend income is essential. If the underlying company isn't financially healthy, its dividend probably won't last very long.That won't be a problem with Johnson & Johnson ( NYSE: JNJ ) and Medtronic ( NYSE: MDT ) .",
    "banner_image": "https://g.foolcdn.com/editorial/images/798928/stethoscope-on-money-cash-1200x801-d21b45d.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.316257,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.47672",
        "ticker_sentiment_score": "0.511046",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.063594",
        "ticker_sentiment_score": "0.251518",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.423504",
        "ticker_sentiment_score": "0.330514",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Surgical Robotics Market Size to Reach USD 28.54 Billion by 2031 at 13.7% CAGR| The Insight Partners",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42184464/surgical-robotics-market-size-to-reach-usd-28-54-billion-by-2031-at-13-7-cagr-the-insight-partners",
    "time_published": "20241126T111653",
    "authors": [],
    "summary": "US & Canada, Nov. 26, 2024 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, global surgical robotics market is observing significant growth owing to a surging number of surgical procedures and a growing prevalence of chronic diseases.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/b3dbb4a6-1685-4360-aaf3-1b8f109ec8dd/image1.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.276783,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SNN",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STE",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.111747",
        "ticker_sentiment_score": "0.123577",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.166935",
        "ticker_sentiment_score": "0.151874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.111747",
        "ticker_sentiment_score": "0.151376",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RNSHF",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights",
    "url": "https://www.globenewswire.com/news-release/2024/11/26/2987196/0/en/ONWARD-Medical-Provides-Q3-2024-Update-and-Year-to-Date-Highlights.html",
    "time_published": "20241126T063000",
    "authors": [
      "ONWARD Medical NV"
    ],
    "summary": "Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer Interface ( BCI ) as part of the Company's investigational ARC-BCI System",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/a60261ec-0c66-4acb-8726-e567073990a2",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.216745,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.047844",
        "ticker_sentiment_score": "0.166031",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.023933",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42181037/onward-medical-provides-q3-2024-update-and-year-to-date-highlights",
    "time_published": "20241126T063000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer Interface ( BCI ) as part of the Company's investigational ARC-BCI System",
    "banner_image": "https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.221299,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.046363",
        "ticker_sentiment_score": "-0.033606",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.023191",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "MDT Stock May Gain Following the Positive Data From Optimize PRO Study",
    "url": "https://www.zacks.com/stock/news/2376609/mdt-stock-may-gain-following-the-positive-data-from-optimize-pro-study",
    "time_published": "20241128T155500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic announces new positive data for its Evolut TAVR from the Optimize PRO clinical research.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.280105,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GMED",
        "relevance_score": "0.158173",
        "ticker_sentiment_score": "0.150876",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.358521",
        "ticker_sentiment_score": "0.303961",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MASI",
        "relevance_score": "0.158173",
        "ticker_sentiment_score": "0.111371",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "2 Excellent Healthcare Stocks to Hold Through the Next Decade",
    "url": "https://www.fool.com/investing/2024/11/28/2-excellent-healthcare-stocks-to-hold-through-the/",
    "time_published": "20241128T124500",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies aren't automatically worth investing in just because they provide essential medical services. Only those that can keep up with the changing nature of the industry can hope to deliver ...",
    "banner_image": "https://media.ycharts.com/charts/158051f531e814223a82176fbb2fb53f.png",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      }
    ],
    "overall_sentiment_score": 0.312221,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.118647",
        "ticker_sentiment_score": "0.028266",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.290952",
        "ticker_sentiment_score": "0.202139",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.345674",
        "ticker_sentiment_score": "0.118588",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.059488",
        "ticker_sentiment_score": "0.025",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues",
    "url": "https://www.zacks.com/stock/news/2377105/growing-epd-business-supports-abt-stock-amid-macroeconomic-issues",
    "time_published": "20241129T151500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Abbott has a unique opportunity to scale a capital-efficient licensing model that can help the emerging market population access life-changing medicines.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983605"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      }
    ],
    "overall_sentiment_score": 0.252174,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PEN",
        "relevance_score": "0.100518",
        "ticker_sentiment_score": "0.054133",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.199447",
        "ticker_sentiment_score": "0.338788",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.100518",
        "ticker_sentiment_score": "0.054133",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.050359",
        "ticker_sentiment_score": "0.157271",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.150278",
        "ticker_sentiment_score": "0.115502",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.050359",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medical Robots Market to Witness Massive Growth at USD 34.32 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42243070/medical-robots-market-to-witness-massive-growth-at-usd-34-32-billion-by-2031-skyquest-technology",
    "time_published": "20241129T130000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Nov. 29, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the medical robot market will attain a value of USD 34.32 Billion by 2031, with a CAGR of 17.4 % during the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.288673,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AHKSF",
        "relevance_score": "0.040969",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.040969",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.040969",
        "ticker_sentiment_score": "0.191391",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ASBRF",
        "relevance_score": "0.040969",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Reasons to Retain Medtronic Stock in Your Portfolio Now",
    "url": "https://www.zacks.com/stock/news/2376863/reasons-to-retain-medtronic-stock-in-your-portfolio-now",
    "time_published": "20241129T123800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Investors continue to be optimistic about MDT due to its impressive international expansion. Yet, the dull macroeconomic scenario poses a concern to the company's margins.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.287448,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GMED",
        "relevance_score": "0.152178",
        "ticker_sentiment_score": "0.152463",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.051003",
        "ticker_sentiment_score": "0.122382",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.051003",
        "ticker_sentiment_score": "0.122382",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.051003",
        "ticker_sentiment_score": "0.122382",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.201944",
        "ticker_sentiment_score": "0.123432",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.345674",
        "ticker_sentiment_score": "0.266811",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.201944",
        "ticker_sentiment_score": "0.143241",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Price Over Earnings Overview: Medtronic - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/news/24/12/42301103/price-over-earnings-overview-medtronic",
    "time_published": "20241203T203050",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Looking into the current session, Medtronic Inc. MDT shares are trading at $85.62, after a 1.06% decrease. Over the past month, the stock fell by 4.53%, but over the past year, it actually increased by 8.32%.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1733257847_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.114465,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.330286",
        "ticker_sentiment_score": "0.077333",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Acutus Medical Announces Operational Downsizing - Acutus Medical  ( OTC:AFIB ) ",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42325968/acutus-medical-announces-operational-downsizing",
    "time_published": "20241204T210100",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "CARLSBAD, Calif., Dec. 04, 2024 ( GLOBE NEWSWIRE ) -- Acutus Medical, Inc. ( \"Acutus\" or the \"Company\" ) AFIB, today announced a realignment of resources and operational downsizing.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.172178,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.624636",
        "ticker_sentiment_score": "0.290985",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.037213",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42330185/hemodialysis-and-peritoneal-dialysis-market-to-surpass-valuation-of-usd-142-97-billion-by-2031-sky",
    "time_published": "20241205T003000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Dec. 04, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the global hemodialysis and peritoneal dialysis market size will reach a value of USD 142.97 Billion by 2031, with a CAGR of 6.5% during the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.332516,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAX",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.143597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AHKSF",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.143597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FSNUF",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.143597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.143597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ASBRF",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.143597",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DVA",
        "relevance_score": "0.046816",
        "ticker_sentiment_score": "0.143597",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ISRG Stock Reaches All-Time High: Strength in Uptrend to Continue?",
    "url": "https://www.zacks.com/stock/news/2380078/isrg-stock-reaches-all-time-high-strength-in-uptrend-to-continue",
    "time_published": "20241206T135200",
    "authors": [
      "Indrajit Bandyopadhyay"
    ],
    "summary": "Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The has stock also gained during the past month. Let's see if the trend might change.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/61/11728.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.345928,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.057767",
        "ticker_sentiment_score": "0.297062",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.33628",
        "ticker_sentiment_score": "0.423558",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.057767",
        "ticker_sentiment_score": "0.297062",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Reasons to Retain ZBH Stock in Your Portfolio for Now",
    "url": "https://www.zacks.com/stock/news/2380074/reasons-to-retain-zbh-stock-in-your-portfolio-for-now",
    "time_published": "20241206T135000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zimmer Biomet's robust efforts to expand market share and a gradually stabilizing musculoskeletal market appear promising.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.96136"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.308749,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.294682",
        "ticker_sentiment_score": "0.255588",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.050254",
        "ticker_sentiment_score": "0.135817",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GMED",
        "relevance_score": "0.149966",
        "ticker_sentiment_score": "0.151132",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.050254",
        "ticker_sentiment_score": "0.135817",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.199037",
        "ticker_sentiment_score": "0.122077",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.050254",
        "ticker_sentiment_score": "0.135817",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.199037",
        "ticker_sentiment_score": "0.141674",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Reasons to Retain TNDM Stock in Your Portfolio for Now",
    "url": "https://www.zacks.com/stock/news/2380054/reasons-to-retain-tndm-stock-in-your-portfolio-for-now",
    "time_published": "20241206T134600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Innovations and a robust international market expansion raise investors' optimism for Tandem Diabetes.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.319845,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GMED",
        "relevance_score": "0.144853",
        "ticker_sentiment_score": "0.148114",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TNDM",
        "relevance_score": "0.144853",
        "ticker_sentiment_score": "0.229469",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.19231",
        "ticker_sentiment_score": "0.118958",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PODD",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.068777",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.048523",
        "ticker_sentiment_score": "0.068777",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.19231",
        "ticker_sentiment_score": "0.138069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.096866",
        "ticker_sentiment_score": "0.249956",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Microwave Ablation Devices Market to Surpass $1 Billion by 2034 Driven by Advances in Cancer Treatment | Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42360622/microwave-ablation-devices-market-to-surpass-1-billion-by-2034-driven-by-advances-in-cancer-treatm",
    "time_published": "20241206T115500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc.-, Dec. 06, 2024 ( GLOBE NEWSWIRE ) -- Microwave ablation ( MWA ) technology represents a groundbreaking approach to tumor treatment, utilizing microwave energy to generate heat and effectively destroy cancerous tissues.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/d17701f1-fb17-48dd-ba9d-d221f09c9531/microwave-ablation-devices-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.327902,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.032164",
        "ticker_sentiment_score": "0.052265",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "0.18839",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.050858",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.064276",
        "ticker_sentiment_score": "0.18839",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "2 Healthcare Dividend Stocks to Hold for the Long Haul",
    "url": "https://www.fool.com/investing/2024/12/07/2-healthcare-dividend-stocks-to-hold-for-the-long/",
    "time_published": "20241207T141700",
    "authors": [
      "Prosper Junior Bakiny"
    ],
    "summary": "Investors looking for stocks to hold on to for a while might want to consider dividend-paying companies. Besides offering a regular stream of passive income, dividend stocks have generally outperformed their non-dividend peers over the long run.That's not surprising.",
    "banner_image": "https://g.foolcdn.com/editorial/images/799933/pharmacist-talking-to-patient.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      }
    ],
    "overall_sentiment_score": 0.245949,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.363388",
        "ticker_sentiment_score": "0.160467",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting",
    "url": "https://www.globenewswire.com/news-release/2024/12/09/2993627/0/en/Orchestra-BioMed-Announces-AVIM-Therapy-Program-Presentations-at-ICI-Meeting.html",
    "time_published": "20241209T120000",
    "authors": [
      "Orchestra BioMed Holdings",
      "Inc."
    ],
    "summary": "NEW HOPE, Pa., Dec. 09, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, \"Orchestra BioMed\" or the \"Company\" ) , a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced two presentations ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/00697d05-bd34-4570-822b-f204caf21694",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.071614,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.03458",
        "ticker_sentiment_score": "0.140849",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.03458",
        "ticker_sentiment_score": "0.088251",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.303592",
        "ticker_sentiment_score": "0.168703",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.03458",
        "ticker_sentiment_score": "0.088251",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - Orchestra BioMed Hldgs  ( NASDAQ:OBIO ) ",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42386086/orchestra-biomed-announces-avim-therapy-program-presentations-at-ici-meeting",
    "time_published": "20241209T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW HOPE, Pa., Dec. 09, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc.",
    "banner_image": "https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.083428,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NHPEF",
        "relevance_score": "0.032916",
        "ticker_sentiment_score": "0.131203",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.032916",
        "ticker_sentiment_score": "0.084763",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OBIO",
        "relevance_score": "0.32014",
        "ticker_sentiment_score": "0.21506",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.032916",
        "ticker_sentiment_score": "0.084763",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Soft Tissue Anchor Market is Projected to Reach US$ 8.7 Billion with Growing at 5.3% CAGR by 2034 | Fact.MR Report",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42434052/soft-tissue-anchor-market-is-projected-to-reach-us-8-7-billion-with-growing-at-5-3-cagr-by-2034-fa",
    "time_published": "20241211T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Dec. 11, 2024 ( GLOBE NEWSWIRE ) -- The global soft tissue anchors market is expanding significantly in tandem with rapid technological breakthroughs in the medical field.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/3454ef66-490b-4066-8b14-e4b019c0cbdc/soft-tissue-anchor-market.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.320565,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.081001",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.081001",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IART",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.040553",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes",
    "url": "https://www.zacks.com/stock/news/2382700/innovations-and-buyouts-support-bsx-stock-amid-macroeconomic-woes",
    "time_published": "20241212T142600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.990678"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.875462"
      }
    ],
    "overall_sentiment_score": 0.209215,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EW",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.06077",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNN",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.06077",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.06077",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.46494",
        "ticker_sentiment_score": "0.128537",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.06077",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PEN",
        "relevance_score": "0.134339",
        "ticker_sentiment_score": "0.090351",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PAHC",
        "relevance_score": "0.089797",
        "ticker_sentiment_score": "0.052721",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.06077",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.134339",
        "ticker_sentiment_score": "0.108445",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AXNX",
        "relevance_score": "0.04497",
        "ticker_sentiment_score": "0.146008",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "TransMedics Stock Plunges 57.5% in Three Months: What's Next?",
    "url": "https://www.zacks.com/stock/news/2383547/transmedics-stock-plunges-575-in-three-months-whats-next",
    "time_published": "20241213T171700",
    "authors": [
      "Debanjana Dey"
    ],
    "summary": "TMDX is enhancing its current focus on making meaningful progress across each of its growth initiatives. However, macro challenges are likely to hurt its performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.254218,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.114137",
        "ticker_sentiment_score": "-0.017215",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMDX",
        "relevance_score": "0.58401",
        "ticker_sentiment_score": "0.407278",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.076236",
        "ticker_sentiment_score": "-0.01538",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.114137",
        "ticker_sentiment_score": "-0.017215",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Air Products Files Investor Presentation Highlighting Successful Two-Pillar Strategy to Deliver Superior Shareholder Value - Air Products & Chemicals  ( NYSE:APD ) ",
    "url": "https://www.benzinga.com/pressreleases/24/12/n42564837/air-products-files-investor-presentation-highlighting-successful-two-pillar-strategy-to-deliver-su",
    "time_published": "20241218T214000",
    "authors": [
      "PRNewswire"
    ],
    "summary": "The Company's Board and Management, Under Chairman and CEO Seifi Ghasemi's Leadership, Have Delivered Over $44 Billion in Shareholder Value Creation1 Continues to Successfully Execute Two-Pillar Growth Strategy to Grow Core Industrial Gas Business While Capitalizing on First-Mover Advantage in ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999499"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.236888,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "META",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "0.086543",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRBO",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "0.086543",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMAWF",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TTE",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "0.107899",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DLTR",
        "relevance_score": "0.024446",
        "ticker_sentiment_score": "-0.021371",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EMR",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "0.117504",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AIQUF",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BWA",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "-0.146837",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARMK",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "0.009789",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "0.086175",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TYNPF",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "0.014104",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "X",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "0.085019",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "-0.067495",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SO",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "-0.042428",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FPH",
        "relevance_score": "0.00815",
        "ticker_sentiment_score": "0.164064",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PSHZF",
        "relevance_score": "0.016299",
        "ticker_sentiment_score": "0.175904",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "BSX Trades Near 52-Week High: Does the Stock Hold More Potential?",
    "url": "https://www.zacks.com/stock/news/2385371/bsx-trades-near-52-week-high-does-the-stock-hold-more-potential",
    "time_published": "20241218T155200",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/1076.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999864"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      }
    ],
    "overall_sentiment_score": 0.268113,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.099504",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.488161",
        "ticker_sentiment_score": "0.333015",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Surgical Robots Market to Exceed US$ 20.8 Bn by 2031 Amid Soaring Demand for Precision-Driven Minimally Invasive Surgeries - TMR",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42552434/global-surgical-robots-market-to-exceed-us-20-8-bn-by-2031-amid-soaring-demand-for-precision-drive",
    "time_published": "20241218T133418",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, Transparency Market Research Inc., Dec. 18, 2024 ( GLOBE NEWSWIRE ) -- Rising Demand for Surgical Robots: A Game-Changer for the Healthcare Industry",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/a23bc600-26b3-45fd-a35f-44e0dee378a1/surgical-robots-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.321728,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.054561",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBH",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.330676",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ARAY",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.330676",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.229239",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.085936",
        "ticker_sentiment_score": "0.186666",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ISRG",
        "relevance_score": "0.085936",
        "ticker_sentiment_score": "0.231148",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "RNSHF",
        "relevance_score": "0.04303",
        "ticker_sentiment_score": "0.330676",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.128592",
        "ticker_sentiment_score": "0.027156",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Infusion Pump Market is expected to generate a revenue of USD 24.09 Billion by 2031, Globally, at 6% CAGR: Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/12/g42592789/infusion-pump-market-is-expected-to-generate-a-revenue-of-usd-24-09-billion-by-2031-globally-at-6-",
    "time_published": "20241219T150000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Jersey City, New Jersey, Dec. 19, 2024 ( GLOBE NEWSWIRE ) -- The Global Infusion Pump Market Size is projected to grow at a CAGR of 6.0% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/aa09b8da-ab48-4c35-94b5-7899236d636c/global-infusion-pump-market-size-and-forecast-1024x576.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.300349,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "FSNUF",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.077783",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MOG-A",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ICUI",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.026503",
        "ticker_sentiment_score": "0.007458",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?",
    "url": "https://www.zacks.com/stock/news/2386414/medtronic-stock-declines-56-in-a-month-time-to-buy-the-dip",
    "time_published": "20241220T154400",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "MDT stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5e/1093.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      }
    ],
    "overall_sentiment_score": 0.058709,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.594341",
        "ticker_sentiment_score": "0.128564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.201944",
        "ticker_sentiment_score": "-0.119756",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 BNY Mellon Mutual Funds to Enhance Your Portfolio Performance",
    "url": "https://www.zacks.com/stock/news/2386117/3-bny-mellon-mutual-funds-to-enhance-your-portfolio-performance",
    "time_published": "20241220T115300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in BNY Mellon mutual funds like DREVX, MPISX and DLDRX for diversified growth and data-driven strategies.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6a/353.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.989041"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.36376,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.050144",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.050144",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.050144",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSCO",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.050144",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "T",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.050144",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEM",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.053155",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EQT",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.053155",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FCX",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.053155",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.069094",
        "ticker_sentiment_score": "0.050144",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Medtronic's Recent Short Interest - Medtronic  ( NYSE:MDT ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/12/42675366/looking-into-medtronics-recent-short-interest",
    "time_published": "20241224T193021",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Medtronic's MDT short percent of float has fallen 16.13% since its last report. The company recently reported that it has 10.01 million shares sold short, which is 0.78% of all regular shares that are available for trading.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1735068618_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "4 Dividend Stocks to Double Up on Right Now",
    "url": "https://www.fool.com/investing/2024/12/25/4-dividend-stocks-to-double-up-on-right-now/",
    "time_published": "20241225T151500",
    "authors": [
      "Selena Maranjian"
    ],
    "summary": "You can pat yourself on the back if you're thinking of loading up your portfolio with dividend-paying stocks -- because they're surprisingly strong wealth builders. ( If you weren't thinking of doing so, you can start now! ) Dividend payers aren't slouches. They're not sleepy stocks only suitable ...",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F801804%2Fgetty-happy-person-in-sunglasses-smiling.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.998333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.714479"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.291418,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NVDA",
        "relevance_score": "0.05833",
        "ticker_sentiment_score": "0.121185",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.230235",
        "ticker_sentiment_score": "0.219967",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.173749",
        "ticker_sentiment_score": "-0.027257",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "O",
        "relevance_score": "0.173749",
        "ticker_sentiment_score": "0.154137",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Is Abbott Stock Worth Buying at a Discounted P/S Valuation?",
    "url": "https://www.zacks.com/stock/news/2388392/is-abbott-stock-worth-buying-at-a-discounted-ps-valuation",
    "time_published": "20241226T160000",
    "authors": [
      "Urmimala Biswas"
    ],
    "summary": "Abbott's strong market position, promising growth prospects and consistent share gains make it a compelling pick for investors.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.5855"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.298173,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.120185",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Medtronic  ( MDT )  Stock Moves -1.05%: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2389029/medtronic-mdt-stock-moves--105-what-you-should-know",
    "time_published": "20241227T225018",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Medtronic (MDT) closed the most recent trading day at $80.74, moving -1.05% from the previous trading session.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default70.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.108559,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.606946",
        "ticker_sentiment_score": "0.195983",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Growing Biosimilars Business, New Partnerships Support ABT Stock",
    "url": "https://www.zacks.com/stock/news/2388694/growing-biosimilars-business-new-partnerships-support-abt-stock",
    "time_published": "20241227T134600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/db/2802.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.983783"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      }
    ],
    "overall_sentiment_score": 0.221679,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PEN",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.056567",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.102449",
        "ticker_sentiment_score": "0.056567",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.203215",
        "ticker_sentiment_score": "0.264128",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.161439",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.153145",
        "ticker_sentiment_score": "0.076075",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FOREX:EUR",
        "relevance_score": "0.05133",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Dividend Stocks to Double Up on Right Now",
    "url": "https://www.fool.com/investing/2024/12/28/3-dividend-stocks-to-double-up-on-right-now/",
    "time_published": "20241228T133000",
    "authors": [
      "Royston Yang"
    ],
    "summary": "If you are an avid dividend investor, here are three attractive dividend stocks you should accumulate now.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F802130%2Fworker-welding-oil-pipeline.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.340962,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDT",
        "relevance_score": "0.242199",
        "ticker_sentiment_score": "0.230874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GD",
        "relevance_score": "0.242199",
        "ticker_sentiment_score": "0.273364",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ITW",
        "relevance_score": "0.208464",
        "ticker_sentiment_score": "0.218158",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More",
    "url": "https://www.zacks.com/stock/news/2389273/5-top-ai-in-medtech-stocks-for-big-gains-in-2025-mdt-bsx-more",
    "time_published": "20241230T122600",
    "authors": [
      "Indrajit Bandyopadhyay"
    ],
    "summary": "Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/31/74133.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      }
    ],
    "overall_sentiment_score": 0.502738,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GEHC",
        "relevance_score": "0.19931",
        "ticker_sentiment_score": "0.33893",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.263586",
        "ticker_sentiment_score": "0.41656",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TEM",
        "relevance_score": "0.166628",
        "ticker_sentiment_score": "0.283136",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.231647",
        "ticker_sentiment_score": "0.379949",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.166628",
        "ticker_sentiment_score": "0.28046",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3 American Century Investments Mutual Funds for Higher Returns",
    "url": "https://www.zacks.com/stock/news/2389783/3-american-century-investments-mutual-funds-for-higher-returns",
    "time_published": "20241231T101500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Consider investing in American Century Investments mutual funds like ALVDX, BGEIX and BULIX for long-term returns.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ad/591.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      }
    ],
    "overall_sentiment_score": 0.260052,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZIJMY",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.047412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CEG",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.050442",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.051452",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEM",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.047412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AEM",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.047412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DUK",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.051452",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.051452",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SO",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.050442",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEE",
        "relevance_score": "0.075397",
        "ticker_sentiment_score": "0.050442",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  }
]